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Abstract 
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune condition affecting multiple 
body systems. Murine models of RA are vital in progressing understanding of the disease. The 
severity of arthritis symptoms is currently assessed in vivo by observations and subjective 
scoring which are time-consuming and prone to bias and inaccuracy. 
 
The main aim of this thesis is to determine whether multispectral imaging of murine arthritis 
models has the potential to assess the severity of arthritis symptoms in vivo in an objective 
manner. Given that pathology can influence the optical properties of a tissue, changes may be 
detectable in the spectral response.  
 
Monte Carlo modelling of reflectance and transmittance for varying levels of blood volume 
fraction, blood oxygen saturation, and water percentage in the mouse paw tissue 
demonstrated spectral changes consistent with the reported/published physiological markers 
of arthritis. Subsequent reflectance and transmittance in vivo spectroscopy of the hind paw 
successfully detected significant spectral differences between normal and arthritic mice. Using 
a novel non-contact imaging system, multispectral reflectance and transmittance images were 
simultaneously collected, enabling investigation of arthritis symptoms at different anatomical 
paw locations. In a blind experiment, Principal Component (PC) analysis of four regions of the 
paw was successful in identifying all 6 arthritic mice in a total sample of 10. The first PC scores 
for the TNF dARE arthritis model were found to correlate significantly with bone erosion ratio 
results from microCT, histology scoring, and the manual scoring method. In a longitudinal study 
at 5, 7 and 9 weeks the PC scores identified changes in spectral responses at an early stage 
in arthritis development for the TNF dARE model, before clinical signs were manifest.  
 
Comparison of the multispectral image data with the Monte Carlo simulations suggest that in 
this study decreased oxygen saturation is likely to be the most significant factor differentiating 
arthritic mice from their normal littermates. 
 
The results of the experiments are indicative that multispectral imaging performs well as an 
assessor of arthritis for RA models and may outperform existing techniques. This has 
implications for better assessment of preclinical arthritis and hence for better experimental 
outcomes and improvement of animal welfare. 
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1 
1 Introduction 
 
This thesis reports the results of investigating the use of multispectral imaging (MI) for 
the assessment of mouse models of rheumatoid arthritis. A non-invasive imaging 
technology which allowed objective assessment of physiological changes could be 
very useful in extending the efficacy of in vivo studies by staging the development of 
arthritis symptoms more accurately. MI has several inherent advantages over 
alternative methods of in vivo imaging.  Visible and near-infrared (NIR) radiation is non-
ionising and non-damaging (providing the light intensity is kept within a certain limit). 
The equipment is generally relatively cheap and no extra clinical procedures are 
necessary such as the injections required for contrast enhancement. MI has good 
spatial and good spectral resolution, which is useful in the case of small and 
heterogeneous tissues like the mouse hind paw. The mouse hind paw is a thin tissue 
of approximately 2–3 mm depth making it suitable for both reflectance and 
transmission imaging regimes across the visible and NIR spectrum, as light should 
traverse the tissues relevant to the symptoms of joint inflammation. Spectral imaging 
gives information about physiological changes in the tissue which may precede the 
structural changes imaged by traditional imaging methods. Multispectral imaging could 
be useful in its own right but could also be potentially used as an adjunct to other optical 
imaging methods. 
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Aims  
 Assess whether arthritis causes detectable changes in the visible and NIR infrared 
region of the spectrum by modelling the observed changes in line with quantitative 
changes cited in literature.  
 Build a multispectral imaging system for the purpose of imaging mouse feet in the 
visible and NIR wavelengths.  
 Correlate spectral changes with other indicators of arthritis damage.  
 Establish the credentials of this technique as a possibility for monitoring mouse 
health. 
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2 Background  
 
This chapter presents the background material covering the following areas of this 
interdisciplinary work: The medical background, pathophysiology of rheumatoid 
arthritis (RA), together with the changes induced by disease that impact the optical 
properties of tissue (section 2.1 and 2.2). Current methods of imaging utilized in clinical 
and research settings are outlined and used to set developing optical imaging 
modalities in context (section 2.3). Mouse models of RA are introduced and described 
in terms of their role in RA research and the methods used to assess mouse arthritis 
symptoms (sections 2.4 and 2.5). The physics background introduces the basic 
concepts of light interaction with tissue and the modelling techniques used for 
simulation of radiative transfer (section 2.6). Finally, an introduction to multispectral 
imaging is provided (section 2.7). 
2.1 Rheumatoid Arthritis Pathology 
The following section gives background on the development of RA, the timeline of the 
symptoms of the disease, and the pathophysiology of disease progression.     
2.1.1 The Immune System and Autoimmune Disease 
Rheumatoid arthritis is believed to be an autoimmune disease, arising from 
deregulation of the hosts immune defence system where it mistakes components of 
the body’s own tissues for a foreign antigen and attempts to attack and eliminate it as 
it would for an invading pathogen. The inappropriate recognition of the host tissues 
causes an inflammatory response that damages the affected area progressively over 
time, often irreparably, and continues throughout the lifetime of the host.  
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The mammalian immune system comprises the innate immune system and the 
adaptive immune system. The innate immune system responds to a set number of 
highly conserved pathogenic moieties, whereas the adaptive immune system is flexible 
and has the potential to recognise and respond to any foreign antigen. It is essential 
for resistance to infection and is responsible for immune memory. In the case of 
infection, specialised immune cells of the adaptive immune system coordinate a 
pathogen-specific response by recognising foreign molecules present on the surface 
of invading pathogens and initiating an inflammatory response to destroy them. In 
rheumatoid arthritis, this protective process turns against the host, inappropriately 
recognising and attacking the native tissues.  
 
Developing adaptive immune cells undergo a random genetic mutation process that 
allows them to recognise a potentially infinite array of molecules, including ‘self’ 
molecules present in the hosts own body. Normally, these self-recognising cells are 
deactivated or destroyed in the developmental process, but in the case of autoimmune 
disease, they escape detection and become activated, driving an inflammatory 
response against the host’s own tissues (1).  
2.1.2 Clinical Presentation and Progression of Rheumatoid Arthritis 
Rheumatoid arthritis is predominantly a disease of the joints. Early RA is characterised 
by pain, swelling, redness and stiffness in one or several articular joints, which is 
generally worse in the mornings or following periods of rest. RA most often arises in 
middle age and has a noticeable gender bias towards women with 75% of sufferers 
being female (2).  Diagnosis follows a series of clinical tests and physical examinations 
where the affected joints will be examined individually by clinicians and blood tests will 
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be taken looking for markers of inflammation. The early symptoms do not guarantee 
full development of RA. In approximately 50% of cases, the symptoms will 
spontaneously resolve (3). However, for the patients who go on to develop RA, early 
diagnosis is an important factor in the successful symptom management and 
treatment, and therefore highly influential in patient prognosis (4). Whilst it cannot 
currently be cured, targeting early disease with disease modifying anti-rheumatic drugs 
(DMARDs) and biologics is known to slow the progression of joint damage over time. 
Other treatments focus on management of pain and inflammation, with steroids or non-
steroidal anti-inflammatory drugs (NSAIDs).  
2.1.3 The Structure of the Synovial Joint 
Joints allow flexibility and movement of the skeleton. Some joints such as those in the 
spine or skull are semi-flexible or fixed, but the majority of joints are formed where two 
or more bones meet and articulate to allow for mobility and motion. These are known 
as synovial joints (see Figure 1), eponymously named for the synovial cells which line 
the joint capsule, forming a tough, fibrous membrane enclosing the joint space that 
produces synovial fluid. The two ends of the bone are covered in smooth cartilage 
presenting a low friction interface, lubricated by the fluid that fills the cavity. Figure 1 
presents the general structure of the synovial joint.  
2.1.4 The Development and Pathophysiology of Rheumatoid Arthritis 
In early RA, inflammation begins in the synovial membrane. The synovial cells normally 
form a thin layer one to three cells thick and function as a nutrient source for the 
avascular cartilage tissue via the production of synovial joint fluid. However, in RA, 
proliferation of the synovial cells and infiltration of activated immune cells into the joint 
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Figure 1: Schematic diagram of the typical structure of a synovial joint.  The articular capsule surrounds the joint 
but in the diagram has been cut in half to show the synovial tissue lining the capsule and the cartilage covered 
articulating surfaces of the bones. Arrows indicate different tissue types.  
 
tissues causes hyperplasia of the membrane, thickening the synovium by around 10 
times (5). Outwardly, symptoms of pain, swelling and redness occur in affected joints. 
During the inflammatory response the synovial fluid may increase in volume, decrease 
in viscosity, and vastly increase in immune cell count. However, the cartilage and bone 
typically remain intact through the early stages of disease rendering radiographic 
imaging negative of signs of arthritis (6). At this early stage one or several joints can 
be involved, usually the small joints of the hands and feet.  
 
Persistent synovitis, or synovial inflammation, of over 12 weeks duration is known to 
be the strongest predictor of full rheumatoid arthritis development (7). As the early 
stages of disease pathology progress, high metabolic demands of the hyperplastic 
synovium and immune cell infiltrate lower the oxygen tension in the joint triggering 
angiogenic processes to form new vasculature. Synovial cells continue to proliferate 
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and assume a more aggressive fibroblastic phenotype (8). The thickened synovium, 
also known as the pannus, begins to invade the joint space and destroy the underlying 
cartilage and bone (see Figure 2). Consequently, the joint space narrows and mobility 
can be reduced. Pain and swelling may persist and patients may experience general 
malaise, weakness, muscle atrophy, and morning joint stiffness that lasts for several 
hours. Often joint involvement is symmetric across the body.  
 
The symptoms of joint inflammation continue as the disease progresses, often arising 
in episodes of acute flare-ups where joints will temporarily become more swollen 
before symptoms abate in a period of remission. The underlying damage to the hard 
tissues of the joints progresses both through and between these episodes and the 
joints can become progressively more deformed, limiting the range of movement. 
Erosion of periarticular bone is a typical feature observed in advanced rheumatoid 
arthritis patients by radiographic imaging methods. In a healthy individual, bone 
remodelling is a tightly regulated process which preserves bone integrity over time. 
Cells which form bone (osteoblasts) and cells which resorb bone (osteoclasts) are 
responsible for maintaining bone homeostasis. There is a known regulative association 
between the immune system and bone remodelling (9), a process which becomes 
disrupted in RA and tipped in favour of bone erosion. Inflammatory processes have a 
role in triggering bone erosion through osteoclast activation. Synovitis as well as 
osteitis correlate with the degree of radiographic bone erosion (10,11). Bone erosions 
are most observed at the interface between the synovium and the bone, where 
osteoclasts are known to gather. Bone erosion is an important feature in RA monitoring 
because increased erosion results in a more severe disease course. In the later stages 
of the disease, permanent damage to the bone structure and cartilage can lead to loss 
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of joint function. Figure 2 shows a representation of the changes which occur in the 
joint during RA. 
 
 
Figure 2: Schematic diagram showing the morphologic changes which typically occur with rheumatoid arthritis. The 
rheumatoid joint on the right of the image displays hypertrophic expansion of the synovial lining, along with bone 
and cartilage erosion and increased turbidity of the synovial fluid. These RA symptoms typically occur in mid to late 
stage RA.  
 
The chronic inflammation associated with RA can also lead to extra-articular 
manifestations of the disease. Many of the body’s systems can be affected including 
the pulmonary system, the circulatory system, and the skin and eyes. These extra-
articular manifestations are ultimately the cause of increased mortality and a major 
predictor of decreased life span (12).   
2.2 Optically Relevant Variation in Rheumatoid Arthritis 
Inflammatory conditions in the rheumatoid joint are thought to change the 
concentrations of biological chromophores present in the articular and periarticular 
tissues. Evidence for the changes in concentration of biological chromophores is 
discussed below.  
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2.2.1 Hypoxia 
Hypoxia refers to the state of insufficient oxygenation in the tissues and is known to 
occur in conjunction with inflammation. In the rheumatoid joint, the high metabolic 
demands of immune cell influx and the phenotypically altered, hypertrophic synovium 
is known to result in a decrease of dissolved oxygen in the joint tissues (13). Oxygen 
probes in the form of spectrometers coupled to optically active chemical sensors can 
directly measure the partial pressure of dissolved oxygen in mmHg. Oxygen partial 
pressure has been measured as 63mmHg in healthy finger joints compared to 27 
mmHg in RA (14) and has more recently been measured as 22.5mmHg in the affected 
synovium (15). Crucially, the partial pressure of oxygen was shown to correlate with 
markers of inflammation (15), indicating that hypoxia may correlate with disease 
severity. This property of RA is relevant to optical imaging because hypoxia in the 
tissue is thought to reduce the ratio of oxygenated haemoglobin to deoxygenated 
haemoglobin, two biological chromophores with differing absorption spectra (described 
in section 2.6.3.2). However, whilst low partial pressure of oxygen will induce lower 
haemoglobin oxygen saturation in the surrounding tissue, exact values of haemoglobin 
oxygen saturation are difficult to measure in vivo. Blood oxygen level dependent 
(BOLD) MRI exploits the differing magnetic properties of haemoglobin in its 
oxygenated and deoxygenated forms and shows decreased signal in rheumatoid joints 
indicative of decreased oxygenation in the microvasculature of rabbit models of arthritis 
(16). In modelling the rheumatoid finger joint Milanic et al. (17) used values of 95% 
saturation for the healthy joint and 48% saturation for the rheumatoid synovium, which 
correspond to the oxygen partial pressure values mentioned above according to the 
haemoglobin saturation curve. Microscopic multispectral imaging of tendon 
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microvasculature in a model of murine RA has measured haemoglobin oxygen 
saturation as 94.8 ± 7.0 % for healthy mice and 84.0 ± 13.5 % for inflamed (18). Overall 
there is reasonable evidence to suggest that hypoxia occurs in the rheumatoid joint 
and that the haemoglobin oxygen saturation of the local tissues reduces, giving it the 
potential to change the bulk optical properties of rheumatoid tissue.   
2.2.2 Blood Volume Fraction 
Angiogenesis in the rheumatoid synovium happens in response to inducible factors 
which are released under hypoxic conditions. There is a marked increase in the 
expression of cellular factors related to hypoxia (19), such as Hypoxia Inducible Factor 
(HIF-1), which activates genes associated with the formation of new vasculature (20). 
In RA, the new vasculature fails to restore normoxia and the joint environment remains 
hypoxic (13). The formation of new blood vessels brings increased blood flow to the 
tissue, therefore increasing optical absorption. Biopsy of synovial tissue shows a high 
proportion of vessels expressing neovascular markers, which is evident even in early 
disease (21). The degree of synovial vascularity is evidently important in disease 
pathogenesis as Power Doppler assessment of the synovial vascularity correlates well 
with radiographic damage (22). Using microCT to measure vascularisation in the knee 
joints of human TNF transgenic mice perfused with lead containing contrast agent, the 
vessel volume per tissue volume was seen to increase in 4 concentric, spherical 
volumes of interest surrounding the synovial cavity, excepting the 1st ROI containing 
the area immediately around the joint (23). The results of this paper by Gayetskyy et 
al. suggest that blood volume fraction (BVF) increases in the joint tissue and 
periarticular tissue due to angiogenesis by approximately 60 – 70%, although the 
immediate synovial area can be seen to decrease. This is hypothesised to be because 
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although vascularisation increases overall, the healthy synovium has better 
vascularisation which decreases as the synovium hypertrophies, contributing to 
hypoxia.  
2.2.3 Oedema 
Rheumatoid arthritis symptoms result in local swelling of the joints. In inflammatory 
conditions, the endothelial barrier of local blood vessels becomes disrupted and 
vasodilation increases blood flow to the tissue, increasing the outflux of fluid and the 
extravasation of immune cells into the interstitial space (24). In the majority of mouse 
models of RA, some form of oedema is evident in the paws as an increase in the 
volume with symptom development. Given that oedema represents an increase in the 
tissue volume of water, which has increased absorption coefficients in the longer NIR 
wavelengths, it is potentially detectable by optical imaging methods. In a paper by 
Perilli et al. measuring soft tissue volume increase with microCT, collagen antibody-
induced arthritis (CAIA) mice have an average paw volume increase of 36% (25).  
2.3 Imaging of Rheumatoid Arthritis  
A window of opportunity occurs in RA for the targeting of novel drugs which slow the 
early progression of disease. With the development of these drugs and the increasing 
emphasis on early diagnosis, traditional clinical imaging methods are becoming 
inadequate for detection of early pathology. This has led to increasing interest in the 
development of novel imaging modalities targeting early disease. Outlined below are 
some of the clinical techniques for imaging RA pathology, along with more recently 
developed techniques aimed at detecting changes in the developmental stages.  
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2.3.1 Radiographic Imaging 
Imaging has proved a useful addition to clinical examination in rheumatoid arthritis 
diagnosis and management, improving the accuracy of assessment of inflammation 
(26). Planar radiographic imaging is commonly used in the assessment of RA in the 
hands and feet. It is cheap, quick, and can provide longitudinal imaging of the 
progression of bone erosion and joint space narrowing (figure 3a). Computed 
Tomography (CT) is thought to be the most sensitive imaging technique for detection 
of bone erosions but is rarely in clinical use (27). One crucial drawback of radiographic 
imaging, however, is that early disease is characterised by synovitis before bone 
erosion occurs which cannot be detected by x-ray imaging. Deformation of the hard 
tissue is mostly confined to the later stages of disease and therefore radiographic 
imaging is rarely informative in the diagnostic and early stages of RA. The increasing 
focus on early diagnosis and treatment has lead to greater use of alternative imaging 
techniques in clinical assessment. Magnetic resonance imaging (MRI) and ultrasound 
sonography (US) and are used increasingly in clinical practice to assess soft tissue 
morphology.  
2.3.2 Magnetic Resonance Imaging 
Magnetic resonance imaging (MRI), where images are taken by exploiting the 
magnetic properties of hydrogen atoms in the tissue, is also able to detect the soft 
tissue changes occurring in early RA. Contrast-enhanced MRI (figure 3b) is able to 
detect all of the physiological changes that can be seen in US, but in addition can 
detect bone marrow oedema, a symptom of RA known to be the strongest predictor of 
radiographic disease progression (10). Disadvantages associated with MRI are low 
availability of facilities and long waiting times, high cost of imaging, and 
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contraindications of imaging due to the magnetic field. The imaging resolution is 
comparatively low when compared to US and administration of contrast agent is 
generally required for distinction of the synovial tissue from the joint space (28).  
2.3.3 Ultrasound Imaging 
Ultrasound sonography (US) is able to form images of soft tissues where there is an 
acoustic window into the tissue (figure 3c). The images are formed by the variation in 
the reflections of ultrasound waves from the different tissues types, providing more 
information about soft tissue pathologies than conventional radiographic imaging. 
Ultrasound imaging of the joints can detect synovial hypertrophy, tenosynovitis, bone 
erosion, and cartilage thinning. It can also be used for guiding invasive procedures 
such as biopsy and injections that are often a part of diagnosis and treatment. US is 
relatively low cost, non-ionising, and informative. However, it is disadvantaged by low 
availability of ultrasound operators, inter-operator variability, inaccessibility of imaging 
to tissue beyond the bone, and difficulty with longitudinal imaging assessment. Scoring 
methods for assessment of symptoms have been introduced to reduce inter-operator 
variability with some success (29). Power Doppler imaging, where Doppler signals in 
the ultrasound are amplified for the detection of moving material, is able to detect 
increased vascularisation in the inflamed synovium even in joints deemed in remission 
by clinical examination (30).  
2.3.4 Nuclear Imaging  
Alternative imaging techniques have been investigated in the imaging of early and 
established rheumatoid arthritis but are currently rarely in clinical use. Nuclear imaging 
techniques like bone scintigraphy, single-photon emission computed tomography 
(SPECT) and positron emission tomography (PET), produce images by targeting 
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radiotracers to molecular markers associated with inflammation in the joints, but suffer 
from high cost, low availability, low resolution, and ionising radiation. Research 
continues to develop new radioisotopes targeting novel cellular markers of 
inflammatory activity in order to increase its viability as a clinical imaging method 
(31,32).  
2.3.5 Optical Imaging 
In a research environment, several experimental optical imaging techniques have been 
applied to the problem of imaging inflammation in rheumatic joints. The most common 
approach relates to the imaging of non-specific near-infrared fluorescent (NIRF) dye, 
indocyanine green, for the detection of synovitis through increased NIRF concentration 
in areas of ‘leaky’ blood vessels in inflamed tissues (figure 3d). Methods of imaging 
with NIRF dyes have been found to be relatively as successful as MRI and US in the 
detection of synovitis (33,34), but this finding is contested (35). Currently, indocyanine 
green is the only NIRF dye approved for clinical use by the Food and Drug 
Administration in the United States (36).   
Thermography, far-infrared imaging for measurement of surface temperature, detects 
a statistically significant difference between joint temperatures in normal, RA, and 
osteoarthritis (OA) patients (37), but may struggle in the recognition of mild arthritis 
symptoms and in small joints (38). 
Photoacoustic tomography (PAT) takes advantage of the photoacoustic effect to map 
the optical absorption properties of a tissue with higher resolution than is achievable in 
diffuse optical tomography (DOT). In the preliminary assessment of osteoarthritis, PAT 
was able to detect increased absorption in the joint space of arthritic fingers (39).    
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Other optically based imaging approaches have included optical spectral transmission 
(OST), where the transmittance of two or more wavelengths of light are measured and 
analysed according to how they vary over time or spatially, and diffuse optical imaging 
(DOI) where multiple light measurements are taken at varying distances and the 
properties of the tissue are reconstructed either as a static measurement or how they 
vary over time. Theoretically, the symptoms of arthritis cause changes in the spectral 
transmission profile of a joint (17). Significant differences were found between healthy 
and inflamed joints in a system measuring the spectral transmission profile of proximal 
interphalangeal (PIP) joints in combination with an inflatable pressure cuff in a simple 
optical spectral transmission approach (40–42).  
 
Other methods attempt to reconstruct the optical properties of the tissue to give an 
estimation of the distribution of scattering and absorbing distribution of the finger joint. 
Due to cross-talk between scatter and absorption in biological tissue, this is a non-
trivial problem. The first attempt to reconstruct optical properties of the finger joint was 
a sagittal laser optical tomographic (SLOT) reconstruction where a single wavelength 
laser was directed at discrete locations along the finger and the transmission profile of 
light measured on the other side. Applying non-linear error minimisation to an iterative 
forward model reconstructed an estimation of the optical properties in finger joints of 
healthy volunteers and patients with RA. They showed a characteristic pattern of 
scatter and absorption changes. In healthy fingers, a dip in scatter and absorption 
values occurred in the central region of the joint, whereas, in inflamed fingers the 
decrease of scatter and absorption values in the joint space was much less 
pronounced (43–45). More recent continuous-wave imaging methods have included 
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multispectral diffuse optical tomography which aims to use the difference in spectral 
data to separate the contributions of scattering and absorption (46,47).  
 
 
Figure 3: Examples images for clinical and experimental methods of imaging the effects of rheumatoid arthritis in 
the hand joints. Figures a-e depict x-ray (48), MRI (49), ultrasound (50), near-infrared fluorescence imaging (51) 
and frequency-domain diffuse optical tomography (52) respectively, reproduced from the cited sources. 
 
Frequency-domain diffuse optical tomographic (FD-DOT) techniques have 
reconstructed optical properties of human PIP joints, both affected by and unaffected 
by rheumatoid arthritis. The two groups were found to have statistically significant 
differences in particular features extracted from the reconstructions. With additional 
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tools for feature extraction and computer aided analysis, the FD-DOT images can 
provide classification of RA and healthy joints with similar sensitivities and specificities 
to MRI and ultrasound (53). Figure 3e displays the typical features in a tomographic 
optical reconstruction where there is an increase of scatter and absorption in the joint 
space upon development of RA. The low scatter and absorption in the centre of the 
joint in a healthy finger is thought to be due to the low scatter and absorption 
coefficients of healthy synovial fluid and cartilage. In rheumatoid arthritis the 
reconstructed scattering coefficients of the joint space increase, thought to be due to 
thicker synovium and immune cell infiltrate in the fluid. The reconstructed absorption 
coefficients increase, thought to be due to hemodynamic changes in the synovial lining 
(54). Whilst FD-DOT avoids the requirement for contrast agents and ionising radiation, 
the equipment is expensive and imaging results are difficult to interpret. It is not yet 
clear whether these methods can distinguish early arthritis symptoms.  
2.4 Mouse Models in Rheumatoid Arthritis Research  
The aetiology of rheumatoid arthritis is difficult to study because patients only present 
with symptoms once the disease pathways are established. Likewise, studying the 
progression of the disease requires tissue samples from patients which are painful or 
impractical to obtain. Cell culture and computational modelling are a vital part of 
research but cannot completely replicate the multi-tissue effects of disease in a whole 
organism. Animal models have therefore been developed to aid in research of the 
condition. Whilst none of the animal models are a perfect replica of RA, they have 
collectively been used to further the knowledge of the pathological immune processes 
underlying the disease and in the development of new types of drugs which are now 
an indispensable part of RA treatment.  
 18
 
Mouse models of RA can simulate aspects of the disease that are of interest to 
researchers. The breadth of the factors involved in the development of RA has allowed 
the development of a variety of murine models. These can be broadly categorised as 
either genetic or induced depending on whether the symptoms were introduced 
through genetic modifications, or though exposure to inflammation-inducing serum 
factors. They present with symptoms which include evident inflammation and swelling 
in the joints of the limbs and paws, as well as erosion of the bone and cartilage in some 
models. Common murine models which have been included during this research 
project have been detailed below. 
 
Genetic mouse models have modifications to their DNA which cause disease 
symptoms to arise spontaneously. Most target the regulation of inflammatory cytokines 
which are known to be important in RA development and progression. Inducible 
models involve the introduction of inflammation causing agents into a genetically 
normal (wildtype) mouse strain, or otherwise non-arthritic genetically-altered mouse. 
In this case, symptoms tend to peak over the course of several weeks, then they may 
abate or perpetuate depending on the nature of model (55).   
2.4.1 TNF dARE  
Tumour necrosis factor alpha (TNF-α) is one of the dominant inflammatory cytokines 
implicated in progression of pathology in rheumatoid joints. It can be expressed by a 
variety of cells in response to acute inflammatory signals (56). In a resting cell, levels 
of TNF-α are reduced by the ARE (AU-rich element) regulatory region at the 3’ end of 
the mRNA transcript. The presence of the ARE region causes degradation of the 
transcripts and consequent downregulation of TNF-α. Upon activation of the cell with 
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inflammatory signals, the mRNA transcripts are stabilised and consequently translated 
leading to a rapid upswing in the expression of the protein. In relation to RA, the 
pathological roles of TNF-α include upregulation of osteoclast activity initiating bone 
erosion and upregulation of a melange of pro-inflammatory cytokines leading to the 
recruitment of lymphocytes to the synovial tissue (57). 
 
Mechanism: In the TNF dARE mouse, the ARE region of the gene is deleted causing 
chronic upregulation of TNF-α (58). This mouse model, and other models which 
upregulate TNF-α, have highlighted the importance of the TNF-α cytokine in disease 
and led to the successful discovery of several types of TNF-α targeted drug treatments, 
which are now a mainstay of RA treatment (59).  
 
Symptoms and appearance: In the heterozygous TNF dARE mouse, development of 
chronic polyarthritis and irritable bowel disease begin at approximately 3 weeks of age, 
overt arthritis around 6 – 8 weeks of age, and by 16 weeks typically nearly all joints are 
affected (55,58). As symptoms develop discolouration of the paws is evident as they 
take on a ‘brown’ appearance (see Figure 4). With advanced symptoms, there is 
generally visible evidence of deformation of the joints and the heels and wrists can 
bow assuming a characteristic spoon shape. There is usually little measurable swelling 
of the footpad, however the toes generally appear thicker than in the normal control. 
When the mouse is picked up by the scruff so that the feet can be examined, the toes 
tend to remain bunched rather than spreading out. Peculiar to this mouse model is 
development of irritable bowel disease analogous to Crohn’s disease, resulting in a 
tendency to be underweight compared to control (wildtype) littermates.  
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Figure 4: Photographs showing a single case of a TNF dARE hind paw affected by symptoms of arthritis and a 
single case of a normal mouse foot. 
 
2.4.2 K/BxN Serum Transfer 
The K/BxN serum transfer (ST) model is an inducible mouse model, where pathology 
is initiated by the transfer of auto-antibody containing serum obtained from the K/BxN 
transgenic mouse. Transgenic K/BxN mice are a genetic mouse model which develop 
a spontaneous form of symmetrical, deforming polyarthritis, highly reminiscent of 
rheumatoid arthritis, around 4 – 5 weeks of age (60). The intentional target of the KRN 
T-cell receptor (TCR) is a form of bovine RNase, but crucially for the arthritis model the 
transgenic KRN receptor also recognises epitopes of glucose-6-phosphate isomerase 
(GPI) when displayed by the major histocompatibility complex (MHC) class II molecule 
I-Ag7. GPI is a ubiquitously expressed enzyme involved in the glycolytic pathway. 
Lymphocyte recognition results in the activation of B cells, releasing autoantibodies 
specific for GPI. The pathogenesis behind the joint-specific inflammation is not entirely 
clear but appears to involve recruitment of factors of the innate immune system (61).  
 
A single injection (intravenous or intraperitoneal) of serum from symptomatic 
transgenic K/BxN mice into a naïve wild-type mouse results in the development of 
arthritis symptoms within 2 days (62). The main difference between the transgenic 
K/BxN mouse and the serum transfer K/BxN is the transient nature of the disease 
symptoms which resolve after approximately 15 days. These mice develop a 
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hyperplastic synovium and show cellular infiltration into the joint as well as damage to 
the cartilage. They are generally used in studying the innate immune response since 
the adaptive immune response does not become involved.  
 
Mechanism: The anti-GPI autoantibodies introduced during the serum transfer have 
been found to locate to the joints within minutes. Subsequent formation of immune 
complexes activate complement pathways  and humoral inflammatory processes 
resulting in a self-limiting joint-specific inflammatory process (63).  
 
Symptoms and appearance: Paws can appear swollen and red, often localised to 
areas such as the heel or single digits. Inflammation is more common in the paws and 
ankles than the hips and tends to be symmetrical. Symptoms peak around 5 days after 
serum transfer after which time visible evidence (clinical symptoms) begin to diminish. 
After 15-21 days, clinical symptoms have usually abated although the effects of 
cartilage and bone damage may still be evident (61,63).  
2.4.3 Collagen Induced Arthritis (CIA) 
CIA mice are considered the gold standard for research because the method of 
induction is the most analogous to autoimmune induction in humans. It is an induced 
form of polyarthritis where mice are inoculated with heterologous type II collagen, a 
principal component of articular cartilage, mixed with complete Freund’s adjuvant, an 
immunopotentiator used to provoke an immune reaction. The consequent immune 
response occurs around 20-30 days later displaying many of the same pathological 
symptoms as observed in rheumatoid arthritis. The development of arthritis in the CIA 
model is dependent on the MHC haplotype of the mice, therefore the main mouse 
strain used for the CIA model is DBA/1, due to the expression of H-2q MHC molecules. 
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Symptoms can also be induced in other mouse strains but different protocols are 
required and there are lower rates of successful symptom induction. CIA mice tend to 
have symmetric joint involvement, synovitis, cartilage and bone erosion, and cellular 
infiltrate in the joint (64).  
 
Mechanism: Induction of disease is mainly T-cell dependent (although a weaker form 
of pathology can be introduced though CIA on a recombinant activation gene (RAG) -
1 deficient background (65)), but the mechanism of pathology is due to the collagen 
autoantibodies which bind to native collagen in the joints and induce an inflammatory 
response (66).  
 
Symptoms and appearance: In terms of appearance, CIA mice display similar 
symptoms to K/BxN serum transfer mice where they have red, swollen joints. Joint 
deformity is also observed (see Figure 5).  
 
 
Figure 5: Increasing severity of CIA symptoms in a mouse front paw. Reproduced from Hawkins et al (67). 
 
2.5 Assessment of Mouse Model Disease Symptoms  
Mouse model symptom characterisation is required over the course of an experiment 
to observe the progress of disease against the experimental hypothesis and also to 
monitor the mouse’s general health.  Pain management measures may be introduced 
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if the disease is deemed to exceed a critical threshold, and in severely affected cases, 
will elicit a humane endpoint. Currently, assessment methods of live mice mainly rely 
on a clinical assessment where researchers manually examine and score mice for 
indications of arthritis. Various imaging methods have been applied to the imaging of 
mouse arthritis models (see section 2.5.1.2), but are not widely used in routine 
symptom assessment due to the expense, expertise, and added experimental 
procedure necessary. In most cases, culling the mouse and excising tissues is 
necessary for a more accurate assessment of the arthritis progression.  
2.5.1 In vivo Assessment of Murine Disease  
2.5.1.1 Scoring System  
The scoring system currently used to assess the severity of the symptoms in arthritic 
mice is based on a number of behavioural and physical observations. Figure 6 shows 
the scoring sheet that is used for assessment of all arthritis models at the University of 
Birmingham. The scoring sheet was designed initially in 2012 by Dr Amy Naylor based 
on discussions with researchers using arthritis models at the Kennedy institute of 
Rheumatology. Since that time, it has been adapted to better capture welfare 
parameters and clinical symptoms through consultation with researchers, animal 
technicians and veterinary surgeons at the University of Birmingham.  
 
The mice are scored for a series of physical traits relating to their health and symptoms 
of arthritis including their gait, their behaviour around littermates, mouse ‘grimace’ (68), 
and the appearance of their paws. The mouse is picked up in a ‘scruff’ and held supine 
so that all four paws can be examined and scored for swelling, deformity, and 
discolouration.  
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Figure 6: The complete scoring form used to monitor mouse models of arthritis at the University of Birmingham. 
The form includes a section where the paws of the mouse are scored by visual assessment for traits such as 
swelling, discolouration and deformity. 
 
 
This method of scoring is entirely manual, time consuming, and highly reliant upon the 
experience of the assessor. The data collected are both superficial and subjective in 
nature and prone to conformation bias where the mouse is known to be arthritic (69). 
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Depending on the nature of the symptoms, it can be supplemented by quantitative 
physical measurements such as mouse weight, grip strength, paw thickness, paw 
volume, and ankle thickness, but such pathological changes are often dependent on 
model of RA.  
 
2.5.1.2 In vivo Imaging Based Assessment  
Specialised small animal imaging systems exist for many of the imaging methods 
commonly applied to humans. Most of these methods have been applied to small 
animal models of RA in a research environment, to see how efficiently they detect 
inflammation.  
 
MicroSPECT and MicroPET 
Nuclear imaging techniques microSPECT and microPET are used comparatively more 
often in the imaging of small animal models of rheumatoid arthritis (Figure 7a). Novel 
radiotracers have been developed and tested for efficacy of arthritis detection in a 
variety of mouse models using microSPECT imaging, often imaged in combination with 
microCT for improved anatomic localisation. Targets including proteoglycans (70), 
macrophage mannose receptors (71),  apoptotic cells (72), fibroblast-like synoviocytes 
(73,74), and integrin αvβ3 (74), have all shown correlation with arthritis symptoms. 
Tracers aiming to quantify pathological bone destruction correlated with alternate 
measures of bone destruction (75),  tracers targeting cell proliferation saw advanced 
uptake with mild clinical symptoms in K/BxN serum transfer mice (76), and targeting 
T-cell activation markers correlated with arthritis symptoms (77). Specialised nuclear 
imaging techniques achieve a resolution of approximately 1mm3 and have proved able 
to image several of the molecular events associated with development of symptoms in 
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rheumatoid arthritis models. However, as in clinical imaging, the use of nuclear imaging 
is restricted by the expense of the imaging equipment, the inconvenience of tracer 
preparation, and the difficulty in translation to clinical imaging due to regulatory issues 
(78).  Compared to optical molecular imaging techniques, its advantage is the absence 
of depth-dependent photon attenuation and tissue scattering.  
 
MicroMRI 
Specialised small animal microMRI systems have also been applied to the imaging of 
RA models, to image morphological changes occurring in both the soft and hard 
tissues (Figure 7b). The small scale of the joints can be problematic, but symptoms 
like synovial fibroplasia, oedema, joint effusion, and bone erosion can potentially be 
defined. Often, contrast agents such as gadolinium or ultrasmall superparamagnetic 
iron oxide (USPIO) particles are employed to help delineate target tissues. Using 
contrast agents, metrics of MR imaging have been found to correlate with classic 
inflammatory parameters and histologic signs of arthritis (79). Longitudinal assessment 
of inflammation and bone erosion is possible (80) and early signs of disease can be 
detected (81). USPIO particles have been successfully targeted to macrophages 
(82,83) and T-cells (84) and using synovial volume to facilitate drug intervention was 
found to reduce variability of outcome in treatment intervention experiments compared 
to age (80). As with nuclear imaging techniques, the main disadvantage of microMRI 
is the expense of the imaging equipment.   
 
NIRF and Bioluminescence Imaging  
Technology for in vivo optical molecular imaging techniques involving the injection of 
fluorescent probes, or the generation of bioluminescence expressing cells, has 
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become more available and more common in the past decade and thus is now used 
more regularly in experiments. Several methods have been attempted in visualising 
arthritis symptoms. Like in humans, non-specific near-infrared fluorescence (NIRF) 
dyes, show significantly more signal in joints affected by arthritis (85,86) due to 
naturally ‘leaky’ blood vessels in inflammatory regions (Figure 7c). However, for most 
fluorescence imaging in RA models, probes are targeted to molecular markers relating 
to the inflammatory processes to measure specific molecular responses.  
 
In testing a Matrix Metalloproteinase (MMP)-3 targeted probe on CIA mice, significantly 
higher NIRF signal was found in CIA mouse hind limb joints than in their littermate 
controls before any clinical signs of disease were visible (87). This molecular imaging 
probe has proved capable of monitoring drug responses (88). ‘Smart’ probes activated 
by target proteases have also been trialled in monitoring therapeutic drug response 
(89). A folate targeted probe has been used in the K/BxN mouse model to elucidate 
macrophage activity in the joints (90), and to the F4/80 antigen on the surfaces of 
macrophages in adjuvant induced arthritis (AIA) mice (91). More recently, 
commercially available NIRF ‘smart’ probes cleaved and activated by proteases, 
neutrophil elastase, MMP’s, and cathepsin K were imaged and the intensity shown to 
significantly correlate with manual scoring and histology scores, and can be delivered 
in tandem due to separable emission spectra (92). 
 
Molecular imaging is undoubtedly a valuable tool in RA research, offering the ability to 
monitor the localisation and relative intensity of cellular activity in vivo. However, it is 
disadvantaged by the need for expensive equipment, targeted probes, anaesthetics, 
and other imaging concerns such as low resolution compared to alternative 
 28
techniques, around 5mm compared to PET 2mm and MRI 0.1mm (93). It does however 
have short imaging times compared to scintigraphic methods (91).  
 
Non-Contrast Enhanced Optical Imaging 
Several alternative optical imaging methods not requiring contrast enhancement have 
been trialled on animal models of rheumatoid arthritis for symptom assessment. Cross 
polarisation colour (CPC) imaging and laser speckle contrast of the hind paws of AIA 
mice showed correlation with histological results (94). Multi-wavelength time-resolved 
diffuse optical spectroscopy (TR-DOS), was used to estimate Hb, HbO2 and, with the 
aid of dynamic-contrast enhancement, blood flow to the knee joint of an RA model 
rabbit finding trends towards decreased oxygenation and significantly larger blood flow 
in the arthritic measurements (95). Thermal imaging has also found significant 
differences in the surface temperature of arthritic paws compared to normal paws in 
CIA mice (96)  and in AIA rats (97).  
 
Ultrasound and Photoacoustic Imaging 
Alternative methods of imaging applied to small animals are comparatively rare. 
Despite its increasing clinical usage, literature on the ultrasound (US) imaging of small 
animal models of RA (Figure 7d) is relatively sparse. The joint space volume and power 
doppler volume calculated from US images has been found to correlate with synovial 
volume as calculated from contrast-enhanced MRI in TNF transgenic mice (98), and 
doppler US score has been found to correlate with histological and clinical scoring in 
CIA mice (99). Photoacoustic imaging has been experimentally applied to the imaging 
of small animal joints. Enhancement of signal was found in arthritic rats compared to 
normal controls, indicating an increase of blood flow and neovascularisation in the joint 
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(100). In rat tail joints, significant differences in optical absorption were found following 
carrageen injection to induce arthritis (101). Contrast agents have also been 
experimentally investigated for photoacoustic imaging of RA models. Gold nanorods 
improved the imaging of inflammation in CIA mice (102) and more recently, significant 
differences were found between arthritic models and controls using multispectral 
optoacoustic tomography (MSOT) with a NIRF dye targeting P-selectin/L-selectin 
(103). 
 
 
 
Figure 7: Examples of in vivo imaging for symptoms of joint inflammation in rodent models of rheumatoid arthritis. 
Consecutively, these images depict a) ultrasound imaging of a mouse ankle joint (99) b) radiolabelled 
microSPECT/microCT targeting integrin αvβ3 expression on osteoclasts in CIA mice (74) c) T1 microMRI of a 
normal rat ankle (79) and d) non-specific near-infrared fluorescence imaging of a CIA rat (85).   
 
Multispectral Imaging 
Multispectral imaging (MI) is not in common usage for the imaging of murine arthritis. 
Putten et al. (18) applied a multispectral imaging to microscopy of tendon 
microvasculature of RA mice, but to our knowledge multispectral imaging has not been 
used for bulk tissue imaging in murine models of RA. In general, multispectral imaging 
is seldom used for clinical assessment of pathology, but has had several successful 
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applications in research such as imaging of melanoma in human skin (104). 
Multispectral imaging is covered in more detail in section 2.7. 
2.5.2 Ex Vivo Arthritis Assessment  
2.5.2.1 Histology  
Evaluation by histology is considered the gold standard for disease evaluation in RA 
models, as the pathology can be seen and graded by eye. Disease symptoms such as 
inflammatory infiltrate, synovial hyperplasia, and bone erosions can be scored from 
simple Haematoxylin & Eosin (H&E) stained samples (Figure 8). However, the clear 
disadvantage of such scoring is that obtaining the tissue sample necessitates culling 
the mouse. In long-term experiments large groups of mice are often required so that 
mice can be culled at certain time points to investigate the progress of pathology.  
 
 
Figure 8: Haematoxylin and Eosin stained sagittal sections of mouse hind paws. Image a) contains a normal paw 
where no evidence of inflammation can be seen around the joints. Image b) contains a section from a TNF dARE 
mouse, with evidence of inflammation. In the magnified image on the right, inflammatory infiltrate containing immune 
cells can be seen around the bone.  
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2.5.2.2 MicroCT 
MicroCT is routinely used in imaging ex vivo tissue samples of RA models, containing 
joints expected to be affected by bone erosion or bone growth. Most mouse models of 
RA exhibit some degree of bone erosion in the periarticular cortical bone, which can 
be observed in microCT scans as pitting around the joint area (Figure 9). 
Reconstructed microCT meshes can be scored by eye according to the perceived 
progression of bone damage.  
 
 
Figure 9: Reconstructed meshes of wildtype and TNF dARE mouse hind paws imaged by microCT. Instances of 
bone erosion can be seen around the metatarsophalangeal joints in the TNF dARE mouse due to chronic joint 
inflammation. 
 
For this project an analysis method developed by Brown et al. (105), was used to 
measure bone deformity in hind paw microCT scans of arthritis models by comparison 
with a statistical shape model (SSM). A microCT scan gives high-resolution 3-
dimensional data about progression of hard tissue damage in arthritis models but 
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contains no information about soft tissue pathology. Figure 9 displays a typical scan of 
a healthy hind paw with an arthritic TNF dARE hind paw for comparison. 
2.6 Light Interaction with Tissue 
2.6.1 Reflection 
Most materials will reflect a proportion of the light incident upon them. The incident 
light can be reflected by either specular or diffuse regimes. Specular reflection occurs 
when light is reflected from the surface of the material, without propagating into the 
material itself. In a material with a smooth surface this results in a ‘mirror-like’ reflection, 
or on a rougher surface, the specular reflection disperses less uniformly. For many 
materials, however, the majority of reflected light is reflected diffusely. This happens 
when photons enter beneath the surface of a material, undergo scattering events within 
and are re-emitted from the surface.  
2.6.2 Transmission 
Light which propagates through the material and exits on the other side is referred to 
as transmitted. If photons do not scatter along their path the transmission is considered 
ballistic, otherwise it is diffuse (Figure 10). In most materials a proportion of light will 
be absorbed. The structure and composition of the material determines which 
wavelengths will be absorbed preferentially and this pattern of absorption lends a 
material its colour. Schematic examples of the light - material interactions are displayed 
in Figure 10. 
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Figure 10: Schematic of a block of tissue describing the paths of ballistic and diffusely transmitted photons, specular 
and diffusely reflected photons, and photon absorption. 
 
2.6.3 Physics Concepts 
Optical properties of materials can be characterised by their refractive index, 
absorption coefficient, scattering coefficient and anisotropy factor. This section 
provides a brief introduction to these concepts in context of light-tissue interaction. 
2.6.3.1 Refractive Index 
The refractive index of a material (n) describes the reduction in the velocity of light in 
a vacuum (c) to the velocity of light in the medium (v) according to  
 n =   . (1) 
 
The refractive index of a material influences the percentage of light specularly reflected 
at a material boundary according to Fresnel’s equation 
                                                          R =   
( )
( )
 1 + 
[ ( ) ]
[ ( ) ]
                                         (2) 
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where R is Fresnel reflection, c =  cos(θ ), θ  is the angle of incidence, and a =  n +
c + 1. In Fresnel reflection, the angle of incidence is equal to the angle of reflection 
about the normal to the surface. Any light that then continues into the material will be 
refracted at an angle according to Snell’s law 
                                                                  θ = arcsin sin θ                                                            (3) 
 
where θ  is the angle of refraction (106). Biological tissues have an average refractive 
index higher than that of air. Taking human skin as an example, an incident beam of 
light first hits stratum corneum of the epidermis. The refractive index mismatch from 
the air (n=1.0) to the tissue (n≈1.4) leads to Fresnel reflection of approximately 5 – 7% 
of the incident light. The wavelength dependence of Fresnel reflection is generally 
relatively small and therefore all wavelengths will be reflected fairly equally.  
2.6.3.2 Absorption 
Photon absorption occurs in a quantised manner where photon energy is converted to 
a different form through absorption by an atom or molecule called a chromophore. 
Each chromophore has an associated range of wavelength-dependent absorption 
coefficients (µa[cm-1]), which describe the probability of photon absorption occurring 
per unit distance. For a given path length through a material containing an absorbing 
chromophore of a certain concentration, the absorption coefficients of the material can 
be calculated through the modified Beer-Lambert law 
                                                 A =  log = μ ×  d ×  DPF + G                                              (4) 
 
where Iin is the incident intensity, Iout is the transmitted intensity, and μa is the 
wavelength-specific absorption coefficient of the material, d is the distance, DPF is a 
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factor which accounts for the increase in the pathlength in a scattering material and G 
describes the geometry dependent loss of light. In a mixture of chromophores the 
absorption coefficients of the material can be linearly decomposed to give the 
concentrations of the individual chromophores. In a mammalian tissue the main 
absorbing chromophores are melanin, haemoglobin and oxyhaemoglobin as shown in 
figure11a. To a lesser extent bilirubin and carotene contribute and in the near-infrared 
(NIR) wavelengths, the absorption of water begins to increase. 
 
Figure 11: Absorption and scatter coefficients for common biological chromophores and tissues. a) Absorption 
coefficients (μa/cm-1) of common biological chromophores in the range 450nm to 1000nm. b) Scatter coefficients 
(μs/cm-1) of different tissue types in the range 450nm to 1000nm.  
 
2.6.3.3 Scatter 
Scattering of a photon refers to the change in the direction of propagation, and the 
scattering properties of a material can be referred to by its scattering coefficients 
(µs[cm-1]), a wavelength dependent value which describes the probability of photon 
scatter occurring per unit distance, shown in figure11b. Scatter within a turbid material 
occurs when photons collide with scattering particles which have different refractive 
indices from that of the medium in which photons propagate. Depending on the size of 
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the scattering particles in relation to the wavelength of light, it is common to refer to 
two different regimes.  
 
Rayleigh scattering is scattering from particles much smaller than the wavelengths 
of light, less than a tenth of the size. The magnitude of Rayleigh scattering is highly 
dependent on the wavelength, with scattering proportional to 1/λ4 where λ is 
wavelength in nm. This means Rayleigh scattering is most relevant at the shorter 
wavelengths in the visible region of the spectrum, but much less significant at longer 
wavelengths. In Rayleigh scattering, the scatter acts as an electrical dipole oscillating 
in phase with the wavelength of the photon and scatters incident light isotropically 
(107). Rayleigh scattering can be caused as a result of tissue components such as 
collagen fibres.  
 
Mie scattering is the scattering of photons from particles of the same order of 
magnitude as the wavelength of incident light. In tissues it accounts for most of the 
scattering events in the visible and NIR wavelengths. Mie scatter is anisotropic and 
predominantly forward oriented. The incident light is therefore mostly scattered at a 
small angle from its initial direction of propagation. The angular distribution of Mie 
scattering is proportional to the ratio of the wavelength to the particle size. As particle 
size increases relative to wavelength, light scattering becomes more forward directed. 
 
Mathematically, Mie theory describes the scattering of light from spherical particles of 
diameter d and refractive index np embedded in the medium of refractive index nm. 
Given these parameters and the density of scattering centres, the scattering coefficient 
µs can be computed as a function of wavelength (). The structures in biological tissues 
responsible for Mie scattering in the visible and NIR wavelengths include cell nuclei, 
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mitochondria, vesicles and collagen fibres, which tend to range from 0.4m and 2m 
in size (108). Because of their relative sizes, the larger angle scattering in a tissue 
appears to come from mitochondria and the smaller angle scattering from cell nuclei.  
 
Both Mie and Rayleigh scattering are considered elastic scattering processes where 
the energy of the photon is substantially preserved but the direction is changed.  The 
total scattering coefficients of a tissue is a composite of scatter of Rayleigh and Mie 
regimes (Figure 12).  
 
An essential parameter for describing the angular scatter distribution is the anisotropy 
value (g) which is the average of the cosine of the scattering angle for the tissue 
                                                         g =  ∫ p(θ)(cos θ)(2π sin θ) dθ                                               (5) 
 
where p(θ)  is the scattering phase function (defined below). Anisotropy g ranges 
between -1 and 1, where -1 is complete backscatter, 0 is isotropic scatter, and 1 is 
complete forward scatter. Mammalian tissues tend to be forward scattering with an 
average anisotropy value around 0.9 (109).  
 
The probability density of scattering angles for a particular tissue can be described by 
a phase function, which gives the probability of scatter at different polar angles. In 
biological tissues, the scattering phase function can be approximated by the Henyey-
Greenstein equation (110) 
                                                               p(θ) =
 
( ) /
 .                                                   (6) 
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Figure 12: Graph describing the Rayleigh and Mie contribution to the reduced scattering coefficient of typical human 
dermis. Values predicted by Mie theory applied to values isolated from the measurement of collagen fibres (87). 
 
The reduced scattering coefficient (µs’[cm-1]) is a useful parameter for modelling light 
propagation in a diffusive regime where scatter dominates over absorption (111). It can 
be calculated from the scattering coefficient and anisotropy via the equation  
                                                                            µs’ = µs(1-g).                                                               (7) 
 
Additional useful descriptors of scatter within a tissue is the Mean Free Path (mfp = 
1/µs), which is equal to the average distance a photon will travel in a tissue before a 
scattering event. 
2.6.4 The Optical Properties of Biological Tissues 
Biological tissue is a complex, multi-layered, structure composed of a mixture of optical 
scatterers and absorbers. The absorption coefficients of biological tissues depend on 
the concentrations and locations of a number of different biological chromophores. The 
combined effect of their concentrations and position within the tissue gives the tissue 
its colour (15). Included in figure11a are the absorption coefficient spectra of the main 
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three chromophores that are of interest to this project, haemoglobin, oxyhaemoglobin 
and water, across a range of wavelengths from 450nm to 1000nm. 
 
Most biological tissues are turbid (optically opaque), due to high density of scattering 
centres, although exceptions exist such as the lens and cornea of the eye, 
cerebrospinal fluid, or the synovial fluid (112). Higher scattering coefficients are 
associated with skin and bone, which contain dense extracellular collagen networks, 
while lower scattering coefficients are associated with muscle (figure11b).  
 
The light which is scattered and escapes absorption can be re-emitted from the surface 
of the material or transmitted through it. The angular distribution of diffusely reflected 
light in biological tissue generally approximates a Lambertian distribution (113), where 
the apparent brightness of the tissue remains constant regardless of the viewing angle 
of the observer. In mathematical terms, the luminance is directly proportional to the 
cosine of the angle between the direction of propagation and the surface normal. Any 
transmitted light is diffused, with a negligible proportion of ballistic photons. 
Transmission (I) of light over pathlength (L) without a scattering event can be 
calculated with  
                                                                           I = I e                                                        (8) 
 
where I0 is intensity of the incident light and µs is the scattering coefficient. Using this 
equation together with a typical scattering coefficients value for biological tissue (100 
- 200cm-1), the percentage of true ballistic photons in a tissue slab 2mm thick, the 
approximate width of a mouse hind paw, is practically zero.  
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2.6.5 Modelling of Photon Transport within a Biological Tissue 
Modelling of light interaction with biological tissues is common in many domains. In 
biomedical imaging the purpose of forward modelling is to simulate the application of 
a light source to a tissue to gain an estimation of an optical effect such as the 
reflectance, transmission, or fluence. All modelling methods implement an estimation 
of photon propagation through a tissue by ascribing tissue properties to a tissue 
geometry, then simulating the injection of photons from a model light source.  
2.6.6 Methods of Modelling Photon Transport 
Modelling of photon transport within a turbid tissue can be approached through several 
different methods. Fundamentally, photon propagation within a tissue can be described 
using the radiative transfer equation (RTE)  
        
( , , )
+ ∇ ∙ L(r, s, t)s =  −μ L(r, s, t) +  μ ∫ L(r, s, t)P(s ∙ s
 
′)dΩ′ +  Q(r, s, t) .     (9) 
 
In this equation L(r, s, t) is the radiance, or the energy flow per unit area per unit solid 
angle per unit time at position r, direction s, and time t. μ  is the total interaction 
coefficient, equal to μ + μ . The scattering phase function P(s ⋅ s′)dΩ′  is the 
probability of light scattering from direction s to solid angle dΩ′ about direction s‘ , and 
Q(r, s, t) is the energy emitted from a light source at position r, direction s, and time t. 
 
Derived from Maxwell’s equations, the RTE describes the propagation of photons 
through a medium in terms of absorption and elastic scattering events. However, given 
that most biological tissues present multi-layer, heterogeneous, complex, scattering 
media in the Visible and NIR wavelengths, the RTE cannot be solved analytically. The 
solution can either be resolved with approximations to the RTE or numerical methods. 
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Methods for solving the problem of photon transport within a tissue include Kubelka-
Munk (114), adding-doubling (115), discrete ordinate method (116), four-flux (117) and 
seven-flux models (118), the diffusion approximation (119), and Monte Carlo (120).  
Each method has its advantages and disadvantages dependent on the requirements 
of modelling, but the most ubiquitous for forward modelling of photon propagation in 
macroscale biological tissues are the diffusion approximation (DA) and the Monte 
Carlo (MC) method. Given that the DA assumes isotropic scattering and uses the 
reduced scattering coefficients of the tissue, it is inappropriate for modelling photon 
propagation over short distances like the mouse hind paw where light may not have 
been scattered isotopically before exiting the tissue. 
 
The Monte Carlo solution to the RTE is regarded as the most accurate method for 
modelling photon transport within a complex biological tissue (121), often used as 
validation for other methods (122–124). The MC method does not make the same 
approximations as the DA and will therefore model photon propagation accurately even 
in the case of highly absorbing or low scatter tissues. It is based on repeated random 
sampling and is a flexible technique, widely applicable to the modelling of under-
determined problems. In modelling radiative transfer, MC discretises photons, 
simulating scattering and absorption events individually according to probabilistic 
measures determined by properties associated with the tissue. There are several 
subtly different implementations of the method, but in general the algorithm is thus 
(shown as a flow diagram in Figure 13 and modelled photon paths in Figure 14). A 
single photon packet is launched and a proportion of light is reflected at the tissue 
boundary in accordance with Fresnel’s equations. The remainder carries on into the 
tissue. The weight of the photon is reduced by the probability of absorption with each 
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step, and the new step size and scattering angle calculated based on randomly 
sampling their respective probability distributions. The photon packet propagates in the 
tissue until it exits or is completely absorbed. Figure 13 displays a simple Monte Carlo 
flow chart of the algorithm process.  
 
 
Figure 13: Flow diagram for the basic process of Monte Carlo calculations for propagating photons in a homogenous 
semi-infinite slab.  
 
Given an appropriate number of photons, the Monte Carlo method is accepted as the 
most accurate solution to the RTE and serves as a validator for other modelling 
methods. The main disadvantage of Monte Carlo is the computationally intensive 
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nature of algorithm. Several approaches exist for speeding up Monte Carlo modelling 
of light, including scaling methods, perturbation MC, hybrid MC methods and variance 
reduction techniques, but the most effective is computational parallelisation, to which 
MC is well suited (125).  
 
 
Figure 14: Several examples of simulated photon walks through a tissue slab using the Multi-Layered Monte Carlo 
(MCML (126)) model of photon propagation through layered media (described in section 3.2.1). Each black dot 
represents an incidence of scattering.  
 
2.6.7 Extracting Optical Properties from Optical Measurements  
Given that the optical properties can contain information about the composition of a 
tissue, many methods exist for the reconstruction of optical properties in tissues. The 
method of reconstruction depends primarily on imaging method used to obtain the data 
which can vary vastly. In general, the problem of reconstructing optical properties for 
a turbid, heterogeneous tissue, is non-linear, ill-conditioned and ill-posed, due to cross 
talk between scattering and absorption coefficients.  
 
Commonly reconstructed tissue parameters for absolute imaging are the total 
haemoglobin concentration (HHb), the oxygen saturation (SO2), and the concentration 
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of melanin, or for dynamic imaging the change in the concentration of these 
parameters from an unknown start value. 3D reconstruction of tissue parameters 
generally involves inputting estimation values into a 3D model then performing an 
iterative optimisation procedure to converge the model to a minimum error with real 
data (43,46). Spatially resolved spectroscopy (SRS) uses the rate of attenuation of 
light with distance in the tissue to analytically derive values for tissue oxygenation 
(127). For tissue parameter estimation from multispectral images, different methods 
have been applied in literature. The modified Beer-Lambert law (equation 4) can be 
used in conjunction with Monte Carlo models to find a linear relationship using multiple 
regression to calculate the coefficients of absorbing chromophores (128–130), 
analytical models have been applied where the behaviour of light in the skin is 
approximated mathematically (131), and inversion by defining a unique mapping from 
spectral space to chromophore concentrations using Monte Carlo simulations covering 
all possible combinations of chromophores (104,132).   
2.7 Introduction to Multispectral Imaging  
Multispectral imaging (MI) refers to imaging modalities which record spectral 
information at multiple wavelengths, and hyperspectral imaging refers to imaging with 
hundreds of wavelengths or more.  Traditional colour imaging with a standard camera 
records a colour vector of red, green and blue (RGB) for each individual image pixel. 
When displayed simultaneously, the colours can be interpreted by the human eye 
because they correspond to the red, green and blue cone receptors of the retina. 
However, contracting the full spectral power distribution down to three values 
represents a significant loss of spectral information. Different spectral distributions can 
be perceived as identical colours providing their RGB ratio is the same, in an effect 
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known as metamerism. Recording higher resolution spectral information results in a 
truer representation of the spectral power distribution and better distinguishes spectral 
features. The range and resolution of recorded wavelengths depends on the 
instrumentation and on the purpose of imaging. Examples of uses for multispectral 
imaging are quite diverse and include functions such as remote sensing, examination 
of paintings, and microscopy (133).  
 
Macroscale multispectral imaging is not currently commonly used in clinical 
applications, although a number of research-based techniques have been developed 
with an increasing number of potential applications. The primary application of MI is 
some form of physiological parameter estimation from reflectance images. Given 
diffuse scattering in tissue, reflectance MI samples the diffusely reflected light from the 
surface of a tissue which represents light scattered within approximately 2mm of the 
surface in the visible wavelengths (134). If applicable, the method of parameter fitting 
varies from simple mathematical models to model based fitting regimes. The majority 
of literature focuses on MI of skin and skin lesions (104,135–138), but other 
applications include fundus imaging (139), endoscopy (140), and laparoscopy 
(141,142). Many different approaches have been taken to MI with functional 
modifications including multimodal imaging (143) with additional optical imaging 
techniques and recently, spatial frequency domain imaging  (SFDI) where structured 
light of multiple wavelengths is used to estimate tissue scatter (144). Software 
adaptations have included the use of machine learning algorithms for the purpose of 
classification (135,142).  
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2.8 Hypothesis  
On the basis of the changes in chromophore concentrations believed to occur in tissue 
affected by arthritis symptoms (section 2.2), and the capability of multispectral imaging 
to measure the spectral response of materials in addition to spatial data (section 2.7), 
this thesis examines the hypothesis that symptoms of arthritis in murine models of 
rheumatoid arthritis can be detected and quantified through analysis of spectral 
measurements. Stated more formally the hypothesis for the project is: 
 
Symptoms of inflammatory arthritis are detectable in mouse hind paws by multispectral 
imaging because of disease-induced variation in the relative quantities of biological 
chromophores. 
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3 Monte Carlo Modelling Optical Reflectance and Transmittance of 
the Mouse Hind Paw  
 
3.1 Introduction 
This chapter covers work done on modelling multispectral reflectance and 
transmittance spectra of the mouse hind paw using a multi-layered Monte Carlo model 
simulation of photon transport through a layered medium. The aim of this work was to 
model (in silico) tissue changes occurring with arthritis and evaluate the effect on the 
tissues optical response. To this end, section 3.2.1 describes the choice of computer 
model, section 3.3.1 describes the optical parameters used in the model. Section 3.3.2 
describes the changes induced to simulate arthritis. Section 3.4.1 describes the optical 
reflectance and transmittance data resulting from the model and section 3.4.2 details 
the effects of chromophore changes in different tissues.  
3.2 Equipment and Methodology 
3.2.1 The Multi-Layered Monte Carlo Model  
Modelling the mouse hind paw was approached using the prevalent and highly cited 
Multi-Layered Monte Carlo (MCML) code published by Wang et al in 1995 (126). The 
MCML program, written in ANSI standard C, was designed for modelling steady-state 
light transport in a semi-infinite multi-layered tissue. MCML uses dynamic data 
allocation for tissue and model properties, allowing the user flexibility over the model 
design and complexity. These attributes make it suitable for modelling the mouse hind 
paw. 
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For the modelling experiments outlined below, 30 individual wavelengths were used, 
shown on the modelled reflectance and transmittance spectra in section 3.4.1. The 
wavelengths were chosen to capture the spectral features resulting from the presence 
of biological chromophores in the tissue and they match the wavelengths later used in 
the multispectral imaging system described in chapter 5. For each wavelength, 
500,000 photon packages were simulated, sufficiently sampling reflectance and 
transmittance spectra to reduce noise artefacts (standard deviation of 10x repeat 
simulations <= 8.19e-4 in reflectance and <= 5.31e-4 in transmittance for all 
wavelengths). The photon packages simulate individual photons moving through the 
tissue (Figure 14) and their weight decreases with each scattering movement, 
simulating the probability of absorption. The weight losses are interpolated from 3D 
coordinates onto a 2D gridded area representing the tissue (Figure 15), which could 
be displayed after the Monte Carlo program has terminated. The weights of photons 
leaving the tissue are recorded, simulating the probability of reflectance/transmittance, 
angle of exit, and distance from photon entry point. A grid resolution of 5 μm (r, z) was 
adequate for displaying the layered tissue model (tissue boundaries fell on grid lines), 
and an angular resolution of 3 degrees, the accuracy to which the angle of photons 
exiting the tissue is described, was deemed suitable (the Lambertian properties of 
reflectance and transmittance could be demonstrated – section 8.A2).  
In addition to input values for grid size, resolution, and photon variables, MCML 
required the user to input values for macroscopic properties of the tissue layers, 
described in section 3.3.1.1. The values of the optical parameters were assumed to be 
homogenous across the specified tissue layer.  
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Figure 15: The coordinate system used by MCML for modelling photon propagation. The MCML program (126) 
uses a 3D coordinate system for modelling photon propagation with results interpolated onto a gridded 2D area 
described by the r and z axes. The origin of the 2D grid, where photons are injected sits at 0,0 of the (r,z) axes.  
 
3.3 Experimental Method Development  
3.3.1 Tissue Optical Parameters  
3.3.1.1 Sourcing the Input Parameters 
For the purpose of modelling the mouse hind paw, optical properties were required for 
several different tissue types across a range of wavelengths covering the visible and 
NIR spectra. The quantities required for modelling each individual tissue layer were 
the absorption coefficients (μa [cm-1]), scatter coefficients (μs [cm-1]), refractive index 
(n), anisotropy (g) and the tissue layer thickness (d [cm]). The sources of these values 
are addressed in sections 3.3.1.2 through 3.3.1.3. 
3.3.1.2 Tissue Layer Measurements  
For estimating the thickness of the tissue layers, images of H&E stained tissue sections 
from entire mouse hind paws were analysed. Mouse hind limbs were fixed in 4% 
neutral buffered formalin for 24 hours and then decalcified in 10% EDTA (a calcium-
chelating agent) pH7.4 for a period of 3 weeks. Samples were then embedded in 
 50
paraffin and sectioned along the sagittal axis by microtome, stained with haematoxylin 
and eosin and mounted with DPX and a coverslip. The slides were imaged by Zeiss 
Axioscanner and analysed with Zen Blue software, available from (145), taking 
measurements of typical tissue layer width across the paw.  
 
Ten slides, from a total of 6 mice (the same group of mice as imaged in section 
6.4.1.1), were analysed at four anatomical locations to measure the thickness of each 
of the tissue layers, with the results shown in Figure 16. In this thesis, these areas 
have been called the heel, midfoot, joints and toes. They were chosen due to broad 
anatomical differences in the structure of the foot. The ‘toes’ area included all the digits 
of hind paw. The ‘joints’ were isolated to include the area of tissue above the 
metacarpophalangeal joints connecting the toes to the central region of foot. This area 
is where the footpads are mostly located, thicker protuberances of skin where the paw 
is most in contact with the floor. The ‘midfoot’ encompassed the area above the 
metacarpal bones of the foot where there is a thicker layer of soft tissue, mostly 
muscle, between the skin and the bone. The final area was the ‘heel’, the area of skin 
over the collection of bones that form the heel of the foot.  
 
Five main tissue types were identified in the paw and the order of the layers used for 
in silico modelling were identified based on these sections. These were epidermis, 
dermis, muscle, bone and bone marrow. The midfoot was used to model the normal 
and arthritic spectral responses of the paw shown in section 3.4.1. The thickness of 
the tissue layers is described from the plantar surface (underside) of the paw to the 
dorsal (topside) surface, in line with the later reflectance and transmittance results for 
spectroscopy (chapter 4) and multispectral imaging (chapter 6).  
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Figure 16: Measurements of tissue layer thickness obtained from analysis of H&E stained mouse paw sections. 
Ten representative H&E slides were chosen from the group of 6 mice described in section 6.4.1.1 to ensure a good 
cross section of the four areas of interest. The measurements were divided into four anatomical regions to 
correspond to heterogeneity in structure a) Heel b) Midfoot c) Joints d) Toes. Epidermis 1 corresponds to the surface 
layer on the underside of the paw and epidermis 2 corresponds to the surface layer of the top of the paw. In the 
box plots the central line is the median, the bottom and top edges of the box are the 25th and 75th percentiles, the 
whiskers extend to the most extreme values not considered outliers and crosses indicate outlier values calculated 
by Matlab (a value more than 3 scaled median absolute deviations from the median) e) Example H&E section from 
a mouse hind paw with the anatomical regions described in section 3.3.1.2 highlighted.  
 
3.3.1.3 Absorption and Scatter Coefficients 
The optical properties used in the model are described below. For a description of the 
underpinning physics, covering the interaction of light with biological tissues, see 
section 2.6.  
 52
3.3.1.3.1 Absorption Coefficients: 
The major biological absorbers for the Visible and NIR wavelengths are haemoglobin, 
in its oxygenated (HbO2) and unoxygenated (Hb) forms, and water. The absorption 
coefficients for these three molecules are shown in Figure 17, along with the absorption 
coefficients for melanin and adipose which were also considered in the model. Melanin 
is present in the hair follicles on the upper surface of the mouse hind paw and lipids 
are present in the adipose tissue of the bone marrow. Haemoglobin is present in all 
tissues except the epidermis and water is ubiquitous, though concentrations of both 
may vary depending on tissue type. For Monte Carlo modelling, the absorption 
coefficients of a tissue were treated as a linear combination of constituent absorbers 
in each of the five tissue types. 
 
 
Figure 17: Absorption coefficient values (cm-1) in the wavelength range 450nm to 1000nm for common biological 
chromophores water (146), oxygenated haemoglobin (147), deoxygenated haemoglobin (147), adipose(148), and 
melanosomes (149). 
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3.3.1.3.2 Scatter Coefficients: 
In the case of biological tissues, scattering coefficients generally assume a decreasing 
exponential relationship with wavelength across the visible and NIR spectrum, due to 
the combined effects of Rayleigh and Mie scatter. Due to difficulty in measuring 
scattering coefficients and natural variation in tissue, exact values in literature are 
rarely consistent between different mechanisms of measurement and often do not 
cover the full visible and NIR spectra. Jacques et al (150) collated values of reduced 
scatter coefficients from many sources and fitted an empirical equation to the 
coefficients with a least squares approximation, generalising reduced scatter to cases 
of skin, bone, fibrous tissue, fatty tissue, and others.  This served to average variability 
between separate sets of scatter measurements and made accurate interpolation 
between wavelengths possible where measured data were sparse. For MCML 
modelling of the simulated mouse hind paw, reduced scatter coefficients were 
converted to scatter coefficients through equation 7 then fitted to the equation 
                                                                        μs(λ) = A + Me                                                         (10) 
 
where A, M, and k are independent variables: the parameters M and k describe a 
decreasing exponential curve and additive offset A was included to improve the fit. The 
fitting procedure was a least squares fitting of the equation to the coefficient values, 
implemented using Matlab (151). The scatter coefficients used in modelling the paw 
are shown as a function of wavelength in Figure 18 and the corresponding values for 
the parameters A, M, and k in different tissues are shown in the accompanying table.  
 
 54
 
Figure 18: Scatter coefficients for biological tissues fitted to equation 10. a) Scatter coefficients (cm-1) in the 
wavelength range 450nm to 1000nm for dermis, muscle, bone, epidermis, and adipose. Values calculated from the 
fitting of equation 10 to data collated and fitted by reference (150). b) Values for A, M and k in equation 10, for the 
five tissue types included in the mouse paw model. 
 
 
Anisotropy and Refractive Index: 
For the purposes of modelling the mouse hind paw using MCML, anisotropy (g) and 
refractive index (n) were assumed to be constant across the visible and NIR 
wavelengths. The values used in modelling, as well as their sources, are tabulated in 
Table 1.  
 Anisotropy (g) Refractive Index (n) 
Epidermis 0.7 (152) 1.34 (152) 
Dermis 0.8 (153) 1.4 (153) 
Muscle 0.93 (154) 1.33 (153) 
Bone 0.9 (155) 1.644 (155) 
Adipose 0.9 (156) 1.4 (156) 
   
Table 1: Tabulated values for anisotropy and refractive index used for Monte Carlo modelling of the mouse hind 
paw. The source reference for each value is given in subscripted brackets.  
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3.3.2 Chromophore Concentrations 
For simulating reflectance and transmittance from the mouse hind paw, the optical 
properties described above (section 3.3.1), remained constant in the tissue model. This 
section describes the parameters that were varied in order to model the tissue changes 
in arthritis. The variables of interest for modelling the arthritic paw were the blood 
volume fraction (BVF), blood oxygenation, and tissue water concentration (see section 
2.2 for a description of the biological processes underlying these changes).  The 
objective was to identify how spectral reflectance and transmittance vary as the result 
of changes in concentrations of the three absorbers, and to indicate the range of 
expected spectral changes with arthritis symptoms before running experiments with 
live mice.  
 
 Blood Volume Fraction 
Norm (min-max) 
Hb balance 
Norm (min-max) 
H2O 
Norm (min-max) 
Epidermis - - 20 (157,158) 
Dermis 2 .5 (0.5 – 8) (150,159,160) 65 (40 - 80) (150,161) 65 (50 - 70) (157,158)  
Muscle 3 (1 – 12) (150,162,163) 65 (40 – 80) (150,164,165) 75 (70 – 85) (166,167) 
Bone  2 (1 – 5) (150) 65 (40 – 80) (2) 30 (155,167) 
Bone Marrow  3 (2 - 8) (168,169) 65 (40 – 80) (2) 30 (30 – 40) (168) 
    
Table 2: Values for blood volume fraction, blood oxygenation (Hb balance), and water concentration (H2O) used in 
the Monte Carlo model. The values outside the brackets indicate typical values for concentration of the three 
absorbers within the tissue types. Ranges of values indicated by literature are given within brackets and the 
subscripted brackets contain references.  
 
Typical values of absorber concentration and ranges of values, shown inside the 
brackets, are given in Table 2.  As with some of the optical values, there is a lot of 
variation in the literature concerning blood volume fraction, oxygenation and water 
concentration. The values and ranges established in Table 2 were informed by 
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literature which includes values from various tissue types, from a variety of species, 
different areas of the body, and using different calculation methods. Given the variation 
in values, and assuming natural physiological fluctuation in the parameters, Table 2 
shows values within ranges commonly identified.   
3.4 Results 
3.4.1 Modelling the Spectral Variation with Arthritis 
As discussed in section 2.2, inflammation of the joints is thought to induce a change in 
the concentration of the three absorbers, oxygenated haemoglobin, deoxygenated 
haemoglobin, and water in the joint and in the local tissues due to the biological 
processes associated with inflammation. In this section, computer-simulated ‘normal’ 
and ‘arthritic’ tissues were modelled for their reflectance and transmittance spectra. 
The changes in absorber concentrations may vary depending on factors like mouse 
model, time point in disease progression, and possibly other factors such as age/ 
genetic strain/ gender/ housing conditions, so the model of arthritis used in MCML 
should be considered a generic in silico model of murine paw inflammation and cannot 
be assumed to accurately model specific in vivo murine models of disease. For 
modelling the normal paw, the norm values in Table 2 were used. For modelling the 
changes in absorber concentrations in a generic, simulated arthritis the following 
changes were implemented in the model: 
Blood Volume Fraction: BVF increased from 3% of tissue volume in the normal tissue 
model to 5.4% in the arthritis tissue model in the muscle tissue layer, mainly informed 
by Gayetskyy et al. (23), where the increase in vessel volume was measured in 
successive regions of interest in the tissues surrounding the joint by microCT.  
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Oxygen Saturation: The haemoglobin oxygen saturation values were reduced in the 
arthritis model from 65% in the normal tissue to 50% oxygenated haemoglobin in the 
arthritic tissue model in the muscle and bone. This reduction is an estimation mainly 
informed by Van der Putten et al (18) where a 10.8% drop in oxygenation was 
measured in the microvasculature of the inflamed mouse tendon measured by 
multispectral microscopy and Rajaram et al (95) who measured an 11% drop in oxygen 
saturation in rabbits inflamed knee joints with time-resolved diffuse optical 
spectroscopy.  
Oedema: Oedema was represented in the model by an increase in the water 
percentage of the muscle by 15%. In reality this would increase the volume and in turn 
affect the scattering coefficients and other chromophore concentrations, however for 
the purposes of modelling just the water percentage was altered. Perilli et al. (25) 
showed an increase of 36% in the volume of CAIA mouse paws, supporting the 
increase of water content in oedema.   
Figure 19 displays the reflectance and transmittance spectra calculated for a layered 
tissue model of a mouse hind paw. ‘Normal’ and ‘arthritic’ reflectance and 
transmittance spectra are displayed in blue and red respectively, modelled according 
to the values discussed above. The raw spectra have been interpolated by a cubic 
spline, estimating the spectral response across all wavelengths from 480nm to 
1000nm. The circular marks on the spectra in Figure 19a and b indicate the 
wavelengths modelled by MCML.  
Figure 19 indicates that the incidence of biological chromophore changes present in 
the arthritic mouse paw should be detectable in the reflectance and transmittance 
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spectral response of the tissue, according to the Monte Carlo modelling results. Figure 
19c and Figure 19d displaying the difference between the two spectra indicate that, for 
reflectance, there is a decrease across all wavelengths between 480 nm to 1000 nm, 
with the maximum difference located between 600 and 700 nm (7.40% decrease in 
reflectance at 610 nm). Transmittance, absorption and backscatter in the tissue 
resulted in very low transmittance in the visible spectrum, and differences between the 
normal and arthritic spectra were only apparent at wavelengths exceeding ~600nm 
where light transmission through the tissue is likely to become detectable. The 
maximum difference in transmittance of 2.46% occurs at 642 nm.  
 
Figure 19: Reflectance and transmittance spectra from a Monte Carlo model of the ‘midfoot’ mouse hind paw in a 
‘normal’ and ‘arthritic’ state. a) Reflectance spectra from the Monte Carlo tissue layer model of the mouse hind paw, 
where a case of a normal (blue) paw and an arthritic (red) paw have been modelled using optical parameters from 
literature and measurements from H&E tissue sections. b) Transmittance spectra produced from the same model. 
c) Root Mean Square difference between the normal and arthritic reflectance spectra. d) RMS difference between 
the normal and arthritic transmittance spectra. 
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In general, arthritic symptoms lead to a reduction in reflectance and transmittance 
response across all wavelengths; a logical result considering the predicted increased 
concentration of biological absorbers in the tissue. Modelling results from the other 
areas of the feet showed smaller changes (section 8A3), but considering that the 
thickest muscle layer is found in the midfoot region and the modelled chromophore 
changes focus on the muscle tissue, this result was expected. Additional outputs of the 
MCML program for the modelling of the mouse hind paw have been included in the 
appendices (section 8.A2). 
3.4.2 Spectral Variation with Localised Parameter Changes  
In rheumatoid arthritis, the main site of pathology centres around the joint and the 
synovial lining of the joint capsule, affecting local tissues as modelled above. Although 
RA is a systemic disease and can have effects of other tissues, tissue distant from 
sites of inflammation shows no overt pathological changes.  
 
The MCML model of the central region of the mouse hind paw described above 
(section 3.4.1) was used to model changing optical parameters in the deeper tissue 
(e.g. muscle) versus superficial tissue (e.g. reticular dermis). Given that the signal from 
arthritic inflammation is likely to reside in the deeper tissue layer, it is informative to 
see whether the spectral response of the tissue is affected by the depth of the 
chromophore changes.  
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3.4.2.1 Tissue Layer vs Change in Spectra  
This section looks at the effect of tissue layer depth on the spectral effect of 
chromophore changes. Given the aim of multispectral imaging to look at the spectral 
changes caused by arthritis symptoms, the imaging system needed to be able to 
distinguish chromophore concentration changes in superficial tissues from 
chromophore changes at the site of pathology. Given that the mouse hind paw is a thin 
structure which contains a variety of different tissue types, the distance between 
different layers is less than 1mm. Detectable tissue changes resulting from arthritis 
were expected to be mostly in the muscle layer peripheral to the bone, roughly 0.8mm 
below the skin surface although this would vary with the anatomy of the paw. In this 
section we aimed to test whether the chromophore changes in tissue layers adjacent 
to the bone could be contaminated by cross-talk from chromophore changes in 
superficial layers of the skin. Figure 20 displays the results for changing the blood 
volume fractions in the dermis and muscle (Figure 20a and b), the oxygenation in the 
dermis and muscle (Figure 20c and d), and the water content (Figure 20e and f). 
3.5 Discussion 
3.5.1 Discussion of Results  
In the Monte Carlo in silico model described above, changes in the concentration of all 
three absorbers produce spectral changes in the reflectance and transmittance 
response of the tissue. For the concentration changes shown in Figure 20a and b, 
increasing the BVF causes the largest changes in reflectance and transmittance for 
the dermis and for the muscle layers. 
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Figure 20:The effect of changing individual model parameters on reflectance and transmittance spectra for a Monte 
Carlo model of the mouse hind paw a) Spectral changes in the tissue reflectance response resulting from increasing 
blood volume fraction (BVF) in the dermis (DermisModerate: darker blue 2.5-4.5%, DermisExperimental: pale blue 
4.5-5.75%), and the muscle layer (MuscleModerate: darker red 3.0-5.4%, MuscleExperimental: pale red 5.4-6.9%). 
b) Transmittance spectral response resulting from the tissue changes outlined in a. c) Spectral changes in tissue 
reflectance resulting from decreasing blood oxygen saturation from in the dermis (darker blue 65-50%, pale blue 
50-40%), and the muscle layer (darker red 65-50%, pale red 50-40%).  Blood volume fraction was set to 4.5% in 
the dermis and 5.4% in the muscle. d) Transmittance spectral response resulting from the tissue changes outlined 
in c. e) Spectral changes in the tissue reflectance response resulting from increasing water concentration in the 
dermis(darker blue 65-78%, pale blue 78-87%), and in the muscle (darker red 75-90%, pale red 90-100%). f) 
Transmittance spectral response resulting from the tissue changes outlined in e. 
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Figure 21: Root mean squared (RMS) difference resulting from changing individual model parameters for  
reflectance and transmittance spectra for a Monte Carlo model of the mouse hind paw a) The root mean squared 
difference between the reflectance spectra shown in Figure 20a, where BVF was changed in the dermis (blue and 
pale blue) and muscle (red and pale red). b) The RMS difference between the transmittance spectra shown in 
Figure 20b, where BVF was changed in the dermis (blue and pale blue) and muscle (red and pale red). c) The RMS 
difference between the reflectance spectra shown in Figure 20c where the blood oxygen saturation was altered in 
the dermis (blue and pale blue) and muscle (red and pale red). d) The RMS difference between the transmittance 
spectra shown in Figure 20d where the blood oxygen saturation was altered in the dermis (blue and pale blue) and 
muscle (red and pale red).  e) The RMS difference between the reflectance spectra shown in Figure 20e where the 
water content was altered in the dermis (blue) and muscle (red). f) The RMS difference between the transmittance 
spectra described in Figure 20f where the water content was altered in the dermis (blue) and muscle (red).  
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Figure 21a and Figure 21b demonstrate that for reflectance the spectral response of 
the tissue changes according to the depth of the tissue layer in which the absorber 
concentration change occurs. Increasing the BVF in the dermis decreases the 
reflectance response of the tissue primarily in the visible region of the spectrum 
between 500 and 600nm, whereas increasing the BVF of the muscle causes a 
decrease in the reflectance across all wavelengths of the visible and NIR spectrum, 
with a maximum response at around 620nm. In the case of vasodilation/angiogenesis 
in response to inflammatory activity in the joint, an increase in the BVF would be 
expected in the local tissues. These simulations suggest that multispectral imaging of 
the mouse hind paw would detect a decrease in reflectance across all the visible and 
NIR wavelengths in response to increased BVF in the joint tissue/ muscle.  
 
For the variation of the haemoglobin oxygen saturation, changes detectable in the 
simulated spectral responses of the tissue were dependent on the BVF. Unsurprisingly, 
decreasing the oxygen saturation has a larger effect on the spectra if the concentration 
of blood in the tissues is higher. Consequently, if the blood concentration of the mouse 
hind paw is lower than predicted by the model, changes in the spectral shape resulting 
from decreasing oxygen saturation may be difficult to detect.  
 
Changing the blood saturation in the dermis and muscle resulted in approximately 
equivalent changes in the reflectance response of the tissue for the visible wavelengths 
from 500 nm to 600nm, but saturation changes in the muscle resulted in larger changes 
in the reflectance response from 600nm to 1000nm. Another notable feature of 
saturation change was the isosbestic point at 800nm apparent in Figure 20c and d, 
showing an increase of reflectance and transmittance at these wavelengths with 
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decreasing saturation. This decrease in absorbance is in opposition to the effect of 
increasing BVF due to the relative effect of decreasing oxygenated haemoglobin. For 
imaging live arthritis models, these simulations suggested that changes in oxygen 
saturation resulting from increased metabolism in the inflamed tissue around the joint 
should be detectable in the reflectance and transmittance spectrum by an increase in 
absorption in the 600 – 800nm region.  
 
Measurable changes in the spectral response of the tissue resulting from changing 
water concentration were primarily contained in the region from 900 to 1000nm. The 
percentage change of the spectral response was relatively low, which may make it 
difficult to detect in an imaging system when noise is taken into consideration. Some 
arthritis models also experience less oedema than others so the presence of spectral 
changes resulting from water would depend also depend on the model being imaged.  
 
In general, longer wavelength photons sample the tissue to a greater depth, whereas 
the shorter wavelengths sample the more superficial layers, resulting in concentration 
changes of the same chromophores having a different effect on the spectral response 
of the tissue depending on the depth of the tissue layer. The results of these 
experiments suggest that arthritis-associated chromophore concentrations in the 
deeper layers of tissue adjacent to the bone should be detectable in the reflectance 
and transmittance spectra and should be distinguishable from superficial chromophore 
concentration changes.  
 
The MCML method of modelling photon transport in turbid media is a well-established 
model used often in modelling photon interactions with layered tissues (125,170–173). 
Although 3D Monte Carlo methods exist (121), a slab approximation was used for this 
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work to avoid the need for building an accurate 3D mesh. Although the effects of RA 
have been modelled in human fingers (17), to the authors knowledge this is the first 
incidence of modelling spectra from arthritic mouse hind paws. This work does 
however corroborate results detailed from previous imaging experiments in literature 
(94). 
3.5.2 Limitations 
The limitations of this modelling method were mainly due to difficulty in sourcing optical 
parameters from the literature and the approximations made by the MCML model.  
Lack of corroborated values to use as inputs to the model and differences in the 
geometry of the tissue can introduce uncertainty and error into the resulting spectra, 
and because of this the results of the model cannot be considered a replacement for 
real imaging data.  
3.5.3 Conclusion 
Modelling of the mouse hind paw using a multi-layered Monte Carlo based 
implementation of photon transport indicated detectable changes of the reflectance 
and transmittance spectra in a simulated model of arthritis. Values from literature were 
used to model the expected changes in chromophore concentrations. Further 
investigation with changing chromophore concentrations individually showed that 
increasing BVF, decreasing oxygen saturation, and increasing water concentration all 
contributed individually to the changes seen in the tissue spectral responses. They 
also produced characteristic changes in the tissue reflectance depending of the depth 
of the tissue layer. The next chapter details the first examples of hyperspectral data 
from live mouse arthritis models using spectroscopy.  
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4 Spectrophotometry of Rheumatoid Arthritis Mouse Models 
4.1 Introduction  
Modelling the mouse paw using Monte Carlo suggested that spectral changes should 
be detectable in the 450 to 1000nm spectral region in both reflectance and 
transmission geometry (section 3.4.1). This chapter discusses the first application of 
spectral imaging on the mouse paw using spectrophotometry in a reflectance and 
transmittance format, procuring high-resolution spectral data of the changes occurring 
due to arthritic symptoms. Section 4.2 introduces the equipment and calibration 
methods. Section 4.4.1 displays the data taken from live anaesthetised mice and 
Section 4.5 discusses the findings and issues of spectrophotometry for data collection 
from live mice.  
4.2 Equipment and Methodology 
The aim of spectrophotometry of live mice was to collect high-resolution spectral data 
simultaneously in a reflectance and transmittance geometry from the hind paws of live 
mice. The equipment used in designing the set-up for imaging is described below.  
4.2.1 Light Source  
The light source used for illuminating the subject of imaging was an Ocean Optics HL-
2000-FHSA tungsten halogen with a quoted spectral range from 360nm to 2400nm 
and a 6.7mW output, Figure 22a displays the spectrum of the light source measured 
in the reflectance geometry of the spectrophotometry system (section 4.3.1) using a 
99% reflectance standard.  
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Figure 22: Ocean Optics HL-2000-FHSA light source used for collecting spectrophotometry measurements. a) 
Spectral output of the Ocean Optics HL-2000-FHSA tungsten halogen light source. b) Photo of the Ocean Optics 
HL-2000-FHSA light source. 
 
4.2.2 Spectrometer(s)  
An Ocean Optics Flame-s spectrometer was used to measure diffuse reflectance data. 
The spectrometer has a wavelength measurement range from 190nm to 1100nm 
(spectral resolution approximately 0.3nm to 0.4nm increasing linearly over wavelength 
range), high thermal stability, a variable integration time from 1ms to 65 seconds and 
a quoted signal to noise ratio of 250:1 at full signal. OceanView software was used to 
control the spectrometer for taking measurements. The spectrometer was used in 
conjunction with a bifurcated 2m R200-7-VIS-NIR optic fibre with a 200μm core and a 
wavelength range from 400nm to 2100nm. For measuring diffuse reflectance, a probe 
was also designed in openSCAD and printed in black PLA plastic to keep the distance 
of the fibre from the tissue constant and to locally block background light (Figure 23a). 
It would not, however, block light which migrated through the tissue.  
An Edmund Optics BSR112E-VIS/NIR spectrometer was used to take transmission 
data from the imaging subject, with a wavelength range from 242nm to 1052nm 
(spectral resolution varying between 0.3nm and 0.5nm), and a variable integration 
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time. Instead of an optic fibre, a diffuser was placed in front of light input to the 
spectrometer.  
 
Figure 23: Spectrometers used to collect reflectance and transmittance spectral measurements. a) Reflectance 
probe designed using openSCAD and Slicer software for holding the reflectance probe optic fibre at a set distance 
of 3mm from the tissue and blocking background light illumination. b) Photo of the Edmund Optics BSR112E-
VIS/NIR spectrometer used for transmittance data. c) Photo of the Ocean Optics Flame-s spectrometer used for 
reflectance spectroscopy. 
 
4.2.3 Mouse Models 
All experiments were carried out at the University of Birmingham, UK, following strict 
guidelines governed by the UK Animal (Scientific Procedures) Act 1986, under PPL 
licence number 70/8003 and approved by the local ethics committee (BERSC: 
Birmingham Ethical Review Subcommittee). All mice were fed a standard chow diet 
and maintained on a 12-hour light-dark cycle. 
4.2.3.1 TNF dARE  
The TNF dARE colony (58), originally a gift from Prof. George Kollias (BSRC 
Alexander Fleming Athens University Medical School), was maintained in-house at the 
University of Birmingham. Mice were genotyped by Transnetyx for the presence of the 
transgene and were monitored weekly for signs of arthritis. TNF+/dARE mice develop 
arthritis symptoms whilst littermate controls TNF+/+ do not.  
 69 
 
Data shown in section 4.4.1.1 were taken from heterozygous C57BL/6 TNF dARE mice 
and their normal companion littermates on a total of three separate occasions. The 
data were combined for analysis. Thirteen mice were analysed in total, five of which 
were TNF+/dARE and eight were TNF+/+ controls. The age of the mice when 
spectrophotometry was performed ranged between the ages of 9 weeks and 13 weeks 
and both male and female mice were imaged. Two females at 9 weeks of age, one 
normal and one TNF dARE, six males at 12 weeks, four normal and two TNF dARE, 
and five males at 13 weeks, three normal and two TNF dARE.  
4.2.3.2 CIA 
6-8 week old male DBA/1 mice (Harlan) were injected subcutaneously at two sites on 
the lower back (100l in total, 50l at each site) with 1mg/ml complete Freund's 
adjuvant (Chondrex Inc., cat.no. 7001) containing 1mg/ml bovine type II 
collagen (Chondrex Inc., cat.no. 2002-2). On day 21 a boost injection of bovine 
collagen at 1mg/ml in Freund’s adjuvant (as above) was given intraperitoneally. Mice 
were scored daily for signs of arthritis which has a variable onset but normally begins 
between 20 and 35 days following the initial injection. Spectrophotometry was 
performed between 30 and 40 days following the initial injection. 
4.2.4 Imaging Protocol  
Spectrophotometry was performed on the hind paws of the normal and arthritic mice. 
The mice were anesthetised immediately prior to imaging then reflectance 
spectrophotometry data were taken from the underside of the paw and transmittance 
data from the upper side using the method described in section 4.3. Both hind paws 
were imaged and 3 repeat measurements were taken for each paw, removing and 
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replacing the probes on each occasion. Erroneous measurements where intensity was 
too low due to bad probe contact with the tissue were discarded and the remaining 
spectra were mean averaged to give one reflectance and transmission spectrum per 
paw. As far as possible, the reflectance measurements were taken from the centre of 
the paw, but due to the surface topology and the small size of the paw, there may be 
small variation in the location of the measurements. All experiments were carried out 
at the University of Birmingham, UK following strict guidelines governed by the UK 
Animal (Scientific Procedures) Act 1986 and approved by the local ethics committee 
(BERSC: Birmingham Ethical Review Subcommittee). 
 
4.3 Experimental Method Development  
4.3.1 Spectrophotometry System set-up 
In order to take measurements in a reflectance and transmittance geometry for live 
mouse subjects, the hind paw was illuminated by the light source though a bifurcated 
optic fibre and the reflected and transmitted light detected simultaneously through the 
use of two separate spectrometers. For measuring diffuse reflectance data, the second 
half of the bifurcated fibre was directed to the Ocean Optics spectrometer. Using this 
set-up light illuminates the tissue through the optic fibre then reflected light returns 
along the same fibre and is detected by the spectrometer. Figure 24a shows a 
schematic diagram describing the equipment set up. For simultaneous measurements 
of transmitted light the same set up was retained for illumination, for light collection the 
Edmund Optics spectrometer was placed directly below the mouse hind paw on the 
opposite side to the source of illumination. Spectral data were taken in a darkened 
room.  
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Figure 24: Spectrophotometry system set-up for collecting spectral measurements from mouse models of 
rheumatoid arthritis. a) Schematic diagram describing the geometry of the system for gathering diffuse reflectance 
and transmittance data from an imaged object. b) Photo taken of the diffuse reflectance and transmittance 
spectroscopy system. 
 
4.3.2 System Calibration  
Given that the calculation of reflectance and transmittance from this spectroscopy 
system was dependent on the instrument response function (IRF), combining the 
collective spectral efficiencies of the light source and components of the optical 
system, the system required calibration so that reflectance and transmittance spectra 
could be calculated for the imaged object.  
For reflectance imaging, Labsphere Spectralon® diffuse reflectance standards, with 
an optically flat reflectance in the range 250nm to 2500nm ±4%, and ±1% in the 
photopic range, were imaged in experiments under the same conditions (exposure 
time, frame averaging, background light) as the object of interest. Figure 25a shows 
the reflectance percentage of the standards calculated by the spectroscopy system 
and Figure 25b displays a photo of the 2%, 50%, 75% and 99% reflectance standards. 
The OceanView software used to control the Ocean Optics Flame-s spectrometer, 
automated the process of calibration by taking a light reading (reflectance data from 
the 99% reflectance standard) and a dark reading (reflectance data from the 2% 
reflectance standard) prior to taking data. The auto-calibrated spectra could then be 
corrected to 100% manually.  
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For transmittance spectrometry calibration, a spectrum of relative light source intensity 
was taken directly by the Edmund Optics Spectrometer with a Neutral Density (ND) 
filter of Optical Density either 1.0 or 0.6 inserted into the light pathway in order to 
reduce the light intensity to a level which would not overexpose the CCD. Calibration 
of the data was done manually using equation 11 
                                                     T =   
( )
( )
 ×  NDTransmission                                           (11) 
 
where Tλ is a vector of object transmission over wavelength, Sλ is the raw uncalibrated 
spectral transmission of the object, Dλ is wavelength dependent dark noise, Iλ is the 
ND filtered light source intensity, and NDTransmissionλ is the published data for the 
ND filter transmission at wavelength λ.  
Due to noise, the spectral data were mean smoothed across 20 data points giving an 
effective spectral resolution of 6.7nm in reflection and 7.9nm in transmission. The 
mean reflectance values for the reflectance standards calibrated by the 99% tile were 
75.35%, 50.92% and 1.63%, with coefficients of variation 2.10%, 4.16% and 13.27% 
respectively. The spectroscopy data from the reflectance imaging of the standards 
suggests that there is some variation in reflectance across the wavelength range of 
400 – 1000nm, but this agrees well with published data (174) and with later 
multispectral imaging of the reflectance standards (section 5.4.1).  
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Figure 25: Spectralon reflectance standards used for calibrating spectrophotometry measurements. a) Reflectance 
spectrophotometry results for the 75%, 50% and 2% reflectance standards calibrated by the 99% reflectance 
standard. b) Photo of the LabSphere 99%, 75%, 50% and 2% reflectance standards. c) ThorLabs published data 
for ND1.0 reflective filter transmission. 
 
4.4 Results  
4.4.1 In Vivo Diffuse Reflectance and Transmission Spectrophotometry  
This section describes the results from performing diffuse reflectance and 
transmittance spectrophotometry on the hind paws of a number of live, anaesthetised 
mice. The aim of these imaging sessions was to examine the spectral differences, 
previously modelled using Monte Carlo (Section 3.4.1), to see if spectral changes were 
apparent in real data. Section 4.4.1.1 deals with data taken from the TNF dARE murine 
model of rheumatoid arthritis alongside normal controls and section 4.4.1.2 discusses 
data taken from the CIA murine model of RA.  
 
4.4.1.1 TNF dARE Spectrophotometry 
The TNF dARE mouse, discussed in section 2.4.1, exhibits a form of erosive 
polyarthritis arising from the deletion of gene region controlling TNFα expression. 
Disease arises spontaneously with age and clinical symptoms of redness and 
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deformity are usually apparent around 9 weeks of age, progressing relatively 
symmetrically. The predictability of arthritis development, and the availability of this 
mouse model makes it a good candidate for preliminary spectral imaging. Details of 
the mice used in this experiment are discussed in section 4.2.3.1. 
 
 
Figure 26: Spectrophotometry average reflectance and transmittance data for normal and TNF dARE mice. N=5 
TNF dARE and N=8 normal mice, with spectra taken from two hind paws per mouse giving a total of 16 spectra for 
reflectance and 21 spectra for transmittance (spectra were removed from the data where repeatability over three 
repeat measurements was not achieved). Standard deviation for the data is displayed as a shaded region around 
the mean. a) Mean reflectance spectra from the hind paws of a sample of 10 normal and 6 TNF +/dARE 
measurements. b) Mean reflectance spectra for the data set shown in Figure 26a min- max normalised by 
reflectance between 575 and 900nm. c) Mean transmittance spectra from the hind paws of a sample of 12 normal 
and 9 TNF +/dARE measurements. d) Mean transmittance values for data set transmission of TNF dARE paw 
measurements min-max normalised by values between 500nm and 900nm.  
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The results of the TNF dARE spectrophotometry experiments are shown in Figure 26. 
Figure 26a and Figure 26c show the mean reflectance and transmittance spectra which 
have been measured and calibrated by the procedure outlined above, and Figure 26b  
and Figure 26d display normalised data showing the spectrally relevant variation 
apparent in the measurements. The spectral data were smoothed by a moving mean 
method, with the size of the window varying depending on the intensity of the light 
source. The effect of this is to smooth the data more in areas of increased noise but 
preserve the spectral shape in areas with decreased noise. All spectra were 
separately min-max normalised between the wavelengths of 575nm to 900nm for 
reflectance and 500nm to 900nm for transmission, excluding the extreme 
wavelengths due to increased noise in these spectral regions. The mean and 
standard deviation were then taken for the normalised data.   
 
In both reflectance and transmittance data, spectroscopy of the hind paws of the TNF 
dARE model of RA showed spectral differences, indicating that the symptoms of 
arthritis had changed the optical properties of the tissue to an extent which was 
detectable by spectrophotometry. In Figure 26b and Figure 26d the mean reflectance 
and transmittance spectra have been normalised to allow better visualisation of the 
changes occurring in spectral shape.  
 
Statistical significance for the separation of the spectra was determined by two-sample 
t-test of the root mean squared (RMS) distance, inter- and intra- diseased and normal 
mice, for the normalised spectral data. The sum of the RMS distance was calculated 
for all 16 spectra giving a total of 425 RMS values. The t-test was then performed 
between two groups, the RMS values for the differences between spectra within the 
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diseased and normal groups, and the RMS values for the spectral variation between 
groups. For the wavelength range 480 to 950nm, the RMS difference between spectra 
within the groups was significantly different from the RMS between the groups at a p-
value of 0.0251. For normalised transmittance between 480nm and 950nm, the RMS 
difference between groups was statistically significant at a p-value of 0.0351.  
 
4.4.1.2 CIA Spectrophotometry 
The results from spectrophotometry of the TNF dARE model of arthritis showed 
differences apparent in the reflectance and transmittance spectra of the hind paws. A 
small experiment was also conducted on the CIA mouse model of RA. The CIA mouse, 
described in section 2.4.3, has a different phenotype to the TNF dARE. Polyarthritis 
appears as classic inflammatory symptoms of swelling (oedema) and redness, and 
joints may be affected in a more localised and non-symmetrical pattern. The mice used 
in this experiment are introduced in section 4.2.3.2. 
 
Figure 27 shows the raw spectra and normalised spectra from a small experiment 
imaging 2 mice, one symptomatic CIA mouse and one experimental control. 
Reflectance spectra were taken from the top of the hind paw and transmission spectra 
were taken from the underside of the foot. The data shown in Figure 27 has been 
processed using the same smoothing and normalisation methods as described for the 
TNF dARE data.  
 
Evident spectral differences were apparent for both reflectance and transmittance data 
in one paw of the CIA mouse (paw 1). Notably, the same paw was scored to be more 
highly affected in the manual examination.   
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Figure 27: Reflectance and transmittance data for CIA mice hind paws, N=1 CIA and N=1 normal with spectra taken 
from two hind paws per mouse giving a total of four spectra. a) Raw reflectance data taken from the tops of the hind 
paws of 2 mice, 1 CIA symptomatic and one normal control. Data from separate feet are indexed by colour. b) Mean 
reflectance measurements from the data shown in Figure 27a, min-max normalised. c) Raw data for transmittance 
taken from the same 2 mice d) Min-max normalised transmittance values taken for the data shown in Figure 27c. 
 
 
Whilst no firm conclusions can be drawn from such a small group number, the results 
indicate that the CIA mouse does show spectrally detectable changes in tissue optical 
properties concurrent with arthritis symptoms, and that the spectral changes induced 
are different to those of the TNF dARE model of RA. The spectral effects in the CIA 
mouse were not symmetrical, the reflectance spectra show a decrease of reflectance 
across the NIR wavelengths in one paw and a more defined ‘w’ shape in the 500nm to 
600nm region indicative of a higher concentration of oxygenated haemoglobin. The 
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transmittance data shows a relative increase of transmission in the 600 to 800nm 
region suggesting that the overall oxygenation of the tissue is increased.  
4.5 Discussion   
4.5.1 Discussion of Results 
The spectrophotometry data has provided an indication that the optical changes in the 
hind paws of mouse models of RA may be detected by hyperspectral/multispectral 
imaging techniques. Whilst there was considerable intragroup variation in the raw data, 
normalising the spectra by the procedure described in Section 4.4.1.1 allowed the 
relative changes in spectral intensity between the arthritic and normal group to become 
clearly apparent. These changes were statistically significant according to the RMS 
distances. In the normalised data, both transmittance and reflectance appear to have 
relatively reduced intensity in the 600nm to 800nm region. Assuming that the 
pathlength of the light is equivalent between the arthritic and normal mice, this change 
is indicative of a decrease in the ratio of oxygenated haemoglobin to non-oxygenated 
haemoglobin, which has a higher absorption in this region. A similar effect is seen in 
section 3.4.2 when decreased oxygenation is modelled with Monte Carlo.  In contrast, 
the CIA data appeared to show increased transmission in between 600 and 800nm 
region perhaps suggestive of an increase in oxygenation. This supports the idea of 
different pathological processes occurring in the two different arthritis models where 
the CIA mouse has a more ‘inflammatory’ phenotype.  
There is also some evidence that the absorption of water can be seen in the TNF dARE 
data where the decrease in absorption at 967nm coincides with the peak in water 
absorption coefficients at 975nm (Figure 26), although the data are more susceptible 
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to noise in this spectral region. This peak is also apparent in the Monte Carlo model of 
the paw.  There is no clear difference between the normal mice and TNF dARE mice  
There also appears to be a variation in the spectral changes detected between different 
types of arthritis models. As discussed in section 2.4.1, the TNF dARE mouse exhibits 
an ‘erosive’ phenotype where bone erosion and inflammatory cell infiltration can occur 
independently of typical ‘inflammatory’ symptoms of swelling and redness. This 
parallels the human disease where bone erosion can progress between episodes of 
inflammation with subclinical synovitis (175). These data suggest that the processes 
involved in these two different mouse models may involve chromophores which 
produce distinct spectral changes.  
4.5.2 Limitations 
There were limitations associated with the spectrophotometric method of measuring 
spectral differences. With no spatial information and difficulty in verifying consistency 
in probe to tissue contact, covariant factors may influence the resulting spectra.  
Cross-population analysis of spectrophotometric data relies on the spatial data 
remaining relatively constant. Whilst spectrophotometry of the TNF dARE mouse 
group did reveal some spectral changes, exact and reproducible placement of the 
probe was difficult to achieve due to the small size of the mouse hind paw and the 
complex surface topography of the paw, which has many small protrusions of the 
dermis, called footpads, for cushioning the foot. The tissue structure of the hind paw is 
heterogeneous and spatial data cannot be ruled out as a factor in influencing spectral 
variation.  Likewise, in transmission, variation in light intensity may result from 
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measuring different tissue thicknesses resulting from measurements taken different 
areas of the hind paw.  
Other confounders with data collection include the reduced signal to noise ratio (SNR) 
at the extreme wavelengths, mainly due to low intensity output of the tungsten halogen 
light source. Whilst exposure time for the spectrometer could be increased to 
compensate low signal, the dynamic range of the spectrometer CCD limited exposure 
time in order to not overexpose the highest intensity wavelengths. In future 
experiments, the spectral output of the tungsten halogen bulb could be tuned with 
filters to attenuate the highest intensity wavelengths and adjusting exposure time 
accordingly, to increase SNR at the extreme wavelengths.  
4.5.3 Conclusion 
Overall, spectrophotometry confirmed that spectral changes in reflectance and 
transmission data occur in line with modelling predictions. The positive results from 
these data set foundations for the design of a multispectral imaging system, described 
in the following chapter, which could image in the both a reflectance and transmission 
geometry, providing spatial data as well as spectral data for the mouse hind paw.  
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5 Multispectral Imaging System Set-up and Characterisation 
5.1 Introduction  
The aim of this chapter is to describe the set-up, calibration, and imaging proficiency 
of the multispectral imaging system designed for the in vivo imaging of mouse models 
of rheumatoid arthritis. The chapter begins by describing the equipment and 
instrumentation (section 5.2), then discusses the spectral calibration of the system and 
the calibration of system components (section 5.3), and finally displays the results of 
a phantom imaging experiment with known optical properties (section 5.4).  
5.2 Equipment and Methodology 
The aim of this multispectral imaging system was to gather multispectral reflectance 
and transmittance data from the hind paws of anaesthetised mice. The wavelengths 
used ranged from 480nm to 1000nm for both reflectance and transmittance imaging of 
the whole hind paw.  This range of wavelengths was chosen to ensure that the 
multispectral imaging system could capture the electromagnetic regions with variability 
in absorption of haemoglobin and water. Imaging for reflectance and transmittance 
ensured that spectral data from deep and superficial tissue layers were detected.  
 
For the imaging of live, anaesthetised mice, the structural and functional design of the 
imaging system had to take several things into consideration. It is recommended for 
mouse welfare that the duration of anaesthesia is kept as short as possible.  If 
anaesthesia exceeds 15 minutes, external heat should be applied via a warming mat 
to help maintain the body temperature. The anaesthetic equipment included a tube for 
the administration of isoflourane, a scavenger tube, and a nose cone to fit around the 
face of the mouse. The system had to be easily dismantled for transportation, to allow 
 82
the location of experiments to vary. And finally, the imaging procedure has to take 
place in a surgery theatre where background light levels may be difficult to control.  
The performance of the imaging system as a whole depended on the performance of 
its components. Before outlining the imaging pathway for reflectance transmission 
imaging (section 5.3.1), the relevant characteristics of the individual components are 
described below. 
5.2.1 Light Source 
The light source used for this imaging system was the Thorlabs OSL1-EC high intensity 
fibre light source, with a tungsten-halogen 150W bulb, coupled to an optic fibre. The 
lamp takes approximately 20 to 40 minutes for thermal stabilisation of the spectral 
emission (section 8.A5). The spectral emission profile ranges from approximately 
390nm to 1020nm and is displayed in Figure 28b. 
 
 
 
Figure 28: ThorLabs OSL1-EC light source for the multispectral imaging system. a) ThorLabs OSL1-EC Tungsten 
Halogen 150W fibre light source. b) Spectral emission profile of the ThorLabs OSL1-EC fibre light source measured 
with an Ocean Optics Flame-s spectrometer. 
 
5.2.2 Filters 
To image at selected wavelengths, two PerkinElmer VariSpec liquid crystal tuneable 
filters were used, a Vis-07 VariSpec covering a wavelength range of 400nm to 720nm 
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and a SNIR-10 VariSpec covering a range of 650nm to 1100nm. The Vis-07 filter has 
a response time of 50ms and an average bandwidth of 7nm, the NIR-10 filter a 
response time of 150ms and an average bandwidth of 10nm. Both VariSpec filters 
possess a 20mm filter aperture, a maximum optical throughput of 500mW/cm2, and a 
wavelength accuracy calculable by Bandwidth/8±0.5nm. The typical transmission 
outside of the bandpass is quoted to be 0.01% or less. The use of liquid crystal 
tuneable filters allows fast, automated, vibrationless switching of bandpass filters 
between imaging wavelengths under computer control.  
 
Light was focussed upon entry and exit of the VariSpec filters. A series of lenses 
focused the light exiting the Thorlabs fibre aiming to collimate light before entry into the 
VariSpec. Likewise, lenses focused the light exiting the VariSpec filter onto the optic 
fibres guiding light to the stage, preventing too much light being lost by absorption into 
the body of the VariSpec.  The fibres were held in place by 3D printed components 
and the lenses used for focusing light were Thorlabs LA and LB lenses with focal 
distances ranging from 35mm to 150mm. The normalised spectral transmission of the 
filters’ transmittance with the Thorlabs OSL1-EC is shown in Figure 29b. 
 
 
 
Figure 29: Spectral transmission of Vis-07 and NIR-10 Varispec filters. a) Photo of the Vis-07 Varispec used to 
bandpass filter selected wavelengths for multispectral imaging. b) Graph showing the normalised transmission of 
the Vis-07 and NIR-10 Varispec filters with spectral input from the Thorlabs OSL1-EC high intensity fibre light source 
in 10nm steps. 
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5.2.3 Illuminating Ring and Optic Fibres 
For the reflectance multispectral imaging application of the system, an illumination ring 
placed around the lens was used for shadow-free illumination of the sample. An 
Edmund Optics 2” fibre optic ring light guide with a working distance from 1.5 to 9 
inches, a wavelength range of 400nm to 2000nm and an output beam angle of 18 
degrees was placed around camera lens for imaging.  
 
In addition, two Thorlabs 91cm, SM1, 5mm core light guides were used to carry the 
illuminating light to the VariSpec filters and from the VarSpec filters to underneath the 
stage platform for the transmittance imaging function.  
5.2.4 Camera 
The camera used in this imaging system was a RetigaExi monochrome firewire CCD 
camera from Qimaging, with 1.4 megapixel (1392x1040), 12 bit digital output, flexible 
exposure time control (10μs to 17.9 minutes), gain control (0.7 to 30x gain), offset 
(-2048 to 2047), and optional binning. The quantum efficiency of the camera adapted 
from published graphical data is shown in Figure 30b (176). The Retiga EXi was 
coupled with a 3.3x macro zoom, c-mount (MLM3X-MP 0.3X-1X 1:4.5) lens from 
Computar, with a 90mm focusing distance, and variable magnification from 0.3x to 1.0x 
and variable f-stop from F4.5 to F22 due to an inbuilt manual iris ring. The lens settings 
used in the system, addressed in section 5.3.3, allowed focusing over an area of 40mm 
x 30mm from a distance of 100mm.  
5.2.5 Polarisers, Diffuser and Mirror 
Several additional optical components were used to alter the path or properties of the 
filtered light, moving through the system. A Thorlabs reflective neutral density filter 
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Figure 30: Quantum efficiency of the RetigaExi CCD camera. a) The RetigaExi monochrome firewire CCD camera 
used in the multispectral imaging system. b) Values of quantum efficiency as a function of wavelength for the 
RetigaExi (176). 
 
ND = 4.0 was used as a mirror to reflect light exiting the light guide at 90 degrees for 
illumination from under the stage. This reflected input light was homogenised with a 
Thorlabs circle tophat diffuser (177), with flat intensity through a 50 degree scattering 
angle around the surface normal and a wavelength range from 380nm to 1100nm. Two 
linear polarisers were positioned in the system immediately after the diffuser and 
directly in front of the camera lens (section 5.3.1.2). The first polariser, set into the 
stage, was a 25mm x 25mm Wire Grid reflective polarising film from Edmund Optics 
(178), Extinction ratio 4250:1, with a wavelength range extending from 400nm to 
1200nm. In front of the lens was a Thorlabs linear polariser with extinction ratio 1000:1 
and a quoted optimal wavelength range from 600nm to 1100nm (polarisation was 
found to be sufficient for the purposes of this system below 600nm).  
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5.2.6 Structural Components 
Additionally, the unique requirements for the set-up of this system meant that several 
custom structural components were necessary. The stage, a holder for the ring optic 
fibre, a holder for the polarising filter, and a shade for blocking background light from 
the stage platform (Figure 31a - d) were designed using openSCAD and Slic3r 
software, then printed in black PLA plastic using a 3D printer. The stage was designed 
to allow the addition of a warming mat for the anaesthetised mouse (Figure 31c) and 
the additional components were designed so that the ring optic light was held at a 
consistent working distance of 9cm and the camera lens at 10 cm from the stage 
platform (Figure 31a, b and d) and directly above the polarising filter set into the stage.  
5.2.7 Additional Components  
A black non-reflective coating was used to cover stage imaging platform and the 
background light block, to try and reduce stray light effects. Acktar Spectral BlackTM 
coated foil was used, which has a hemispherical reflectance ranging between 2% in 
the visible wavelengths to approximately 2.5% in the NIR. Other components of the 
system included a laptop for controlling the equipment and storing the data and a clamp 
stand to hold components of the system in place. 
5.3 Experimental Method Development  
5.3.1 Pathways of Light for Reflectance and Transmittance Imaging 
5.3.1.1 Reflectance Imaging 
Reflectance imaging is designed to take spatial and spectral data for the diffusely 
reflected light of an object of interest. For reflectance multispectral imaging, the 
broadband light emitted from the tungsten halogen lamp was filtered through the two 
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Figure 31: OpenSCAD designs for 3D printed structural components of the system rendered in Meshlab. The 
images show a) a holder for the ring optic component. b) A structure to go around the stage for the dual purpose of 
blocking background light and fixing the height and relative position of the camera lens and ring optic arrangement. 
c) The imaging stage with a hole in the imaging platform for a diffuser, and a differential height to allow the addition 
of a warming mat. d) A holder for the polarising filter and camera lens. 
 
 
Varispec filters (section 5.2.2) in sequence, resulting in a range of illuminating 
wavelengths from 480nm through to 1000nm. Software allowed each of the individual 
Varispec filters to be operated automatically, matching the filter wavelength switching 
to the exposure times of the camera. The changeover between the different filters was 
manual.  
 
The sample was illuminated sequentially with the chosen wavelengths through the ring 
optic arrangement around the camera lens. This arrangement produced relatively 
uniform, shadow-free illumination of the subject. The coefficient of variation of light 
intensity (averaged across all wavelengths) was 12.5%, 9.2%, 9.9% and 9.7% for the 
2%, 50%, 75% and 99% reflectance standards respectively, giving an indication of the 
intensity variation of the projected light across an 8.04cm2 area. Reflected light was 
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then detected and imaged by a CCD camera. Figure 32c shows a schematic describing 
the light path through the imaging system for reflectance.  
5.3.1.2 Transmittance Imaging 
For the transmittance imaging protocol, the same set-up was maintained for the 
Varispec filters and the light source, allowing continuity in the experiment between 
reflectance and transmittance imaging. By replacing the ring optic fibre with a separate 
optic fibre at the output of the Varispec filter, the filtered light could be directed 
underneath the platform holding the subject of imaging. The 3d-printed stage was 
designed to hold a mirror that reflected the light output from the fibre at 90 degrees.  
 
In order to get flat illumination of the subject, the light from the optic fibre was first 
passed through a diffuser, before passing through a linear polariser in the base of the 
stage. The imaging object was therefore illuminated from below by widefield, linearly 
polarised light. This arrangement made it possible to calibrate and calculate the 
transmittance spectra. 
 
A second polariser was placed in front of the lens of the camera at a polarisation angle 
90 degrees to the first. Photons multiply scattered through the imaging object would 
be depolarised before emission from the tissue and would therefore be transmitted 
through polariser in front of the camera lens. Photons exiting the stage and travelling 
directly to the second polariser would remain polarised and therefore be blocked. The 
beneficial effect of such a system is blocking the background light of the stage from 
detection with the camera, preventing overexposure and bloom artifacts in the images. 
Figure 32d shows a schematic of the transmittance imaging pathway through the 
imaging system.  
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Figure 32: Set-up of the multispectral imaging system. a) A photo showing all components of the full multispectral 
imaging system. b) A photo of the imaging stage, with the ring light illumination and RetigaExi camera mounted on 
a clamp stand. c) A schematic of the reflectance mode of imaging where filtered light illuminates the stage platform. 
d) A schematic presenting the transmittance mode of imaging where the filtered light illuminates the sample through 
a polariser set into the stage. 
 
5.3.2 Spectral Calibration of the Imaging System 
The aim of the multispectral imaging system was to extract the percentage reflectance 
or transmittance of the incident light for a series of wavelengths, spatially resolved 
across an imaged object. Hence calculating the percentage of reflected/transmitted 
light was dependent on knowing the value of the incident intensity.  
 
Calculating the incident intensity of the illuminating light for the system across all 
imaging wavelengths is a function the light source output spectra, convolved by the 
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wavelength dependent efficiencies of the Varispec filters, the optic fibres, the camera 
quantum efficiency, any additional effects from optical components, and geometry-
dependent effects. Given that not all of these quantities were known and some would 
be difficult to measure, a calibration method using optical standards was used as a 
proxy to direct calculation of incident intensity.  
 
The images produced by the system were calibrated using diffuse reflectance 
standards for reflectance and neutral density filters for transmission, allowing 
calculation of percentage reflectance/ transmittance by dividing the object image by an 
image of a known optical standard. A description of the reflectance standards used for 
calibration is given in section 4.3.2. Data extracted from published graphical results for 
hemispherical reflectance of the standards used in this project are displayed in Figure 
33a (174). This method of calibration required that the imaging settings were kept 
constant, the tile was larger than the object, and assumed Lambertian reflectance for 
the tile and tissue (113). Equation 12 describes the process of reflectance calibration.   
                                                             [R] =  
[ ]
[ ] [ ]
                                                       (12) 
 
where [R] is an image where the pixels represent the percentage of reflected light, and 
[IObject], [IDark], and [IRefStandard] are images of the object of interest at sequential 
wavelengths, the dark noise, and the reflectance standard respectively.  
 
For transmission calibration, the polariser directly in front of the lens was removed and 
an image was taken of the light coming through the diffuser and polariser inset into the 
stage. To reduce the light intensity to a level that would not overexpose the CCD, a 
Thorlabs reflective ND filter of optical density 2.0 (transmission varies from 0.72% 
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transmission at 480nm to 1.20% transmission at 1000nm) was positioned in front of 
the stage polariser, whilst keeping the imaging conditions constant. Thus the relative 
intensity of the input light for transmission could be measured, and the transmittance 
of the object calculated by division with images of the illuminating light. Figure 33c 
shows published data of wavelength-dependent transmission for the ND filter (179) 
and Figure 33d displays the transmission for the polariser. Equation 13 describes the 
calibration of the transmission images. 
                                                      [𝑇] =  
[ ]
[ ] [ ]
 ×  
⃑
⃑
                                               (13) 
 
where [T] is an image where the pixels represent the percentage of transmitted light 
and [IObject], [IDark], and [IND2] are images of the object of interest at sequential 
wavelengths, the dark noise, and the ND2 filtered light respectively. Multiplying by the 
ND2 filter transmission efficiency per wavelength S  and dividing by the 
transmission of the lens polariser S  corrected for the imaging conditions of the 
object and allowed spectrally calibrated calculation of transmittance.  
 
Although it is not accounted for in equation 13, the object transmittance is likely to be 
underestimated due to the effect of calibration by light diffused by the tophat diffuser, 
compared to the Lambertian transmittance of the object (modelled for the mouse paw 
in section 8.A4).  Calculation shown in section 8A4 estimates that transmittance is 
underestimated by a factor of approximately 5.  
 
In order to analyse the data, a GUI was built using Matlab so that the user could select 
areas of interest in the image and extract spectral data by location. An average of the 
spectra was taken over selected circular regions of 69 pixels with 2x2 binning, at a 
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distance of 10cm, corresponding to an area of approximately 0.23mm2. This area was 
chosen so as to reduce noise which was evident in the spectral measurements taken 
from single pixels, but still be small enough to sample distinct regions of a mouse paw. 
Section 6.3.2 shows an example image of area selection in the mouse hind paw using 
the GUI.   
 
 
 
Figure 33: Reflectance and transmittance data required for spectral calibration. a) Data for hemispherical 
reflectance for Labsphere reflectance standards extracted from published graphs for the standards 99%, 75%, 50% 
and 2% tiles used in imaging experiments (174) b) Photo of the aforementioned reflectance standards. c) Spectral 
transmission profile of the Thorlabs ND20A used in multispectral transmission calibration, provided by Thorlabs d) 
spectral transmission of the Throlabs polariser positioned in front of the lens.  
 
5.3.3 System Characterisation and Parameter Tuning 
Understanding of the properties and limitations of the imaging system was critical to 
ensure the data were of the highest possible quality and important to the post-
processing of the data which it may affect. Sections 5.3.3.1 through 5.3.3.2 address 
the effect of changing focal depth and signal to noise ratio (SNR) arising from the 
physical effects of the broad wavelength range used and section 5.3.3.3 addresses the 
effect of varying bandwidth with wavelength in the Varispec bandpass filters.  
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5.3.3.1 Point Spread Function Calculation 
Point spread function (PSF) is a measure of the ability of the imaging system to focus 
on a point source of light. This is a well-known problem for microscopes which are 
diffraction-limited due to the physical properties of light, but in the case of the 
multispectral imaging system described above the challenge lay in the extent of the 
change in wavelength. The increasing wavelength causes the light to refract at a 
smaller angle in the lens, leading to blurring of sharp contrast areas in the image in the 
NIR spectral region. This effect had the potential to limit the usefulness of the data by 
causing spectral smearing and therefore was necessary to characterise.  
 
The macro zoom lens used to focus light onto the CCD is manually operated making 
refocusing time-consuming, and could lead to lack of continuity in the apparent size of 
the object. Given that we aim to compare the spectra for an area on a mouse paw 
through a small group of pixel vectors in the z-stack, change of magnification though 
different wavelength images would risk losing accurate preservation of the local 
spectra.  
 
Changing the aperture size was one possible method of controlling for PSF. 
Decreasing the size of the aperture increased the depth of the focal plane by effectively 
blocking more unfocussed background light. This was beneficial for the reducing the 
loss of focus at the longer wavelengths, but reduced the number of photons reaching 
the CCD and therefore the signal to noise ratio (SNR) of the image. The challenge was 
to choose the aperture to obtain the best compromise between small PSF and high 
SNR. 
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For calculating the PSF and the SNR, a set of images were taken at a series of 
wavelengths and several different aperture settings. The images were of an Edmund 
Optics focusing tile, with an example image included in Figure 34b. All of the images 
for the different aperture settings were taken under the same lighting conditions and 
the same exposure times.  
 
The σ-value of the PSF is a measure of the Gaussian spread where the larger the σ-
value the greater the width of the Gaussian bell-curve, and if convolved with an image, 
the more blurred the appearance of the image. Equation 14 shows the mathematical 
context of the σ-value and  Figure 34a shows the σ-value of the PSF of the focusing 
tile images as calculated by a genetic optimisation algorithm. A single line of pixels 
was isolated from each wavelength image across one of the focusing squares shown 
in Figure 34b. The algorithm then generated random Gaussian distributions according 
the equation 
                                                                      G =
√
e                                                            (14) 
 
where G is a Gaussian vector, v is a vector the length of the pixel intensities. These 
Gaussians were then convolved with a randomly generated step function representing 
a tile perfectly in focus and the error calculated between the computationally generated 
pixels and the real ones by squared sum of the difference. The random generation of 
numbers occurred inside bounds set by the user to constrain the algorithm and reduce 
the number of iterations required to reach a minimal error value. The algorithm iterated 
until the Gaussian with the lowest error was found.  
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The lens used by the system was a macro lens where the F-stop number was variable 
between 4.5 and 22 according to both the aperture size and the lens position. To isolate 
the effect of changing aperture size on the image, 5 evenly-spaced markers were 
drawn onto the lens varying the aperture from fully open (mark 1) through to half open 
(mark 5).   
 
Figure 34a shows the plot of the σ-value against wavelength for the different markers 
of the aperture settings. 
 
 
Figure 34: Gaussian sigma value describing image blur with changing aperture size. a) Optimal fitting of the σ-value 
for a Gaussian equation to images taken by the multispectral imaging system across the wavelengths range 450nm 
to 975nm. A series of images was taken for an increasing aperture size in the lens, demonstrating the imaging 
effects of narrowing the focal plane. b) Image taken at 750nm and ‘Mark 2’ aperture of an Edmund Optics focussing 
tile used to assess Point Spread Function and Signal to Noise Ratio in the multispectral imaging system.   
 
5.3.3.2 Signal to Noise Ratio Calculation 
Image noise is a combination of Poisson noise and dark current noise. Dark current 
noise is a result of thermal agitation of electrons within the CCD. It follows an 
approximately Gaussian distribution but can result in fixed pattern noise noticeable at 
longer exposure times, due to variability in the sensitivity of individual CCD sensors. 
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This could be corrected for by dark frame subtraction, where an image of equal 
exposure time was taken in complete darkness and subtracted from the data image.  
Poisson noise is a result of statistical variation in the distribution of photons. It has a 
root mean square value proportional to the square root of the image intensity. This is 
generally the primary source of image noise except in low light conditions.  
 
Figure 35 shows the signal to noise ratio calculated from the images of the focusing 
tile. An averaged value was taken from the lighter area of the image (signal) and 
compared to the dark area (noise) in the focusing tile for each individual wavelength 
(180). 
                                                   SNR[dB] =  20 x log ( )                                                 (15) 
 
where SNR is the signal to noise ratio in decibels, RMS signal is the root mean squared 
value of a lighter area of the image and RMS noise is the root mean squared value 
from a dark region of the image.  
 
There is an almost linear drop in SNR between the aperture settings for each 
wavelength indicating the effect of Poisson noise (Figure 35). Whilst this effect could 
be countered by brighter illumination or longer exposure times, the intensity of 
illumination was limited by the brightness of the light source and exposure times should 
be kept minimal for live mouse imaging.  
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Figure 35: Signal to noise ratio measured for a series of images of an Edmund Optics focussing tile across 
wavelengths 450nm to 975nm, taken with the multispectral imaging system. Each series of images was taken with 
a change in the aperture size and the data demonstrate the increasing signal to noise ratio with increasing aperture 
size. 
 
The ideal aperture size for the system would therefore be the widest aperture which 
still fell within an acceptable PSF. When imaging, small amounts of blur in the NIR 
were not found to affect the spectral results, increasing the aperture size offered a 
significant improvement in the imaging time. Mark 3 ( F11< Fstop >F22 ) was chosen 
for imaging of live mice because the image blurring was not found to affect accuracy.   
5.3.3.3 Bandwidth vs Spectra  
In the multispectral imaging system, two Varispec filters were used to filter light from a 
broadband illumination source to a series of selected wavelengths. The Varispec filters 
filter light across a series of wavelengths in a Gaussian centering around the desired 
wavelength (see Figure 29).  The spectral response calculated by the imaging system 
did not therefore belong to a single wavelength as was presumed by Monte Carlo 
modelling of the tissue, but was the sum of the spectral response across a series of 
wavelengths. If the true reflectance/transmission spectra of the tissue were non-linear 
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across the wavelengths covered by the Varispec filters spectral bandwidth, then the 
assumption that the image formed from the Varispec-filtered light was representative 
of the single pre-set wavelength would become invalid. However, the effect could be 
insignificant if changes in the spectral response were not detectable. This section 
details the effect that the filter bandwidth had on the calculated spectral response using 
a simulated reflectance spectrum computed by Monte Carlo modelling of the mouse 
hind paw model described in section 3.4.1. To calculate the effect of the filter 
bandwidth, the spectral response functions of the light source output filtered by the 
Varispec filters was measured using a spectrophotometer (Figure 36a). The spectral 
functions were then normalised by dividing the intensity values by the area under the 
curves  (Figure 36b) and convolved by the Monte Carlo spectrum to simulate the 
process of multispectral imaging (Figure 36c).  
Two individual Varispec filters were used to cover the width of wavelengths utilised by 
the multispectral imaging system. The effect of increasing wavelength could be seen 
to increase the bandwidth (full width at half maximum varies from 3.6nm to 9.3 nm) 
lineally for both Varispec filters with increasing wavelength, due to the method in which 
the Varispec filters light. For the Monte Carlo simulated reflectance and transmission 
spectra of the mouse hind paw, this lead to a maximum error of 1.26% at 975nm in 
reflectance and 0.41% at 1000nm for transmission. This error may vary slightly in 
accordance with the spectral response of the tissue. Overall, although there is likely to 
be small difference between the real reflectance values and the ones calculated by the 
multispectral imaging system at longest wavelengths, the characteristic shape of the 
spectra is retained.  
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Figure 36: Variation of Varispec filter transmission bandwidth and its effect on spectral measurements. a) Relative 
intensity of all the sequential wavelengths used in in vivo imaging detected at the stage platform in the reflectance 
configuration of the system. b) Probability density functions calculated from the Varispec Vis and NIR filter 
transmissions at the wavelengths used for biological imaging. c) Modelled reflectance spectra before (blue) and 
after (red) convolution the Varispec spectral functions. d) Modelled transmittance spectra at the wavelengths before 
(blue) and after (red) convolution with the Varispec spectral functions. 
 
5.4 Results 
5.4.1 Phantom Imaging for Validation of Spectral Calibration Method 
To determine the accuracy of the calibration method for reflectance imaging, several 
reflectance standards were imaged and the value for percentage reflectance 
calculated by calibration with the 99% reflectance standard. The tiles were imaged 
separately using wavelengths from 480nm to 1000nm in 10nm steps.  Figure 37a 
shows the results of this experiment. Exposure times, displayed graphically in Figure 
37c were chosen to get an ‘optically flat’ response from the reflectance standards. In 
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total the imaging time for the standards was approximately 73 seconds, excluding the 
time taken to switch the light input from the Varispec filters.  
 
The transmission mode of the multispectral imaging system was verified against 
hyperspectral data from spectrometer on an optical phantom model of skin (photo 
shown in Figure 37d). For the spectrophotometry data, the phantom was illuminated 
through the stage with broadband light, then calibrated by imaging the stage 
illumination though ND2, and dividing the spectral data by the known transmission of 
the filter to recover the spectral transmittance of the phantom. Figure 37b displays the 
transmittance spectra recovered from the multispectral imaging and 
spectrophotometry.  
 
For reflectance imaging, the average reflectance intensity for the calibrated images of 
the 75%, 50% and 2% tiles across the wavelengths of 480 to 1000nm were 74.49% 
(coefficient of variation 0.84%), 51.30% (coefficient of variation 1.32%), and 1.55% 
respectively (coefficient of variation 5.45%). Any inaccuracies in the reflectance data 
may arise from differences in height of the tile surfaces, noise in the images, or 
deviations from the exact reflectance percentage quoted for the tile. For transmittance 
imaging, the absolute difference in percentage varied between 0 and 0.2% between 
the wavelengths of 480nm to 930nm.  
 
For reflectance imaging, the average reflectance intensity for the calibrated images of 
the 75%, 50% and 2% tiles across the wavelengths of 480 to 1000nm were 74.49% 
(coefficient of variation 0.84%), 51.30% (coefficient of variation 1.32%), and 1.55% 
respectively (coefficient of variation 5.45%). Any inaccuracies in the reflectance data 
may arise from differences in height of the tile surfaces, noise in the images, or 
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deviations from the exact reflectance percentage quoted for the tile. For transmittance 
imaging, the absolute difference in percentage varied between 0 and 0.2% between 
the wavelengths of 480nm to 930nm.  
 
 
Figure 37: Spectral data from multispectral imaging of phantoms. a) Multispectral reflectance imaging of a series of 
reflectance stands. The average reflectance spectra were calculated from 30 spatially separate measurements in 
the image. b) Normalised multispectral transmission average spectra from 30 spatially separate measurements of 
an optical skin phantom, compared to a transmission spectrum measured by spectrometry. c) Exposure times used 
per wavelength. d) Photo of the skin phantom used in transmittance imaging. 
 
5.4.2 Phantom Imaging 
Imaging an object with known optical properties allows a comparison between the 
reflectance spectra predicted by MCML modelling and the reflectance spectra 
evaluated by the multispectral imaging system.  
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This section details the Monte Carlo modelling of an optical phantom (INO biomimic 
optical phantoms), in comparison with the reflectance spectra recovered from the 
multispectral imaging process. The homogenous, cuboidal, phantom (Figure 38c) had 
known reduced scatter (μs’) and absorption coefficients (μa) for the wavelength range 
590nm to 1000nm, recovered from a geometry-specific fitting using time-resolved 
diffuse optical imaging data (181). Figure 38a displays the optical properties of the 
phantom. For the MCML program input, the μs’ values were used for μs with an 
anisotropy (g) value of 0, and the μa values were used directly, together with a depth 
value of 25mm. The reflectance data from the multispectral imaging system were 
calibrated as above with imaging wavelengths from 480nm to 999nm in steps of 10nm, 
and an average reflectance spectrum was computed from 30 randomly selected areas 
of the image. Figure 38b displays the MCML modelled reflectance spectra with the 
average of the measured spectra. The experimental set-up was designed so that the 
surface of the block was at the same imaging distance as the corresponding image of 
the reflectance standard.  
 
Figure 38b displays the recovered spectral reflectance of the optical phantom as 
compared to the reflectance spectra modelled using the MCML Monte Carlo method. 
There is a clear resemblance in the shape of the spectra, showing that the effects of 
the phantom’s optical properties are broadly recognisable in the reflectance spectra 
detected by the multispectral imaging system. However, the error between the 
modelled spectra and the imaged spectra is maximum at 4.7% for 750nm.  
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Figure 38: Spectral data from multispectral imaging and Monte Carlo modelling of an INO Biomimic optical phantom. 
a) Absorption and reduced scatter coefficients for INO Biomimic optical phantom sourced from reference (181). b) 
Comparison of the MCML modelled reflectance spectrum for the optical phantom vs the reflectance spectrum 
recovered from multispectral imaging. c) Photo of the INO Biomimic optical phantom. 
 
Reasons for the difference between the modelled and imaged spectra is likely due to 
the difference between the geometry of the image in reality vs the point-source, semi-
infinite set-up assumed in the MCML model. In addition, the MCML model assumes 
single wavelength data whereas the imaging system images across the bandwidth 
imposed by the use of the Varispec filters. Also, approximately 2% of the reflectance 
calculated in MCML is due to specular reflectance, which theoretically is not detected 
by the imaging system.  
5.5 Discussion  
5.5.1 Discussion of Results 
The multispectral imaging system detailed above offers the ability to take multispectral 
data in both a reflectance and transmittance geometry at a flexible series of 
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wavelengths, across the visible and near infrared spectrum, for relatively small objects. 
In this case, the design and layout of the stage is especially suited to the imaging of 
the hind limbs of small animals, and the implementation of imaging meets the demands 
of the application. Comparing this system to commercially available imaging systems 
is apposite, although indirect, due to considerable variation in the method of data 
gathering in commercial multispectral and hyperspectral imaging systems. Relatively 
cheap, fast, solutions for multispectral imaging exist in the form of multispectral 
cameras with a small number of bandwidths fixed by filters or LED illumination. The 
advantage of these kinds of systems is the potential for fast data acquisition, ease of 
use, and low cost. The disadvantage is the inflexibility and low spectral resolution. 
However, this may represent a potential future avenue for this work if a small number 
of optimal imaging wavelengths could be found to work effectively in diagnosing 
symptom severity in mouse models of murine arthritis. The system has comparatively 
lower spectral resolution than other commercially available hyperspectral imaging 
systems such as push broom cameras, but such cameras are generally expensive, 
they rely on moving the object relative to the camera and require time to capture a full 
image.   
 
5.5.2 Limitations 
There are several caveats of the imaging system that influence the recovered 
reflectance and transmittance data. In reflectance imaging, due to the method of 
calibration used, it is assumed that the object of interest is flat and is imaged at the 
same distance as the reflectance standard. Given that intensity has an inverse 
proportional relationship with distance, if the surface height of the object varies, then 
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the calculated reflectance of the object may vary linearly in wavelength according to 
equation 16 
                                                                   I ∝    or  =  
 
                                                              (16) 
 
where I is intensity and d distance. Similarly, the angle of the imaged surface compared 
to the reflectance standard will also affect the calculated percentage of reflectance.  
For a lambertian surface, Lamberts Cosine Law states that the radiant intensity of a 
surface is directly proportional to the cosine of the angle between the surface normal 
and the measurement angle (equation 17). The same principle applies in reverse for 
illuminating a surface at a non-perpendicular angle. In the case of topologically 
heterogeneous objects such as the mouse hind paw, the incident illumination will not 
always be normal to the surface and hence detected reflectance will be reduced for 
uneven areas according to the cosine law  
                                                                        I = Icos (θ)                                                                  (17) 
 
where Io is the detected intensity, I is the input intensity, and θ is the angle between 
the direction of measurement and the surface normal.  
5.5.3 Conclusion 
This chapter describes the development of a multispectral imaging system made 
specifically for the purpose of imaging mouse paws in a reflectance and transmittance 
geometry.  Combining multispectral reflectance and transmittance (or multispectral 
imaging with fluorescence imaging) is recognized as a method of increasing data 
output (182–186), but is still relatively rare in medical multispectral/hyperspectral 
imaging (187). Tuneable filters were used which are common in imaging stationary 
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objects and generally faster than point scanning methods (188). Overall, the elements 
of the design of the system are relatively standard methods used in multispectral 
imaging, but geared towards the novel function of imaging mouse feet. The following 
chapter introduces the results of multispectral imaging for mouse models of arthritis. 
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6 Multispectral Imaging of Rheumatoid Arthritis Mouse Models  
6.1 Introduction 
This chapter presents the results of multispectral imaging and analysis for two different 
mouse models of rheumatoid arthritis:  TNF dARE and the K/BxN serum transfer, 
which have been described previously (section 2.4). The results of the imaging have 
been analysed and compared to other indicators of disease, with the aim of assessing 
the mice for the severity of their pathology and gaining an insight into the underpinning 
physiology. An experiment was also carried out to see if arthritis could be detected 
earlier using the multispectral method compared to standard clinical measurements of 
deformity or swelling which only capture late stage disease in TNF dARE mice and 
degree of swelling but not composition in K/BxN serum transfer mice.  
The symptoms exhibited by the TNF dARE and K/BxN serum transfer mouse models 
of RA manifest as erosive (characterised by progressive joint erosion and deformity) 
or inflammatory (characterised by measurable swelling of the paw) respectively. The 
initial results from spectrophotometry suggested that these different pathological 
processes result in differing spectral characteristics. This chapter extends the research 
with multispectral imaging of live mice and validates the results by correlating them 
with different measures of disease progression including clinical scoring, calliper 
measurements of paw swelling, scoring of H&E stained histology slides to measure 
the inflammatory infiltrate and degree of bone erosion, and microCT bone erosion 
analysis. 
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6.2 Equipment and Methodology 
6.2.1 Mouse Models 
The experiments were carried out on two different mouse models of rheumatoid 
arthritis. The first mouse model, the TNF dARE, is a classically erosive, genetic model 
of RA which shows symmetrical progressive symptoms beginning at approximately 5 
weeks of age (detectable by histology), manifesting in clinically detectable joint 
deformation and discolouration at approximately 12 weeks; an age at which the 
animals are commonly used in experiments for investigating fully developed arthritis. 
The second mouse model, the K/BxN serum transfer, is distinctly different from the 
TNF dARE model, exhibiting non-symmetrical swelling and a ‘redness’ of colouring, 
often affecting individual digits or areas of the foot. The pattern and number of joints 
affected in each individual mouse is variable and unpredictable. The arthritis peaks 
between 7 and 12 days after the initial injection of K/BxN serum and is clinically 
resolved after 21 days. All experiments were carried out at the University of 
Birmingham, UK, following strict guidelines governed by the UK Animal (Scientific 
Procedures) Act 1986, under PPL licence number 70/8003 and approved by the local 
ethics committee (BERSC: Birmingham Ethical Review Subcommittee). All mice were 
fed a standard chow diet and maintained on a 12 hour light-dark cycle. 
6.2.1.1 TNF dARE 
Details of the TNF dARE colony used in experiments have been introduced in section 
4.2.3.1. Two groups of heterozygous C57BL/6 TNF+/dARE mice and their normal 
companion TNF+/+ littermates were imaged using the multispectral system described 
in section 5. Both imaged groups contained six female mice, three of which were 
TNF+/dARE. For data described in section 6.4.1.1 the mice were aged 12 weeks at the 
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time of imaging, and for data in section 6.4.1.2 the mice were imaged at three 
timepoints from the ages of 5 weeks, 7 weeks, and 9 weeks old. 
6.2.1.2 KBxN ST 
Imaging data from K/BxN serum transfer mice are discussed in section 6.4.2. 6-8 
week old male C57Bl/6 mice, supplied by Harlan, were injected intravenously with 
100l K/BxN serum (a gift from Harris Perlman, Northwestern University, USA). 
Arthritis was monitored daily and was evident clinically at between 1-2 days following 
injection. Mice were imaged on day 12 following injection. 
6.2.2 Mouse Imaging  
For all imaging experiments, mice were anaesthetised for the duration of the imaging 
session using 3% isoflourane and a standard anaesthetic set up. A nose cone was 
used to maintain anesthetisation of the mouse during imaging session. The mouse 
was positioned lying prone on top of a warming pad with one hind paw extending 
backwards and resting on top of the stage polariser. The right paw was imaged first, 
then the left paw was moved into position above the polariser and imaged second. Full 
acquisition of reflectance and transmittance imaging data took approximately 7 
minutes per mouse and mice were culled by a schedule 1 procedure, once all imaging 
data had been obtained. Hind limbs were then dissected for microCT and histology.  
6.2.3 Histology 
Staining sections of the dissected paws with haematoxylin and eosin allows the soft 
tissue pathology and bone erosion to be seen and scored at a cellular level. Full 
brightfield images of the stained sections were taken with a Zeiss Axioscanner. The 
histology scoring procedure was then carried out (by Sophie Glinton) whilst blinded to 
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the genotypes of the mice. The protocol was as follows: for slides where the cartilage 
interface of individual joints could be clearly seen on the imaged section, the joints 
were given a score of 0 – 3 for severity. 0 = normal with no evidence of inflammation, 
1 = presence of inflammatory infiltrate without joint erosion, 2 = inflammation plus 
erosion of cartilage and/or bone but normal joint architecture intact; 3 = inflammation 
with severe joint erosions to the extent that joint architecture appears deformed. 
Examples of joint images are given in Figure 39. A mean score was taken for all the 
joints evident on each slide and for all the slides belonging to each mouse to give an 
average score for arthritis severity for each foot. 
 
Figure 39: Example images demonstrating scoring joints affected by arthritis in increasing severity from left to right. 
Score 0: no evident inflammation around the joint; score 1: visible inflammatory infiltrate but no damage to the joint 
structure; score 2: evidence of inflammatory infiltrate and erosion of the hard tissues; score 3: infiltrate with clear 
deformation of the joint. 
 
6.2.4 MicroCT Imaging and Bone Erosion Analysis 
After the mice were culled, hind legs were dissected at the hip joint and stored in a 
10% formalin solution for a period of 24 hours before transferal to 70% ethanol. 
Samples were imaged using a SkyScan 1172 micro-CT scanner from Bruker micro-
CT, which was operated using the accompanying software. The microCT settings were 
adjusted for good contrast for bone imaging: A voltage of 60kV and a current of 167uA 
was used in conjunction with an aluminium filter. Exposure time was set to 580ms with 
a rotation step size of 0.45 degrees and a frame average of 4. Raw data was then 
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reconstructed using nRecon software (Bruker). Flat field correction was performed and 
if necessary, misalignment compensation applied. Images were then reconstructed to 
an approximate image volume of 2000 x 2000 x 1187 voxels. CTAnalyser v1.12 (176) 
software was used to extract an isosurface mesh of the bony structures in the mouse 
hind paw. A global threshold was used to isolate bones from background and kept 
consistent between samples. The mesh was then extracted through a marching cubes 
algorithm and stored in polygon file format (PLY) (190). In order to meet the 
requirements for the microCT analysis software (see section 2.5.2.2 for description) 
(105), further mesh processing was carried out in Meshlab (1.3.2), open source 
software for mesh manipulation. Poisson surface reconstruction was used to smooth 
the appearance of the mesh. The inner surfaces of the bones were selected by setting 
a threshold with an ambient occlusion filter, then deleted, leaving only the outer 
surfaces of the bone. The complexity of the mesh was reduced through quadric edge 
collapse decimation to the approximate point density of the atlas used for registration 
in the software. Processing the samples gives a bone erosion ratio per bone, or the 
proportion of the bones surface area affected by erosions.  
 
In the experimental results shown in this chapter either an average bone erosion ratio 
was taken as a mean of all the individual bone erosion values for each of the bones in 
the hind paw, or a mean was taken for a particular region of the foot by dividing the 
bones into separate areas as shown in Figure 40 corresponding to the areas analysed 
in the multispectral imaging analysis.  
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Figure 40: A mouse hind paw mesh generated from a microCT scan and coloured to indicate how the bones of the 
hind paw were divided into areas for regression analysis with multispectral imaging results.  
 
6.2.5 Image Registration  
Comparatively long exposure times at the longest and shortest wavelengths, the time-
consuming switching between the two Varispec filters, and the breathing motion of the 
anaesthetised mouse meant that small movements of the paw occurred between the 
images taken at different wavelengths. The GUI method for extracting spectra from 
areas of the image relies on the same pixel region of each wavelength frame 
corresponding to the same region of the paw and therefore images were registered to 
align the paw within the multispectral image cube, for both the reflectance and 
transmittance data. The images were registered using a rigid, pixel-intensity based 
registration method within the Image Processing Toolbox in Matlab. Prior to 
registration, the images were calibrated and dark corrected, then registered to the 
image frame taken at 690nm.  
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6.2.6 Principal Component Analysis  
A statistical method was required to extract meaningful information from the 
multispectral data. The data produced from the GUI data extraction is 
multidimensional, effectively incorporating 520 wavelengths, from 4 different foot 
locations, for each separate hind paw of each separate mouse in an imaging session. 
In the experiments described in sections 6.4.1 through 6.4.2, principal component 
analysis (PCA) was used to analyse all of the data produced from the GUI data 
extraction (section 6.3.2) to assess the spectral changes occurring with arthritis 
symptoms.  
PCA calculates an orthogonal linear transformation of the data covariance matrix 
through Eigen decomposition, which maps the data to a new set of axes, known as 
principal components (191). The first principal component, or eigenvector, has the 
largest associated loading (eigenvalue), meaning that it corresponds to the direction 
of the largest variation in the data. Subsequent principal components describe 
directions of variation in order of descending size. Since most variation in the data is 
generally captured by the first few eigenvectors, the dimensionality of the data can be 
reduced. 
When performed on the multispectral data, PCA also produces a series of scores for 
each individual spectra, describing the coordinates of the spectra when transformed 
into the new axes of the principal components, effectively ranking the mice for how 
pronounced their spectral variation is. PCA for all mouse imaging sessions was 
computed using functions available in the Statistics and Machine Learning toolbox of 
Matlab.  
 114
6.2.7 Linear Discriminant Analysis  
In common with PCA, linear discriminant analysis (LDA) defines a transformation of 
the data into a more useful form. In the case of LDA, the input data are classified 
manually into 2 or more groups and the algorithm defines an axis (comparable to the 
eigenvectors in PCA) which best separates the two groups (192). Scores of individual 
data points can then be defined according to the axis. In section 6.4.3, LDA is used to 
define axes which best separate the spectra resulting from changes in chromophore 
concentrations in the Monte Carlo model (section 6.6.1).  
 
6.3 Experimental Method Development  
6.3.1 Multispectral Images of a Mouse Hind Paw 
Figure 41a and c show raw images for one complete set of reflectance and 
transmittance data from an anesthetized mouse’s hind paw, taken with the system 
described in section 5.3.1. In Figure 41b and d the images have been false-coloured 
according the imaging wavelength to represent their physical appearance when 
imaging.  
Figure 41 shows that imaging the paw at different wavelengths changes the 
appearance of the paw in both reflectance and transmittance. More blurring of the 
image is evident at the longest wavelengths, due to the different refraction of 
successive wavelengths within the lens altering the focal plane of image. There is 
also some specular reflectance apparent on the paw, but this was not found to be a 
major obstacle in processing the data. In the transmission images, it is clear that 
transmission of the visible wavelengths is very low for most of the foot, although most 
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wavelengths traverse the toes. However, for the longer wavelengths the effect of 
reduced absorption and scatter can be seen as the whole foot is transilluminated.  
 
 
 
Figure 41: Reflectance and transmittance images taken at a series of wavelengths for a single normal mouse hind 
paw. a) Raw reflectance images of a mouse hind paw taken at the annotated wavelengths. b) The images from a, 
false-coloured according to the wavelength of illumination. c) Raw transmittance images of the same mouse paw 
taken at the same wavelengths using the twin polarizer transillumination system. d) False-coloured transmittance 
images of the same mouse hind paw. 
 
6.3.2 Multispectral Data Analysis 
The raw images taken by the multispectral imaging system were processed in order to 
extract the spectral characteristics of the mouse feet (Figure 42). A GUI system was 
 116
designed in order to manually select regions of the feet for spectral analysis. As 
described in section 3.3.1.2, the images of the paw were analysed according to the 
four areas of the heel, the joints, the midfoot, and the toes due to broad anatomical 
differences in the structure of the foot that were found to influence the spectral 
properties of the tissue. For further spectral analysis, 10 spectra were taken from each 
area and averaged so that 4 mean spectra corresponding to the 4 paw regions could 
be taken from each multispectral dataset.  Figure 42 details the workflow of the spectral 
analysis method with an example from one mouse paw image.  A full set of images 
taken at each wavelength for reflectance and transmittance for one example mouse 
paw is included in the appendices (section 6.3.1).  
 
Figure 42:  Process of multispectral image analysis using a custom Matlab GUI to extract spectral data from regions 
of interest. a) Image of a mouse hind paw taken from the multispectral system, made by averaging all spectral 
frames. b) Image showing the areas manually selected for spectral analysis according to the four anatomical areas 
toes, joints, midfoot and heel. c) Graph showing all the reflectance spectra extracted from the image by the circular 
regions indicated and colour-coded in b. d) The reflectance spectra calculated from the mean of the 10 areas 
selected for each region of the hind paw.  
 
6.4 Results  
6.4.1 Multispectral Imaging of the TNF dARE Rheumatoid Arthritis Model 
Multispectral imaging was performed on TNF dARE mice in a blinded, randomised 
experiment. Section 6.4.1.1 details the imaging of a group of six TNF dARE mice at 12 
 117
weeks of age, taking multispectral data at a time period when the mice are expected 
to exhibit symptoms detectable by manual scoring. Three of the mice were TNF dARE 
heterozygous and the remaining three mice were normal control littermates. The 
results of imaging were compared with the results from histology, manual scoring and 
microCT data.  
 
Section 6.4.1.2 details a series of multispectral imaging sessions on TNF dARE mice 
taken from the ages of 5 weeks to 9 weeks when the mice have histological signs of 
inflammation, but may not yet outwardly display clinical symptoms. In general, 
heterozygous TNF dARE mice first exhibit detectable signs of arthritis in histology 
around 3 weeks old (193) and the clinical symptoms (swelling, discolouration, 
deformation, behavioural changes) become detectable around 6 – 8 weeks (55). This 
phase where arthritis symptoms are established is important in research, as the early 
phase of rheumatoid arthritis represents a window of therapeutic opportunity which is 
thought to influence long-term prognosis (194,195). The results of these two 
experiments are discussed together in section 6.4.1.3. 
6.4.1.1 TNF dARE 12 Week Multispectral Imaging 
The multispectral imaging method described above (section 6.3.2) was used to image 
the TNF dARE mouse model of rheumatoid arthritis. The data has been compared to 
a number of other metrics for assessing the severity of inflammatory symptoms 
(section 6.4.1.1.4). The mice were scored according to the clinical scoring method 
immediately prior to imaging (see section 2.5.1.1 for scoring sheet), then the spectral 
information from the imaging analysed as described above (section 6.3.2 and 6.2.6). 
The same process has been used in all subsequent experiments for the analysis of 
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multispectral reflectance data. In all experiments, manual scoring was carried out 
blindly by a researcher experienced in in vivo models of RA and with these models in 
particular. The details of the mice used in this experiment are discussed in section 
6.2.1.1. 
6.4.1.1.1 Reflectance 
Figure 43 displays the mean spectral reflectance from the healthy group and the 
arthritic group, where the spectra have been min-max normalised to emphasise the 
wavelength-dependent spectral variation between the two groups. Figure 44a displays 
the score along the 1st principal component for each area of the foot individually 
grouping the spectra for that region from all mice. PCA was performed on the raw (non-
normalised) reflectance data. The raw spectral reflectance data can be seen in Figure 
44b where mean spectra for each foot region have been superimposed on to a 
statistical shape model (SSM) (196). The SSM’s demonstrate the effect of the variation 
captured in the 1st principal component, for individual anatomical regions where the 
variation in the 1st principal component has been projected around the mean spectral 
response by 3 standard deviations either side. 
The 1st principal component (PC) was found to be the most effective in being able to 
split the group of healthy mice from their arthritic littermates. For this experiment, the 
1st PC of the reflectance data explains a mean of 95.3% of the data variance for the 4 
areas, computed by calculating the percentage of the eigenvalue for the 1st PC divided 
by the sum of all eigenvalues. 
Reflectance multispectral imaging of the TNF dARE mouse revealed a general 
decrease in intensity with arthritis symptoms which can be seen in Figure 44b, as well 
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as a spectral shape change where reflectance in the 480nm to 550nm and 600nm to 
800nm spectral regions are relatively decreased, apparent in Figure 43.   
 
Figure 43:  Min-max normalised reflectance spectral data from four areas of the TNF dARE mouse hind paw, from 
six 12-week old mice, N=3 TNF dARE and N=3 normal with two paws imaged per mouse giving a total of twelve 
multispectral datasets. Mean spectra for the normal group are displayed In blue with standard deviation shown as 
a pale blue shaded region and in red for the TNF dARE data. a) Average normal vs average TNF dARE reflectance 
spectra for the heel region of the hind paw b)  Average reflectance min-max normalised spectra for normal vs TNF 
dARE for the middle region of the foot. c) Average reflectance min-max normalised spectra for the joints region of 
the foot. d) Average min-max normalised spectra for the toes region of the foot.  
 
Monte Carlo modelling of the arthritic mouse hind paw in chapter 3 showed a decrease 
in reflectance across all wavelengths, which is maximal between 600nm and 700nm. 
This suggests that as modelled, there may be an increase in absorbing chromophores 
present in the tissue, particularly an increase in blood volume fraction and a decrease 
in oxygen saturation.   
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Figure 44: Results from principal component analysis of reflectance spectral data from four areas of the TNF dARE 
mouse hind paws from six 12-week old mice, N=3 TNF dARE and N=3 normal with two paws imaged per mouse 
giving a total of twelve multispectral datasets. a) Scores for the 1st principal component extracted from PCA of all 
the reflectance data for each individual area of the foot.  Spectra from each mouse paw are labeled m1 to m6 with 
right and left hind paws indicated by R and L. Each have been colourised according to their genotyping. b) 
Reflectance spectra for each hind paw from the group of 6 mice, separated into 4 anatomical regions. The spectra 
have been superimposed onto a statistical shape model describing 3 standard deviations of variation within the 1st 
principal component. c) Normal mice mapping of 1st PC score value for individual pixels of the four selected regions 
of the paw. d) TNF dARE mice mapping of 1st PC score value for individual pixels of the four selected regions of 
the paw. 
 
Using PCA to isolate directions of variation in the dataset exploited the fact that the 
primary cause of variation between the mice appeared to be a result of physiological 
changes induced by arthritis symptoms. Evidentially, the 1st principal component of 
the data represented an average of 95.3% of variance for the 4 anatomical areas and 
separated the normal mice from the TNF dARE mice, while (for this experiment) there 
 121
was no separation in subsequent PC’s, which seemingly did not contain variation 
relating to arthritis symptoms.  In the reflectance data shown in Figure 44b, the 
variation explained by the 1st principal component refers to a decrease in reflectance 
across all wavelengths, particularly affecting the 600nm to 800nm spectral region. It is 
likely that this corresponds with ‘greying’ of the paw described in the TNF dARE mouse 
model and is likely due to several physiological processes occurring in tandem. The 
1st PC scores have been represented visually in Figure 44c and d where the PC score 
is given for individual pixels and colormapped where blue is a higher score and red is 
a lower score.  The lower average score can be clearly seen for the TNF dARE mice 
(Figure 44d) compared to the normal mice (Figure 44c) and some TNF dARE displayed 
a more heterogenous score across the paw, for example M3L, compared to others 
which appear more consistent, for example M6R. 
 
The PCA analysis displayed in Figure 44a also highlighted details not revealed by 
standard clinical scoring methods: There appeared to be variation between paw 
regions and between hind paws of the same mouse despite being a symmetric model 
of arthritis. There was also apparent variation within the group of normal mice, 
demonstrating why scoring by eye, which relies on normal mice being scored 0, may 
be problematic.  
The significance of the difference between the two groups of spectra was tested using 
the method described in section 4.5, where a matrix describing the sum of the RMS 
difference per wavelength of every spectra was tested by a 2 factor student t-test to 
assess whether the intergroup difference was significantly more than the internal group 
difference. For the reflectance data of the TNF dARE and normal mice, the difference 
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was significant across all areas (p-values: heel = 0.0112, midfoot = 0.000859, joints = 
0.000111, toes = 3.10e-07). 
6.4.1.1.2 Transmittance 
The transmittance data from the multispectral imaging experiment has been analysed 
similarly (figure 45 and figure 46). In the case of transmittance, PCA was performed 
on min-max normalised data rather than the raw data due to the influence of the 
thickness of the tissue on spectral variation. When performed on the raw spectral data, 
the variation capturing the changes in arthritis were split across two principal 
components, whereas PCA on normalised data split the groups of mice in the 1st 
principal component explaining 91.5% of the variation. This method of analysis was 
used for all subsequent transmittance mouse imaging experiments discussed below.  
In the normalised transmittance data (figure 45), a trend for a change in the spectral 
shape can be seen where transmittance is relatively decreased in the 600nm to 800nm 
region of the spectrum. 
The peak in increased absorbance at 600 – 700nm in both the reflectance and 
transmittance spectra is strongly indicative of decreased oxygen saturation in the 
tissue. This peak correlates with the spectral changes seen with decreased oxygen 
saturation in the Monte Carlo model (section 3.4.1).  The RMS differences between 
the average spectra of the normal and the TNF dARE groups have been included in 
the appendices (section 8.A6).  
Similar to the PCA scoring results of reflectance, the 1st PC score could be seen to 
vary between the paws on the same mouse, between different regions of the paw, and 
within the group of normal mice.  
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Figure 45: Min-max normalised transmittance spectral data from four areas of the TNF dARE mouse hind paws 
from six 12-week old mice, N=3 TNF dARE and N=3 normal, with two paws imaged per mouse giving a total of 
eleven datapoints (M1L removed because spectral imaging failed due to paw movement during exposures). Mean 
spectra for the normal group are displayed In blue with standard deviation shown as a pale blue shaded region and 
in red for the TNF dARE data. a) Min-max normalised data for the heel region of the paw. b) Min-max normalised 
spectral data for the midfoot region of the paw. c) Min-max normalised data for the joints region of the paw. d) Min-
max normalised data for the toes region of the paw.  
 
Figure 46: Results from principal component analysis of transmittance spectral data from four areas of the TNF 
dARE mouse hind paws from six 12-week old mice, N=3 TNF dARE and N=3 normal, with two paws imaged per 
mouse giving a total of eleven datapoints (M1L removed - spectral imaging failed due to paw movement). a) Score 
along the 1st principal component for the normalised transmittance data for each area of the foot. Spectra from 
each mouse paw are labeled m1 to m6 with right and left hind paws indicated by R and L. b) Normalised 
transmittance spectra for each hind paw from the group of six mice for four anatomical regions. The spectra have 
been superimposed on a statistical shape model of the variation contained by the 1st principal component.  
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When performed on the raw (non-normalised) transmittance spectral data, the 1st PC 
spectral variation corresponded to a relatively linear decrease in spectral intensity and 
the 2nd to a decrease of transmittance in the visible wavelengths. Variation due to 
arthritis appeared to be contained within the first two PC’s making the scoring system 
inconsistent. Applying PCA to normalised data effectively removed the linear spectral 
decrease from the data and focussed on changes in spectral shape. Whilst a linear 
drop in spectral intensity also occurred in the reflectance data and could be attributed 
to the arthritic group, intensity in the transmittance data is more sensitive to the 
thickness of the tissue which is unlikely to be a symptom of arthritis in the TNF dARE 
model where swelling does not occur, but more likely due to the angle of the foot whilst 
imaged or the size of the mouse. Notably however, it does appear to be predicative of 
arthritis in the toes in line with the observation that TNF dARE mice tend to have 
thickening of the toes.  
In calculating the significance of the difference between the groups using 2-factor 
student t-test, only the heel had a significant separation between the group of spectra 
from the normal mice and the group of TNF dARE spectra (p-values: heel = 0.0194, 
midfoot = 0.286, joints = 0.852, toes = 0.387).  
6.4.1.1.3 Correlation of Reflectance and Transmittance PCA Scores 
The reflectance and transmittance PCA scores were compared in Figure 47 by 
Pearson correlation for individual paws (Figure 47a), as well as individual paw regions 
(Figure 47b). The reflectance and transmittance spectra may not be expected to 
correlate exactly due to the different paths the photons take through the heterogenous 
tissue. However, given that the imaged tissue was thin and both reflectance and 
transmittance tissues would be affected by chromophore concentration changes in 
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similar local tissue regions, a correlation could be apparent. The graphs in Figure 47 
have been annotated with the p-values calculated by Pearson correlation.  
 
 
Figure 47: Comparison of the 1st principal component scores from principal component analysis of reflectance and 
transmittance spectral data from four areas of the TNF dARE mouse hind paws from six 12-week old mice, N=3 
TNF dARE and N=3 normal, with two paws imaged per mouse giving a total of eleven datapoints (M1L removed 
because transmittance imaging failed due to paw movement during exposures). P-values and r-values calculated 
by Pearson correlation analysis. a) Comparison of the 1st prinicipal component scores for reflectance, averaged for 
each hind paw, to the 1st principal component scores for min-max normalised transmittance. b) Comparison of the 
1st prinicpal component scores for reflectance against the 1st principal component scores for transmittance for each 
individual area of the hind paw.  
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Significant correlations could be seen (p < 0.05) for the individual paw scores and for 
all the individual areas of the paws (except the toes), suggesting that the scores of the 
reflectance and transmittance spectra were influenced by the same local tissue 
physiological changes discussed above.  
6.4.1.1.4 Correlation of Spectral Variation with Other Indicators of Disease 
Multispectral imaging of the TNF dARE mouse model identified and characterised 
changes in the spectral response of the tissue between a group of normal and TNF 
dARE mice. This section aims to establish whether the spectral changes detected by 
the multispectral imaging system correlate with other signs of disease severity, to 
determine whether spectral imaging has potential as a method of disease assessment.   
To investigate whether the spectral variation correlated with several established 
methods of measuring disease progress, three measurements were taken of the TNF 
dARE mice. MicroCT data for all mouse hind paws were scored for bone erosion ratio 
using MArthA software, histology sections of the feet were prepared and scored for 
signs of arthritis as described in section 6.2.3, and the mice were scored manually for 
signs of arthritis using an accepted clinical scoring method prior to imaging (see score 
sheet in section 2.5.1.1). Pearson correlation p-values have been calculated between 
the PCA scores from the spectral data,and the metrics of arthritis symptoms produced 
by these methods.  
MicroCT Bone Erosion  
The bone erosion ratio scores produced by MArthA were compared to the multispectral 
reflectance (Figure 48)  and transmittance (Figure 49) PCA scoring at both the level of 
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each area of the paw and for the average scores of each individual paw, using the 
method discussed in section 6.2.4.  
 
 
 
Figure 48: Comparison of the 1st principal component scores from reflectance spectral data vs the bone erosion 
scores from microCT from four areas of the TNF dARE mouse hind paws from six 12-week old mice, N=3 x TNF 
dARE and N=3 x normal, with two paws imaged per mouse giving a total of eleven datapoints (M4L removed 
because failed registration in MArthA software). P-values and r-values calculated by Pearson correlation analysis. 
a) Comparison between the 1st PC reflectance scores per foot and the average bone erosion output from MArthA. 
b) Comparison between the 1st PC reflectance scores per area of each hind paw and the average bone erosion 
output of MArthA for the relevant bones of the paw.  
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Figure 49: Comparison of the 1st principal component scores from transmittance spectral data vs the bone erosion 
scores from microCT from four areas of the TNF dARE mouse hind paws from six 12-week old mice, N=3 TNF 
dARE and N=3 normal, with two paws imaged per mouse giving a total of ten datapoints (M4L removed because 
failed registration in MArthA software, M1L removed because transmittance imaging failed due to paw movement 
during exposures). P-values and r-values calculated by Pearson correlation analysis. a) Comparison between the 
1st PC normalised transmittance scores per foot and the average bone erosion output from MArthA. b) Comparison 
between the 1st PC normalised transmittance scores per area of each hind paw and the average bone erosion 
output of MArthA for the relevant bones of the paw. 
 
For both reflectance and transmittance a significant relationship (p-value < 0.05) 
existed in this dataset between the PCA score and the Bone Erosion score determined 
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by MArthA for each individual paw. However, the individual areas of the paws showed 
correlations that are significant in some areas but not others.  
 
For the individual feet, the p-value remained significant for reflectance (0.0283), but 
not for transmittance (0.765) when the TNF dARE group was analysed alone without 
the normal mouse data (although the group number was low (5 hind paw values)). This 
correlation suggests that the severity of arthritis is associated with the degree of 
change in the tissue spectral response. This would be a necessary relationship to fully 
establish if the spectral score were to be used as a tool for grading arthritis severity.  
 
 
Figure 50: Two example meshes from the microCT analysis using MArthA described in section 6.4.1.1.4. The mesh 
is coloured according to the Euclidean signed error where blue indicates areas of bone erosion and red indicates 
areas of bone deposition. The mesh produced from microCT of the normal mouse displays no distinct regions of 
erosion, whereas areas of erosion can be seen affecting many of the bones of the heel and around the 
metacarpophalangeal joints of the TNF dARE. 
 
Changes in tissue spectral response are unlikely to be a direct result of erosion, but 
the results from this experiment indicate that the more the spectral tissue response is 
perturbed from normal, the more erosion activity is occurring in the hard tissue. Figure 
50 displays a heatmap of bone erosion output from MArthA analysis of two of the mice 
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from this experiment, indicating typical regions of erosion found in the TNF dARE 
model. Blue regions correspond to bone erosion and red to bone growth.  
 
Histology 
Histology scores were taken for one hind paw from each of the 6 mice and have been 
compared to the corresponding PCA scores in Figure 51.   
Significant relationships were seen for both the reflectance and transmittance data with 
the histology scoring results, although unfortunately the sample number for this 
experiment was very small. The histology scores were based on the presence of 
inflammatory infiltrate as well as the extent of joint erosions. The strong correlation 
therefore corroborates the result of microCT analysis indicating increased erosion with 
1st principal component score and suggests a relationship between inflammatory 
infiltrate and spectral tissue response.  
 
 
Figure 51: Comparison of the mean 1st principal component scores from reflectance and transmittance spectral 
data vs the histology scores for the TNF dARE mouse hind paws from six 12-week old mice, N=3 TNF dARE and 
N=3 normal, with histology results taken from one paw per mouse giving a total of 6 values. P-values and r-values 
calculated by Pearson correlation analysis. a) Comparison between the results of Haemotoxylin and Eosin histology 
scoring for six mouse paws and the 1st principal component reflectance scores.  b) Comparison between the results 
of Haemotoxylin and Eosin histology scoring for six mouse paws and the 1st principal component transmittance 
scores.   
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Manual Scoring  
The manual clinical scoring procedure produces one arthritis score per mouse and 
has been compared to the mean principal component score per mouse for 
reflectance and transmittance in Figure 52a and b.   
 
Both the reflectance and transmittance Pearson correlations with the blinded manual 
scoring results gave significant p-values. In this experiment, all TNF dARE mice were 
correctly identified by blinded manual scoring and the mouse with the most extreme 
spectral response in both reflectance and transmittance was given the highest clinical 
score.  
 
 
Figure 52: Comparison of the mean 1st principal component scores from reflectance and transmittance spectral 
data vs the manual scores for the TNF dARE mice from six 12-week old mice, N=3 TNF dARE and N=3 normal, 
with two paws imaged per mouse and averaged giving a total of six values. P-values and r-values calculated by 
Pearson correlation analysis. a) The correlation between the manual scoring method for assessment of arthritic 
mouse models vs the mean 1st PC reflectance results per mouse. b) The correlation between the manual scoring 
method for assessment of arthritic mouse models vs the mean 1st PC normalised transmittance results per mouse. 
 
Discolouration of the hind paws constitutes only a small component of the clinical 
scoring method, which includes scores for deformity of the joints in both the front and 
back limbs, scores for altered appearance, gait, and behaviour. Significant correlation 
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with clinical scores would therefore suggest that the degree of discoloration of the paws 
is relevant to the health of the overall mouse. 
 
6.4.1.2 Longitudinal TNF dARE Imaging  
Data shown in the previous experiment found a change in the optical characteristics of 
TNF dARE mice to be associated with the exhibition of arthritis symptoms and 
pathology. The aim of this experiment was to image TNF dARE mice at an earlier 
timepoint in arthritis progression, to observe whether multispectral imaging could pick 
up differences at an early developmental stage of disease, before it is clinically 
detectable. Also, to follow how the developing arthritis symptoms influence the 
multispectral imaging results within the same subject mice. A group of 6 mice, 3 TNF 
dARE and 3 controls, were scored blindly by the manual scoring procedure once per 
week from the ages of 5 weeks to 9 weeks and imaged for reflectance and 
transmittance at 5 weeks, 7 weeks and 9 weeks. The mice were culled at the end of 
the week 9 imaging session and the hind limbs taken for microCT analysis before the 
genotypes of the mice were revealed. Details of the mice used in this experiment are 
discussed in section 6.2.1.1. 
PCA was employed for the analysis of the multispectral data to score the mice for 
spectral variation. The analysis was applied to the full group of temporal spectra so 
that the PCA score related the spectra from the three imaging timepoints to the same 
eigenvector. Figure 53 displays the 1st principal component reflectance scores for 
each individual paw (Figure 53a) and for each area (Figure 53b) over the 5 week 
timeframe. The PCA scores have been compared to the progression of manual scoring 
results (Figure 54) and the resulting bone erosion data from MArthA (Figure 55). 
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For this experiment, transmittance results have not been included. As with the results 
of the 12 week TNF dARE imaging, there were slight trends towards decreased 
transmittance in the 600nm to 800nm region of the spectrum, but the PCA scores 
showed a lot of overlap of the two groups and hence were unable to effectively grade 
arthritis symptoms.  
6.4.1.2.1 Reflectance  
The PCA scores from the longitudinal reflectance imaging of the TNF dARE mice 
indicate spectral changes apparent in the model as early as 5 weeks of age, across 
every region of the foot. The scores remain relatively consistent for each individual 
mouse paw across the five week imaging period (Figure 53a). If the 1st PC score is 
correlated with arthritis severity as suggested in section 6.4.1.1.4, this would indicate 
that the most symptomatic mice may be detectable from an early age. It also indicates 
that transient fluctuations in physiology are not overriding spectral changes happening 
due to arthritis. This result is encouraging that spectral imaging could be used to 
indicate the presence of arthritis at an earlier age than would be possible with manual 
scoring. 
 
When applying a 2-factor student t-test to the RMS distances between individual 
spectra for all timepoints separately, nearly all tissue regions for each timepoint 
showed significant separation between the spectral groups (p-values given in order 
heel, midfoot, joints, toes: Week5; 0.000369, 6.10e-05, 0.00383, 0.0108 Week7; 
1.21e-06, 5.36e-06, 0.000778, 0.398 Week9; 0.191, 0.0140, 0.0735, 0.000733). 
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Figure 53: Progression of the 1st principal component scores from reflectance spectral data for TNF dARE mice 
hind paws from six 5-week to 9-week old female mice, N=3 TNF dARE and N=3 normal, with two paws imaged per 
mouse giving a total of eleven values (M2L removed due to failiure of spectral imaging). a) Mean reflectance 1st 
PC scores from 5 weeks to 9 weeks of age for each individual paw from a sample of three TNF dARE mice (red) 
and three Normal controls (blue). Mice are indexed accoring to number and left/ right paw on the right of the graph 
b) Mean reflectance 1st PC scores from 5 weeks to 9 weeks of age for each area of each individual paw from a 
sample of 3 TNF dARE mice and 3 normal controls.   
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6.4.1.2.2 Correlation with Other Indicators of Arthritis 
Manual Scoring  
Clinical scoring was performed once weekly over the five weeks in a blinded 
randomised manner. Figure 54a shows the mean 1st principal component reflectance 
score per mouse from the 3 imaging sessions and Figure 54b shows the manual scores 
for the weekly timepoints.  
 
 
Figure 54: Reflectance score, manual score and weight for TNF dARE mice from 5 weeks to 9 weeks. Scores from 
six 5-week to 9-week old female mice, N=3 TNF dARE and N=3 normal, imaging taken for two paws per mouse 
and averaged giving a total of six values. a) Mean reflectance 1st PC scores (across both hind paws) for each 
mouse (M1 – 6) in the longitudinal TNF dARE imaging experiment, imaging timepoints at week 5, week 7 and week 
9. Disease status is indicated by the colour of the label (blue = normal, red = TNF +/dARE). Individual mice are 
indexed by number on the righthand side of the graph. b) Manual score for the same group of mice, scored weekly 
from 5 weeks to 9 weeks of age. Any score above 0 indicates arthritis symptoms detected by scoring method. c) 
Mouse weights taken at weekly timepoints from 5 weeks of age to 9 weeks. 
 
There is noticeably less consistency in the manual scoring than in the scores from the 
1st principal component of reflectance. Given that the TNF dARE is a genetic, chronic, 
and progressive model of arthritis, large fluctuations in the arthritis score are probably 
not representative of the severity of the symptoms. Pearson correlation analysis 
between the 1st PC scores, manual scores, and mouse weights show that only the 
correlation between 1st PC scores and weights is significant (p-values: weight vs PCA 
scores 0.0230, weight vs manual scores 0.4429, PCA scores vs manual scores 
0.7234).  Even with the benefit of additional parameters for assessment, clinical 
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scoring assessed two arthritic mice to be normal, one at 5 weeks of age and one at 7 
weeks in the longitudinal imaging experiment.  
 
Bone Erosion  
 
Figure 55: Comparison of the 1st principal component scores from reflectance spectral data vs the bone erosion 
scores from microCT for the TNF dARE mouse hind paws. Reflectance scores and bone erosion from six 5-week 
to 9-week old mice, N=3 TNF dARE and N=3 normal, with imaging and bone erosion scores performed for two 
paws per mouse giving a total of ten values (M2L imaging failed, M6L bone erosion registration failed, <10 values 
for individual areas where individual bones failed to register). P-values and r-values calculated by Pearson 
correlation analysis. a) Comparison of 1st principal component reflectance score (meaned across the measurement 
timepoints) against the mean bone erosion ratio produced by MArthA, for each individual foot. b) The 1st principal 
component reflectance score for each individual area compared against the mean bone erosion ratio for each area.  
 
 137
For comparison with the results of bone erosion calculated by MArthA, the 1st principal 
component reflectance scores were averaged over the three imaging sessions to take 
into account disease progression. Figure 55a displays the results for the average score 
per paw versus the bone erosion ratio. Figure 55b shows how the principal component 
and erosion scores compare per region of the foot.  
 
As with the 12 week imaging experiment for the TNF dARE model, a significant 
correlation was found between the bone erosion ratio and the 1st PC reflectance score, 
indicating a relationship between the spectral deviation away from the spectral 
response of the normal mice and the degree of bone erosion in the joints.  
 
 
6.4.1.3 TNF dARE Imaging Discussion  
The imaging experiments of the TNF dARE model have shown a consistent pattern of 
spectral change with the onset of arthritis symptoms in the hind paws. Principal 
component analysis of spectral data from the TNF dARE mouse model of arthritis was 
able to isolate the variation in groups of spectral data and provide a useful metric for 
the spectral variation relative to the group of spectra.  The spectral score for the 1st 
principal component has been found to correlate significantly with several alternative 
indications of arthritis symptom progression, suggesting that the physiological changes 
that influence the spectral response of the tissue are relevant to the pathological 
progression of arthritis. Multispectral imaging also provides a more detailed dataset 
than manual scoring and correlates better with alternative pathological measures such 
as degree of bone erosion and histological evidence of inflammation.  
 
Progression of the spectral scores over time were not obvious from the experiments in 
section 6.4.1.2. However, it was a small sample set so the data were sensitive to 
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outliers and it may be that progression in spectral score would have been detectable 
over a longer timescale.  
 
Both experiments detailed above found that spectral variation was apparent among 
the group of normal mice as well. Although the mice are the same age, sex and from 
the same genetic background, small differences in their physical size and tissue 
composition are expected, potentially resulting in the spectral variation seen. The 
amount of variation between the healthy mice could be interpreted as an indication that 
the variation in the TNF dAREs may not be a direct result of arthritis symptoms, 
however, the scores from the experiments show good correlation with other arthritis 
markers. It is possible that differences present in the tissue of the healthy mice may 
predispose certain mice to worse arthritis symptoms.  
 
Given the spectral changes predicted by the Monte Carlo arthritis model, it is likely that 
decreased oxygen saturation of haemoglobin is resulting in the consistent decrease of 
reflectance and transmittance seen affecting the 600 to 800nm spectral region. The 
relatively consistent decrease in reflectance affecting all wavelengths may be due to 
increased blood concentration, however, other factors which could produce a similar 
effect would be changes in the scattering properties of the tissue or the surface of the 
paw being imaged at an angle.  
 
Of all the arthritis assessment methods used in the experiments, histology scoring is 
the most directly related to soft tissue pathology. Whilst the number of samples was 
low, the experiments were indicative that inflammatory infiltrate and bone erosion 
visible on the slides correlated with the spectral score. An interesting experiment to 
conduct in future would be to investigate whether spectral changes were apparent in 
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the tissue before the onset of joint erosion, when inflammatory infiltrate became 
detectable in the histology, since physiological changes affecting spectral response 
such as hypoxia and increased blood flow are likely to begin with inflammatory cellular 
infiltrate. Other possibilities would be comparing the spectral score to the amount of 
inflammatory infiltrate to see if there was a correlation there.   
 
Bone erosion is an important topic in the study of RA as the gradual destruction of the 
joints contributes to limiting the abilities and quality of life of people with RA. The 
presence of focal bone erosions near the joint can be used as a marker for response 
in therapeutic intervention and the success of biologic drugs is in part due to slowing 
the progression of erosions (197,198). The correlations found between the spectral 
scores and the bone erosion may therefore be a useful measurement in these kinds of 
studies.  
 
6.4.2 K/BxN Serum Transfer Model Imaging  
As described in section 2.4, different murine models of rheumatoid arthritis can have 
different physical manifestation of symptoms. The experiments described in this 
section detail the results of multispectral imaging for the K/BxN serum transfer model 
of arthritis. Details of arthritis induction in the mice used in the experiment are 
discussed in section 6.2.1.2. 
A group of four mice were imaged with one normal control and three symptomatic 
K/BxN serum transfer mice. The mice were scored according to the clinical scoring 
protocol, including calliper measurements of the feet for assessing the degree of 
swelling.  
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6.4.2.1 Reflectance  
Figure 56 displays the normalised mean reflectance spectra together with the standard 
deviation for the normal and the K/BxN serum transfer mice. As with the TNF dARE 
experiments, Figure 57a displays the 1st principal component scores from the raw 
reflectance data, along with a statistical shape model describing the variation in the 
dataset and the superimposed raw spectral data (Figure 57b).  
 
 
 
Figure 56: Min-max normalised reflectance spectral data from four areas of the K/BxN ST mouse hind paw from 
four mice, N=3 K/BxN ST and N=1 normal, with two paws imaged per mouse giving a total of eight spectra. Mean 
spectra for the normal group are displayed In blue with standard deviation shown as a pale blue shaded region and 
in red for the K/BxN ST data. a) Average normal vs average K/BxN ST reflectance spectra for the heel region of 
the hind paw from a group of 4 mice. b)  Average reflectance min-max normalised spectra for normal vs K/BxN ST 
for the middle region of the foot. c) Average reflectance min-max normalised spectra for the joints region of the foot. 
d) Average min-max normalised spectra for the toes region of the foot. 
 
Testing the significance of the RMS distance with 2-factor student t-test between all 
the spectra of the normal and K/BxN serum transfer groups showed that only the toes  
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Figure 57: Results from principal component analysis of reflectance spectral data from four areas of the K/BxN ST 
mouse hind paws from four mice, N=3 K/BxN ST and N=1 normal, with two paws imaged per mouse giving a total 
of eight values. a) Score along the 1st principal component for the reflectance data for each area of the foot. Labels 
indicate mouse number and left/right hind paw. b) Reflectance spectra for each hind paw from the group of four 
mice, separated into 4 anatomical regions. The raw spectra have been superimposed on a Statistical Shape Model 
of the variation contained by the 1st principal component shown as a shaded region c) Normal mouse mapping of 
1st PC score value for individual pixels of the four selected regions of the paw. d) K/BxN ST mice mapping of 1st PC 
score value for individual pixels of the four selected regions of the paw. 
 
area was significant for this experiment (p-value heel: 0.0969, midfoot: 0.228, joints: 
0.629, toes: 0.0014). 
 
In common with the TNF dARE model, there was variation in the spectral shape around 
the 600 to 800nm region which relates to oxygen saturation. However, the effect 
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appeared less predictable, with some of the mice showing greater reflectance in this 
region and some showing less.  
 
Initial review of the PCA scores for the K/BxN serum transfer reflectance data shows 
that the scores for the normal mice vs the K/BxN serum transfer mice do not form 
distinct groups, like those seen in the TNF dARE experiments. However, as noted 
previously, this arthritis model exhibits symptoms less symmetrically than the TNF 
dARE and it is possible that certain paws may remain unaffected by arthritis symptoms. 
Correlation analysis with the calliper scores in section 6.4.2.3 support this theory. As 
with the TNF dARE model, the 1st principal component of reflectance described most 
of the variation in the dataset with an average percentage of 96.8% for the four areas 
of the feet. 
 
6.4.2.2 Transmittance 
Figure 58 shows the mean normalised transmittance data for the normal vs K/BxN 
serum transfer mice with the standard deviation indicated by the coloured region 
around the mean spectra. Figure 59 shows the scores for each spectra resulting from 
performing PCA on the normalised transmittance data.  
 
As with the reflectance data the K/BxN serum transfer paws and the normal controls 
did not form distinct groups, but there was correlation in the scores for reflectance and 
transmittance in all areas except the joints. In general, transmittance was lower in the 
600nm to 800nm region of the spectrum for the K/BxN ST mice, in common with the 
TNF dARE mouse.  
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Figure 58: Min-max normalised transmittance spectral data from four areas of the K/BxN ST mouse hind paws from 
four mice, N=3 K/BxN ST and N=1 normal, with two paws imaged per mouse giving a total of seven values (M1L 
imaging failed due to movement of the mouse during imaging exposure). Mean spectra for the normal group are 
displayed In blue with standard deviation shown as a pale blue shaded region and in red for the K/BxN ST data. a) 
Average normal vs average K/BxN ST transmittance spectra for the heel region of the hind paw from a group of 
four mice. b)  Average transmittance min-max normalised spectra for normal vs K/BxN ST for the middle region of 
the foot. c) Average transmittance min-max normalised spectra for the joints region of the foot. d) Average min-max 
normalised spectra for the toes region of the foot. 
 
Figure 59:  Results from principal component analysis of transmittance spectral data from four areas of the K/BxN 
ST mouse hind paws from four mice, N=3 K/BxN ST and N=1 normal, with two paws imaged per mouse giving a 
total of seven values (M1L removed  due to movement of the mouse during imaging). a) Score along the 1st principal 
component for the normalised transmittance data for each area of the foot. b) Normalised transmittance spectra for 
each hind paw from the group of four mice, separated into four anatomical regions. The raw spectra have been 
superimposed on a statistical shape model of the variation contained by the 1st principal component. 
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Testing the significance of the RMS distance for the normalised transmittance spectra 
of the diseased mice versus the normal mice showed that the midfoot and toes were 
significant (p-value heel = 0.416, midfoot = 0.0470, joints = 0.942, toes = 0.0132). 
 
6.4.2.3 Correlation of Spectral Variation with Other Indicators of Disease 
Calliper Measurements and Manual Scoring  
 
K/BxN serum transfer mice are an inflammatory model of arthritis and exhibit swelling 
of the paws which can be measured by callipers. In Figure 60, the scores for each paw 
resulting from PCA of the reflectance and transmittance spectra have been compared 
to the dorsal to ventral width of the mouse hind paws for the reflectance (Figure 60a) 
and transmittance (Figure 60b) principal component score average per paw.  
 
 
Figure 60: Comparison of the 1st principal component scores from reflectance and transmittance spectral data vs 
the calliper measurements for the K/BxN ST mouse hind paws from four K/BxN ST mice, N=3 K/BxN ST and N=1 
normal, with two paws imaged per mouse giving a total of eight values for reflectance and seven values for 
transmittance (M1L imaging failed due to movement of the mouse during imaging exposure). P-values and r-values 
calculated by Pearson correlation analysis. a) 1st principal component scores for reflectance have been compared 
to the width of the hind paws in mm. b) 1st principal component scores for transmittance have been compared to 
the width of the hind paws in mm. 
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A significant correlation was found between the reflectance principal component score 
and the paw width suggesting that spectral change in the reflectance response of the 
model is concurrent with swelling.  
 
No correlations were found comparing the PCA scores with the manual scores per 
mouse (manual scores M1: 13, M2: 9, M3: 12, M4: 0), but PC scoring and manual 
scoring both rated mouse 2 as least affected, and mouse 3, which was given the 
highest manual score for swelling and discolouration in the hind paws (M1: 4, M2: 3, 
M3: 5, M4: 0), was the most affected according to the 1st principal component 
reflectance scores.  
 
When the significance of the relationship between calliper measurements and 1st 
principal component score is tested after removing the normal controls, it remained 
significant for reflectance at p-value = 0.0169, but not for transmittance (p-value = 
0.558). 
6.4.2.4 K/BxN Serum Transfer Discussion  
Although the K/BxN serum transfer model has a different appearance to that of the 
TNF dARE, the PCA method of analysis was flexible enough to distinguish the spectral 
effects of arthritis when a normal control is included. The spectral results were less 
consistent for the K/BxN ST mice reflecting the less predictable, less symmetric nature 
of the model compared to the TNF dARE. Some similar trends were seen in the 
spectral reflectance and transmittance data, such as a relative decrease in reflectance 
and transmittance in the 600nm to 800nm spectral region, but the RMS difference 
between the mean of the arthritic group and the mean of the normal group was different 
for the TNF dAREs and the K/BxN STs (shown in section 8.A7), where the K/BxN ST 
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model had a relatively larger spectral change in the 800nm to 1000nm wavelengths. 
This could be due to the difference in the phenotype of the arthritis models. For the 
K/BxN ST model, the 4th principal component also appeared to separate the arthritic 
mice from the normal mice suggesting that the spectral change due to arthritis was not 
completely captured within the 1st PC for this model. 
6.4.3 Feature Mapping 
6.4.3.1 LDA Mapping 
Multispectral data inherently provide information about relative concentration of 
chromophores in biological tissue. For the multispectral images taken in section 6.4.1.1 
and section 6.4.2, spatial maps of the chromophore features were constructed. They 
display oxygen saturation, BVF in the deeper tissues, and BVF in the more superficial 
tissue  for the TNF dARE mice in section 6.4.1.1, and for the K/BxN ST mice in section 
6.4.2.  
Axes describing the chromophore concentration were isolated from simulated data 
using linear discriminant analysis (LDA) described in section 6.2.7. A library of Monte 
Carlo tissue spectra (Figure 61) from the mouse paw model (section 3) were classified 
according to particular chromophore changes. The parameter values input into the 
model were used to label each spectra as group one or two depending on the 
concentration of the chosen chromophore (group 1 high, group 2 low and mean). LDA 
was then performed to find axes discriminating the spectral changes. For example, 
spectra where oxygen saturation in the muscle layer of the model was altered were 
classified into two classes of oxygen saturation, regardless of other changes in the 
tissue. LDA of the data then identified the spectral variation corresponding to the 
increasing oxygen saturation in the muscle.  
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To generate the spectra, GPUMCML (199) was run iteratively for every possible 
combination of the parameters shown in Table 3, in total the number of spectral 
simulations was 13122 and the reflectance and transmittance spectra from each run 
were saved. Figure 61 displays the mean spectra and the standard deviation for 
reflectance and transmittance.  Given the additional computational demand of the full 
simulation, a GPU parallelised version of the MCML code was used in combination 
with a Tesla C2070, or GeForce GTS 450 GPU card.  
Table 3: Parameters sampled by the Monte Carlo model 
Dermis 
BVF 
Muscle 
BVF 
Dermis 
Depth/ 
μm 
Muscle 
Depth/ 
μm 
Melanin Conc Dermis 
SO2 
Muscle 
SO2 
Muscle  
Water 
Conc 
Bone Depth/ 
μm 
0.04, 
0.08, 
0.12 
0.04, 
0.08, 
0.12 
90, 100, 
110 
100, 
250, 500 
0.0087, 0.087 0.3, 
0.48, 0.7 
0.35, 
0.49, 
0.84 
0.63, 
0.79, 
0.95 
100, 300, 600 
 
 
Figure 61: Reflectance and transmittance spectra for 13122 iterations of the Monte Carlo hind paw model with 
varying parameters. The blue line shows the mean spectrum and the paler blue shows the standard deviation.  a) 
The mean and standard deviation for the reflectance spectra. b) The mean and standard deviation for the 
transmittance spectra.  
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Figure 62: Feature maps for the TNF dARE mice using linear discriminant analysis of Monte Carlo modelled spectra 
to define axes relating to muscle oxygen saturation, muscle blood volume fraction and dermis blood volume fraction. 
a) and b) Normal control littermates (a) and TNF dARE+/-  (b) mouse hind paws from the experiment described in 
section 6.4.1.1. Individual pixels in the image are scored according to an axis defined by LDA, isolating the spectral 
effects of oxygen saturation in the muscle layer of the Monte Carlo model. c) and d) As above, normal control 
littermates (c) and TNF dARE+/-  (d) mouse hind paws. Individual pixels in the image are scored according to an 
axis defined by LDA, isolating the spectral effects of changing BVF in the muscle layer of the Monte Carlo model. 
e) and f) As above, normal control littermates (e) and TNF dARE+/-  (f) mouse hind paws. Individual pixels in the 
image are scored according to an axis defined by LDA, isolating the spectral effects of changing BVF in the dermis 
layer of the Monte Carlo model. 
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Figure 63: Feature maps for the K/BxN ST mice using linear discriminant analysis of Monte Carlo modelled spectra 
to define axes relating to muscle oxygen saturation, muscle blood volume fraction and dermis blood volume fraction. 
a) and b) Normal (a) and K/BxN serum transfer (b) hind paw images from the experiment described in section 6.4.2. 
Individual pixels in the image are scored according to an axis defined by LDA, isolating the spectral effects of 
oxygen saturation in the muscle layer of the Monte Carlo model. c and d) As above, normal (c) and K/BxN serum 
transfer mice (d). Individual pixels in the image are scored according to an axis defined by LDA, isolating the spectral 
effects of BVF in the muscle layer of the Monte Carlo model. e and f) Normal (e) and K/BxN serum transfer mice 
(f). Individual pixels in the image are scored according to an axis defined by LDA, isolating the spectral effects of 
BVF in the dermis layer of the Monte Carlo model. 
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In Figure 62 and Figure 63, the spectra from individual pixels are scored according to 
the LDA axes and colour mapped. Several features of the mouse hind paws could be 
seen in a general observation of the maps. Areas of higher blood concentration 
appearing in the muscle and dermis BVF maps appeared to show the pattern of larger 
blood vessels in the tissue. The footpads could be seen as areas of lower blood 
concentration but high oxygenation and the heel, where large veins are close to the 
tissue surface, appears to be generally less oxygenated than the central region of the 
foot and the toes. There was also notable variation among the healthy mice, 
particularly for mouse 1 in Figure 62 where blood concentration appeared to be higher, 
most strikingly in the dermis BVF map. It is unclear what the origin of the difference 
was. It may be a result of a temporal change caused by a higher temperature of the 
warming pad or a longer anaesthetic time, or it could be an anomaly in the spectral 
data.  
 
For the TNF dARE mice (Figure 62), lower oxygenation could be seen particularly in 
the heel region of the foot, but extending in to the midfoot, joints and toes regions for 
several of the mice. No clear differences could be seen when isolating the blood 
concentration in the muscle layer, however, the dermis map appears to show lower 
blood concentration in the TNF dARE’s. For the most part, the footpads appear to 
remain well oxygenated and there is still a gradient of oxygenation visible from the heel 
to the toes.  
 
For the K/BxN ST mice (Figure 63), the worst affected paws according to the calliper 
measurements were the right side paws for all of the mice. The hypoxia map data 
appear to reflect these scores with larger regions of lower oxygen saturation visible in 
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the heels and midfoot. The effect of arthritis on blood concentration is not completely 
clear. Even though the K/BxN ST mouse is of a more ‘inflammatory’ phenotype, the 
presence of blood vessels makes it difficult to judge whether there is an increase in 
blood concentration locally in the arthritic tissue. There may be a suggestion of 
increased BVF in the muscle BVF map of a mouse visually affected by swelling of the 
heel area such as the right paw Mouse 2, but more research would be needed to 
establish a relationship.  
 
Overall, according to this method, the effects of arthritis on chromophore 
concentrations of haemoglobins do not appear to be highly localised to joint regions 
and the most notable effect for both arthritis models is decreasing haemoglobin 
oxygenation. These maps are based on a spectral changes calculated from Monte 
Carlo models and unfortunately cannot be evaluated against a ground truth. They 
should however provide some indication of relative chromophore change where unique 
spectral effects due to chromophore changes can be determined.  
6.4.3.2 Spectral Angle Mapping  
An alternative method for mapping the spectral data from the mouse paw figures is 
presented below in Figure 64.  Images of the TNF dARE paws from section 6.4.1.1 
have been colour mapped according to the angle between tangential lines of the 
spectra at 670nm and 585nm. Monte Carlo modelling of the mouse hind paw shows 
this angle increases with decreasing oxygen saturation (Figure 17, Figure 19, Figure 
20c). This method of mapping the spectra is independent of the Monte Carlo model, 
obtaining the angle measurements directly for the spectra associated with individual 
pixels. 
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Figure 64: Spectral angle maps produced from calculating the angle of intersecting tangents to the spectra at 670nm 
and 585nm for TNF dARE mice. a) Maps of the normal mouse hind paws produced from calculating the angle of 
intersecting tangents to the spectra at 670nm and 585nm. Increases in this angle were found to be related to 
decreasing oxygenation in the Monte Caro model. b) Maps of TNF dARE mouse hind paws produced from 
calculating the angle of intersecting tangents to the spectra at 670nm and 585nm. 
 
It is interesting to note that angle maps shown in Figure 64 show changes consistent 
with the changes predicted by LDA mapping where the TNF dARE mouse present a 
larger spectral angle indicative of lower oxygenation than in the normal mice. They are 
also consistent with the 1st PC score mapping in Figure 44 showing that some paws 
are more spectrally heterogeneous and some show more constant spectral values. 
Suggestions of anatomical features such as the veins in the heel can be seen for some 
of the mice. 
6.5 Discussion  
6.5.1 Discussion of Results 
The results of this chapter indicate that adopting multispectral imaging into the 
assessment of RA models could have potential benefits. A method of accurately 
gauging the severity of mouse symptoms in vivo could be a useful addition to 
experiments such as therapeutic intervention studies, for which progression of arthritis 
symptoms could be traced more accurately over the timeframe of the experiment. The 
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results also indicate that arthritis symptoms could potentially be picked up earlier than 
by manual scoring which would be useful for research following the early development 
of arthritis symptoms. There is also the matter of mouse welfare in RA experiments. 
Mice are generally given analgesia when they exhibit signs of pain, for example limping 
or reduction in voluntary movement, however, it is known that mice disguise pain 
(200,201), for which an accurate measure of arthritis progression could guide the 
introduction of analgesics.  Also, many studies assume that a group of arthritic mice 
are equally affected by disease, or use large numbers to get significant results, so 
better grading of the severity of arthritis could lead to more rigorous experimental 
analysis and potentially reduce mouse numbers needed for a significant outcome.   
 
This work would benefit from future experiments to further investigate the capacity of 
spectral imaging for assessment of mouse arthritis. It would be interesting to image 
more mouse models of RA, particularly for the recovery models where it would be 
useful to see if the spectral effects resulting from arthritis abate with the reduction in 
inflammation. If the technique proved valuable in the hind paws, it could be extended 
to include the front paws as well.  
 
Principal component analysis was a good method of capturing the spectral change 
resulting from arthritis and reducing the dimensions of the data to a single dimension 
giving a useful indication of spectral variation. However, applying PCA to small 
experiments such as those in this chapter will only give a score relative to the other 
spectra along the axis of the first eigenvector for the dataset. In future, if a large dataset 
were to be collected from different mouse models, it may be possible to define a global 
coordinate system to grade severity of arthritis symptoms from spectra in a way that 
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would allow comparison between experiments, and possibly between different arthritis 
models. This work has focused on scoring the mice rather than classifying them 
because genotyping already exists for identifying arthritic mice in the genetic models 
and induced models can be marked by ear tagging to be made identifiable.  
6.5.2 Limitations 
 
The correlation analysis with other indicators of arthritis assumes a linear relationship 
with spectral perturbation which may not be the case. If more data were gathered, the 
nature of these relationships could be fully investigated.  
 
One of the main difficulties with imaging the mouse hind paw with the multispectral 
imaging system described in chapter 4.3 is the difficulty in getting the mouse hind paw 
to lie reliably flat. The knee joint obstructed the limb from being extended backwards 
sole-upwards on a flat surface, particularly for the arthritic mice whose joints may 
already be less flexible. In some cases this resulted in the foot being tilted whilst 
imaged. This particularly affected the transmittance data, where the light path through 
the tissue could become much longer if the paw was tilted, resulting in more variation 
in the measurement. Normalising the transmittance data appeared able to correct for 
this to some extent, but reflectance data consistently produced better correlation with 
other indicators of arthritis and transmittance data were unable to separate the normal 
mice from the TNF dARE mice in section 6.4.1.2.  
6.5.3 Conclusion 
 
As discussed in section 2.5.1.2, multispectral imaging is a novel method of analyzing 
arthritis symptoms in mice. PCA is often used in multispectral imaging for unmixing 
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spectral signatures in the imaging of heterogenous materials (202–205). Likewise LDA 
dimensionality reduction has been used in classifying multispectral image data (206–
208). However, the particular application of these methods to the data can vary. In 
general, they are applied directly to image data. In this research, PCA was applied to 
selected groups of spectral data where the variation due to heterogenous tissue 
changes was removed as a factor and therefore the spectral features introduced by 
arthritis symptoms were isolated in the 1st principal component as the primary cause 
of variation. The LDA model was applied directly to image data but only after training 
on MCML model spectra making it a supervised method of isolating chromophore 
concentration-induced spectral changes. The advantage of multispectral imaging data 
is the ability to apply multivariate analysis methods and explore more of the tissue 
parameters as in section 6.4.3. In comparison to other papers, as discussed in section 
7.2, this work also showed success across multiple mouse models. 
 
The following chapter concludes the outcomes of this research project and discusses 
future possibilities for research in the field of multispectral imaging for mouse models 
of rheumatoid arthritis.  
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7 Conclusions and Future Work   
7.1 Summary of Findings 
In vivo assessment of mouse models of rheumatoid arthritis is an area for which the 
capability of several existing imaging tools has been evaluated in literature, but the 
practicality and accuracy of such techniques is debatable. It is also clear that there are 
issues associated with relying on manual scoring methods such as the one described 
in section 2.5.1.1 due to bias and inaccuracy. However, given the notion of 
discoloration included as a part of the scoring criteria, spectral measurements were 
proposed as a method of capturing the natural change in the tissue with the 
development and progression of arthritis symptoms. The aim of this thesis was 
therefore to investigate the ability of multispectral imaging methods to detect native 
changes in the tissue driven by joint inflammation. To this end, several novel 
experiments were carried out to evaluate the potential for multispectral imaging as an 
arthritis assessment method.  
 
Prior to imaging experiments with live mouse models, Monte Carlo simulations of the 
mouse hind paw were used to investigate the effect of changing concentrations of 
biological chromophores in the tissue in line with predictions informed by current 
literature. Changing blood volume fraction, blood oxygen saturation, and water 
percentage were found to contribute individually to reflectance and transmittance 
spectral changes in an ‘arthritic’ model. The spectral response of the simulated tissue 
also varied depending on the depth of the tissue layer where the changing 
chromophore concentration was modelled. These in silico experiments suggested 
spectral changes could be detectable in live mouse models.  
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Following on from these simulated experiments, reflectance and transmittance 
spectroscopy of the hind paw successfully detected significant differences between 
normal mice and TNF dARE arthritic mice. Promising results were also obtained for 
CIA mice. Whilst spectroscopy was not found to be the most reproducible or easily 
implemented method for obtaining spectral data from mouse hind paws, these 
experiments confirmed that differences in the tissue reflectance and transmittance 
were detectable in vivo.  
To gain information about tissue location and investigate whether arthritis symptoms 
could be further localised to areas of tissue using spectral imaging, this project 
developed a non-contact multispectral imaging system specifically designed to 
investigate the reflectance and transmittance spectra of mouse hind paws (Chapter 5). 
A system of sequential illumination with successive wavelengths of light was designed 
where the illumination could be manually directed to the surface of the underside of 
the paw in reflectance mode or redirected to illuminate the paw from below without 
having to move the mouse. A novel method using polarisers was employed to ensure 
the quality of the transmittance image data.  
Multispectral imaging of mouse hind paws detected reflectance and transmittance 
changes concurring with arthritis symptoms, with some degree of anatomical 
localisation. Analysing the spectra separately for four regions of the paws using 
Principal Component Analysis, the first principal component was found to isolate the 
spectral effects of arthritis symptoms. The scores pertaining to individual spectra could 
then be used to evaluate the individual mice relative to others in the experiment. The 
first principal component scores for the TNF dARE arthritis model were found to 
correlate significantly with bone erosion ratio results from microCT, blinded histology 
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scoring, and the blinded manual scoring method. These results suggest that the 
degree of spectral change detected in multispectral data is related to the progression 
of arthritis.  
The reflectance and transmittance spectra were found to vary across the paw due to 
the underlying anatomical structure. They differ between healthy mice and were 
perturbed by symptoms of arthritis. The nature of these changes is likely to involve 
multiple optical parameters, but trends in the spectral data suggest that decreased 
oxygen saturation is likely to be responsible for spectral changes in arthritic mice. It is 
also possible that increased blood volume fraction contributed to the more or less 
uniform decrease in reflectance, but separating this effect from scattering changes, or 
the difference resulting from imaging the uneven surface morphology, is complex and 
was beyond the scope of this thesis. Changes explicitly resulting from increased water 
percentage were also difficult to detect due to the low absorption in the wavelengths 
imaged and the decreased signal to noise ratio of measurements in the relevant 
spectral regions.  
 
Multispectral imaging detected changes in spectral responses of the mouse hind paw 
at an early stage in arthritis development for the TNF dARE model, before clinical signs 
were manifest. Imaging results for the K/BxN serum transfer model of arthritis were 
analysed by the same PCA-based method and found to correlate with calliper 
measurements of the paw. This demonstrates that spectral changes occur in tandem 
with inflammatory events in the tissue. Overall, this research supports the use of 
multispectral imaging for the assessment of arthritis progression and severity in murine 
RA models.   
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7.2 Comparison with Literature   
The requirement for a reliable method of tracking mouse arthritis symptoms is 
recognized (67,209), as it has potential to refine and reduce the number of mice used 
in experiments by overcoming issues introduced by inter-animal variation. As reviewed 
in section 2.5.1.2, different imaging techniques have been applied specifically to the in 
vivo assessment of murine models of RA including fluorescence imaging (92,210), 
infrared thermography (96), PET imaging (76,77), microMRI (80), and optical 
techniques (94). In some cases the authors propose these methods specifically for 
longitudinal assessment of arthritis symptoms in experiments (92,94,211). Other 
methods for assessment have included software for monitoring gait (212) and 
behaviour (213). 
 
Whilst multispectral imaging of mouse arthritis models cannot be used to probe 
molecular mechanisms like fluorescence molecular tomography or PET, it has 
potential advantages in the context of monitoring murine arthritis. Primarily, 
multispectral imaging does not require the expensive equipment and imaging times 
necessitated in fluorescence imaging and PET. Although the system described in this 
thesis requires anesthetics and a seven-minute imaging time, Section 7.4.1 outlines 
potential methods for streamlining the system design so that the imaging time could 
be reduced and aesthesis might not be required.  
 
Due to the ill-posed nature of the fluorescence inversion problem, fluorescence 
molecular tomography (FMT) is known to have errors associated with estimation of 
fluorophore concentration, requiring a priori structural data from integrated multimodal 
imaging systems to improve the estimation (214–216). Error in quantitation may 
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ultimately result in inaccurate grading of arthritis symptoms. For multispectral imaging, 
no injections of molecular markers are required, minimizing pain and distress for the 
animals in the imaging protocol. And, in contrast to PET/SPECT/CT imaging methods, 
no harmful radiation is used. Another potential value of the multispectral imaging 
method is that it could benefit research focusing on the role of hypoxia or angiogenesis 
in rheumatoid arthritis and hence assist understanding of these mechanisms in the 
pathology of arthritis.  
7.3 Wider Implications of Results 
Several of the outcomes of this research are relevant to the field of arthritis research, 
particularly for in vivo imaging. For the multiplexed imaging of fluorophores in vivo, 
multiple filters are being incorporated into some imaging devices to extend into 
multispectral imaging detection (217–219). The multiple wavelengths assist in spectral 
unmixing of fluorophore signals and removal of tissue autofluoresence. If multispectral 
reflectance/transmittance data could be taken with the same device, then the natural 
perturbation of chromophores in the tissue may be found to correlate with molecular 
changes in arthritis.  
 
This project found that changing tissue properties in the hind paws of the mouse 
significantly altered the reflectance and transmittance response of the tissue, indicating 
greater absorbance in the tissue in a wavelength-dependent manner. Given that 
quantitative FMT assumes similar tissue properties between subject mice, the outcome 
of this research is relevant to the results of fluorescence imaging studies, since the 
percentage of light reaching the fluorophore, and the percentage of Stokes-shifted light 
detected, is dependent on absorption by the tissue.  
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7.4 Future Work  
7.4.1 Further Development of the Imaging System  
In order to facilitate widespread adoption of the system, the multispectral imaging 
system could be redesigned to reduce the imaging acquisition time and cost.  
Acquisition time could be decreased through several techniques (section 7.4.2) and a 
system could theoretically be set up which did not require anaesthetizing the animals. 
This would reduce distress and handling time and make more imaging timepoints 
possible over the timeframe of an experiment. Figure 65a shows a restraining device 
commonly used for administering tail injections. If a device like this were placed 
above an adapted multispectral imaging system, reflectance data could be taken for 
all 4 of the mouse paws simultaneously, as demonstrated in the schematic diagram 
in Figure 65b.  
 
If a system could be designed which did not stress the animal, then the number of 
times the mouse could be assessed would essentially be limitless, which is not the 
case with most alternative imaging methods due to ethical reasons.  
 
Figure 65: Potential set-up for a multispectral system which would not require anaesthetic. a) A picture of the type 
of device commonly used to restrain mice for administering tail injections. The source of the image is given in 
reference (220) b) A theoretical set up for a multispectral imaging system which could allow imaging of the arthritis 
models paws without the need for anaesthetics.  
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7.4.2 Potential Methods for Reducing Image Acquisition Time  
7.4.2.1 Reflectance vs Transmittance Imaging  
The outcome of modelling the mouse hind paw and the results of imaging both 
indicated that reflectance multispectral imaging produces more distinctive results than 
transmittance. Both showed larger RMS differences between the normal and arthritic 
groups, and reflectance PCA scores generally correlated better with alternative 
measures of arthritis. Although transmitted light is likely to have traversed more tissue 
layers, information from the visible region of the spectrum is mostly lost due to very 
low transmission, reducing the usable spectral data. The model also predicts lower 
absolute change in the transmittance percentage between the normal and arthritic 
mice, suggesting that the average percentage of the photon pathlength spent in the 
tissues affected by arthritis is less in transmittance. Therefore, for imaging mice, 
reflectance multispectral imaging alone is sufficient for arthritis assessment. However, 
if the imaging system were extended to larger animals or imaging of humans, it may 
be the case that in thicker tissue the transmittance spectra would be more sensitive to 
arthritis symptoms. The penetration of the reflectance may be insufficient to sample 
the affected tissue region and the increased transmission pathlength may increase 
sensitivity to optical contrast.  
7.4.2.2 Wavelength Optimization  
Although the number of wavelengths used in this project were informative, it is likely 
that there is some redundancy in the data. If the number of imaging wavelengths were 
reduced, the imaging time would naturally decrease making the technique a more 
feasible method for arthritis assessment. For continuous-wave DOT, optimal sets of a 
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chosen number of wavelengths are selected through minimizing the residual norm of 
the least squares reconstruction and the condition number of the extinction coefficient 
matrix (221–223). For calculating the best wavelengths in multispectral imaging, 
criteria such as the 1st principal component score and condition number of the 
absorption coefficients could be used in an optimization to preserve the accuracy of 
arthritis assessment but with a reduced number of imaging wavelengths.  
7.4.2.3 Spectral Estimation  
Another potential option for the future of this work is to simplify the data gathering 
process to the use of cheap, easily available equipment, such as RGB cameras, and 
use more sophisticated post-processing algorithms to estimate the spectral data. Using 
a priori spectral data such as RGB photos of colorchecker charts with known 
reflectance spectra, the underdetermined problem of RGB to multispectral estimation 
becomes a regression problem solvable through methods such as neural networks 
and kernel regression (224,225).  
7.4.2.4 Illumination  
Another option for reducing the acquisition time would be to change the method of 
illumination to a fixed alternative such as narrow bandwidth LED’s, or lasers. Using 
dedicated fixed wavelength illumination, imaging time could be reduced through 
comparatively stronger illumination at the low emission regions of a tungsten halogen 
light source. A cheaper filter-based alternative to the tuneable filters used in this project 
would be interference filters with a computerized filter wheel.   
7.4.3 Model Development  
Using the semi-infinite tissue layer model, the initial aim for a direct inversion (104) 
mapping the remitted spectra to tissue parameters was not achieved. The mouse paw 
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is a problematic surface for spectral imaging owing to being nonuniform and the semi-
infinite layer model potentially oversimplified the problem. 3D implementations of 
Monte Carlo models have been designed to allow for more complex morphologies 
(226–228), and microMRI/ contrast-assisted microCT/ histology (229–231) could 
inform a 3D tissue-segmented model of the mouse hind paw. This would not 
guarantee invertibility since combinations of the parameters could potentially result in 
non-unique changes to the spectra but may offer improvements upon the layer model. 
7.5 Multispectral Imaging for Rheumatoid Arthritis in Humans?  
As discussed in section2.3.5, several optical imaging approaches have been 
attempted for the imaging of healthy joints and rheumatoid joints in patients, often 
specifically aiming to detect physiological changes in early arthritis. Several systems 
attempt tomographic reconstruction of tissue optical parameters. They are able to 
show differences occurring with arthritis onset in the patterns of optical parameters in 
the tissue and reconstruct distribution maps of estimated chromophore concentrations 
(45,46,52,53,232–234). Other systems, one of which is commercially available, use 
varying methods of analysis of the data from NIR spectroscopic methods, often with 
the use of pressure cuffs to temporally alter tissue contrast (40,41,235,236). In general, 
these systems are able to detect differences between healthy and arthritic joints and 
in some cases they exhibit sensitivity and specificity equivalent to other clinical imaging 
methods such as MRI and ultrasound, according to optimized classification algorithms 
with selected image features (53). In order for these systems to be adopted clinically, 
their cost-effectiveness and ability to detect and accurately grade subclinical synovitis 
must be proved.  
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Modelling of multispectral imaging for rheumatoid joints showed potential for 
multispectral imaging to detect changes in the joint in reflectance and transillumination 
set-ups (17). Later, hyperspectral reflectance imaging of RA patients detected 
differences between a group of healthy individuals and a group of patients using 
reconstructed estimates of tissue properties (237). To date, to the author’s knowledge, 
no work has been published on widefield hyperspectral/ multispectral transillumination 
of the arthritic joint. Tomographic reconstruction of tissue properties from such images 
would be inappropriate given the number of potential sources, but analysis of the 
spectroscopic data or topographic tissue property reconstruction may be able to detect 
differences in the arthritic joint (preliminary human spectral data shown in section8.A8).  
7.6 Final Conclusion 
Overall, the results of this project showed that physiological changes occurring in the 
arthritic mouse paw are detectable in the reflectance and transmittance response of 
the tissue in the range 480nm to 1000nm. This could form the basis for a method of 
arthritis assessment which could be a more accurate and less biased method of 
grading the progression of arthritis symptoms. The benefits of such a system could be 
improved animal welfare and improved experimental design and data analysis.  
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8 Appendices  
A1 Implementation of MCML modelling  
The input values for the mouse hind paw MCML model were set up for individual 
wavelengths via a Matlab script. The values were written into a mci file, a text file 
containing the input values for MCML in a format that can be read by the program. The 
data produced by MCML can then be read back into Matlab for analysis.  
A2 MCML additional outputs 
The MCML algorithm outputs several values for each wavelength model. For all 
wavelengths, the MCML program records angular distribution of photon remission in 
reflectance/transmittance, the absorption map showing where photons deposit energy 
in the tissue, and radial distribution of photon remission/transmission. Figure 66 
displays the angular and radial distribution of reflectance and transmittance and 4 
example wavelengths of the absorption maps.   
The angular distribution of both the reflectance and transmittance spectra, shown in 
Figure 66a and Figure 66b, can be seen to follow a Lambertian distribution where 
intensity is proportional to the angle from the surface normal. The graphs for radial 
distribution show decreasing reflectance and transmittance with distance from the 
radial origin of photon injection and faster attenuation of the shorter wavelengths in line 
with higher scattering properties and increased absorption. The absorbance maps, 
shown in Figure 66e, reveal the structure of the layer model and show the distribution 
of the deposition of photon weights at different wavelengths. The model also indicates 
that approximately 2% of the reflectance spectra is due to specular reflection from the 
tissue surface. This result is relatively wavelength independent.  
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Figure 66: Results of Monte Carlo MCML simulations of light propagation in the model of normal mouse tissue 
described in section 3.4.1. a) The angular emission of photons in measured in the reflectance spectra, wavelength 
is indicated by colour. b) The angular distribution of the transmittance spectra, wavelength is indicated by colour. c) 
The radial distribution in distance from the origin of photon injection of photon remission in reflectance, wavelength 
is indicated by colour. d) The radial distribution in distance from the origin of photon injection in the radial axis of 
transmittance, wavelength is indicated by colour. e) Absorbance maps of the layer model showing absorption 
distribution within the modelled tissue for different wavelengths. 
 
A3 MCML Model for Alternative Regions of the Paw 
Figure 19 includes a Monte Carlo simulation of the ‘midfoot’ region of the paw 
according to measurements made of H&E stained paw slides. Figure 67 displays the 
 168
results for MCML spectra from hind paw models made using the measurements from 
the other three anatomical areas of the paw, the heel, the joints and the toes.  
 
 
Figure 67: Reflectance and transmittance spectra from a Monte Carlo model of the heel, joints, and toes mouse 
hind paw in a ‘normal’ and ‘arthritic’ state. a and b) MCML reflectance and transmittance spectra for a hind paw 
Monte Carlo model simulating the heel region of the foot. Measurements of the tissue layers are described in section 
3.3.1.2, and changes with arthritis are described in section 3.4.1  c and d) MCML reflectance and transmittance 
spectra for a hind paw model simulating the ‘joints’ region of the foot. e and f)  MCML reflectance and transmittance 
spectra for a hind paw model simulating the toes regions of the foot. 
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A4 Tophat Diffuser vs Lambertian Diffuser 
The transillumination system set up described in section 5.3.1.2 calibrates 
transmittance data by division of the sample transmittance image by transmission of 
the diffuser in the stage floor. This method of calibration assumes the light to be an 
equivalent scatterer to the tissue. The diffuser however is a ‘tophat’ diffuser where 
100% of the light exits within a set angle to the normal (25 degrees for the diffuser 
used in the system) and within this range the intensity is equal (Figure 68b). Assuming 
the light transmitted from the tissue is Lambertian, the calibration system is likely to 
underestimate tissue transmittance since a lower percentage of light is transmitted in 
the direction of the camera. Figure 68a shows a Lambertian profile of emission and 
Figure 68b shows the emission of the diffuser, normalized by area.  
 
 
Figure 68: Difference in the detected transmittance of a Lambertian scatterer and a tophat diffuser. a) A profile of 
intensity for Lambertian light emission with angle from the normal to a surface. The profile is normalised so that the 
sum of all intensity’s is equal to 100. b) A profile of intensity for the tophat diffuser. The profile is normalised so that 
the sum of all intensity’s is equal to 100.  
 
Given the distance of the camera from the stage and the size of the lens, the camera 
accepts light emitted within approximately 8 degrees of the surface normal. The ratio 
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of light emitted within 8 degrees of the normal differs by approximately 5 times. The 
transmittance imaging system is therefore underestimating the absolute percentage of 
light transmission by a factor of around 5.  
A5  Change in the Spectral Output of the Light Source Over Time  
The Thorlabs OSL1-EC used in the multispectral system requires time for the lamp to 
warm up and the spectral output to stabilize. Figure 69 shows the difference between 
5 timepoints after the lamp is turned on from 0 minutes to 80 minutes and the spectral 
output measured at 100 minutes.  
 
Figure 69: Difference over 0 minutes to 100 minutes of the Thorlabs OSL1-EC fibre light source. Difference between 
x and 100 minutes is plotted for 5 timepoints across the wavelengths 450nm to 975nm.  
A6     TNF dARE 12 week Imaging RMS Error  
Figure 70 displays the root mean square error between the mean spectra of the normal 
group and the mean spectra of the arthritic group. Data are from the experiment 
detailed in section 6.4.1.1. In both reflectance and transmittance the raw spectra (non-
normalized) were used to calculate RMS.  
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Figure 70: Root mean squared error for the difference between the mean of the raw spectra of the normal mice and 
the TNF dARE mice in reflectance and transmittance.  
 
A7     K/BxN ST RMS Error 
Figure 70 displays the root mean square error between the mean spectra of the normal 
group and the mean spectra of the arthritic group. Data are from the experiment 
detailed in section 6.4.2.1. In both reflectance and transmittance the raw spectra (non-
normalized) were used to calculate RMS.  
 
 
Figure 71: Root mean squared error for the difference between the mean of the raw spectra of the normal mice and 
the K/BxN ST mice in reflectance and transmittance. 
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A8     Human Imaging  
The system described in chapter 5 was used to image human finger joints. The layout 
of the system is adapted for mice rather than for human fingers, but two examples of 
finger reflectance spectra and of transmission spectra are displayed in Figure 72.   
 
 
Figure 72: Reflectance spectra and transmittance spectra from human finger joints from 2 different subjects. Shaded 
area shows the standard deviation of the 20 spectra collected across the finger joint using the method described in 
section 6.3.2.  
 
The two subjects of imaging show different characteristics in both reflectance and 
transmittance. The transmittance spectra particularly show a large difference due to 
the different size of the fingers imaged. In principle, the system described in chapter 5 
could be adapted for humans and it is possible that features of rheumatoid arthritis 
would be detectable in the spectra.  
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